Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRP,Agouti-related protein,42754,0.196236002600627,0.0047991422301227,0.186829683829587,0.205642321371668,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN1,CCN family member 1,42569,0.282168858745541,0.00680507490248203,0.268830911936676,0.295506805554406,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.123545069455116,0.00307058328474249,0.117526726217021,0.129563412693212,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLR,Low-density lipoprotein receptor,42644,0.331421903019744,0.00413986327710805,0.323307770996612,0.339536035042875,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPY,Pro-neuropeptide Y,42721,0.251506861896279,0.00595351167117978,0.239837979020767,0.263175744771791,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.204469905621387,0.00274397914949072,0.199091706488385,0.209848104754389,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.114768518652912,0.00287885726387895,0.109125958415709,0.120411078890115,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0781785872215967,0.00205853783686617,0.074143853061339,0.0822133213818544,3.40849708370492e-297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.190921347523637,0.00556735826482923,-0.201833369722702,-0.180009325324572,4.81499396606231e-247
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFGE8,Lactadherin,42611,0.140786903497247,0.00411468475572154,0.132722121376033,0.148851685618462,4.49966156290212e-246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROC,Vitamin K-dependent protein C,42663,0.0809107498900443,0.00237044507393333,0.076264677545135,0.0855568222349537,5.54031901363669e-245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F7,Coagulation factor VII,42671,0.0943941562984743,0.00293890293171357,0.0886339065523157,0.100154406044633,3.60770717612771e-218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APCS,Serum amyloid P-component,40419,0.103420506950697,0.00322979155140183,0.0970901155099489,0.109750898391444,2.27074778444607e-215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.223869778543521,0.0071128989923049,0.209928496518603,0.237811060568438,1.72028093508269e-208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHR,Growth hormone receptor,40283,0.0837236377365296,0.00268160981265521,0.0784676825037254,0.0889795929693338,3.52458405588699e-205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.12417126991366,0.00401379824508726,0.116304225353289,0.132038314474031,4.4157573552532e-203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP1,Neuropilin-1,42705,-0.0815485880563358,0.00264089339054171,-0.0867247391017975,-0.076372437010874,2.24665814683642e-202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOM,Apolipoprotein M,42663,0.0785272744387406,0.00269607262595971,0.0732429720918595,0.0838115767856216,6.32773343765649e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0705178578708244,0.00243908737409341,0.0657372466176013,0.0752984691240474,2.08486570338194e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0856453433654705,0.00300459847879724,0.0797563303470279,0.0915343563839131,1.36446521353429e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL23,C-C motif chemokine 23,42676,0.112270361797352,0.00400857400885099,0.104413556740004,0.1201271668547,7.98300774246686e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.0871150110506583,0.00313577359151536,0.0809688948112882,0.0932611272900285,3.0559570612891e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFP,Properdin,40539,0.0592226258155582,0.00213062184374017,0.0550466070018275,0.063398644629289,1.46772483850258e-164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL27,C-C motif chemokine 27,42636,0.154164627013286,0.00564357209031514,0.143103225716268,0.165226028310304,5.98305291385299e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTR,Transthyretin,40424,0.0658646371460161,0.0024156506609423,0.0611299618505692,0.070599312441463,1.46540696186515e-158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0491885177223601,0.00181462531653992,0.0456318521019419,0.0527451833427784,1.40964234665405e-157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOC1,Apolipoprotein C-I,40516,0.0955576957220565,0.00353304186057123,0.0886329336753369,0.102482457768776,3.5762340614791e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FURIN,Furin,42679,0.0838200924598249,0.00312258800174601,0.0776998199764027,0.0899403649432471,1.13361420542863e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES1,Liver carboxylesterase 1,42661,0.207893522117187,0.00775652995946475,0.192690723396636,0.223096320837738,3.24381273637278e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLKB1,Plasma kallikrein,40293,0.0628811123524379,0.00236001727136536,0.0582554785005618,0.067506746204314,1.15158611137657e-151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.206408524833728,0.00778140804032622,0.191156965074688,0.221660084592767,4.43065150375472e-151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.215181565552824,0.00828690393899627,0.198939233832392,0.231423897273257,4.47488460705609e-145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCHE,Cholinesterase,40346,0.0695171355626022,0.00267133740075153,0.0642813142571292,0.0747529568680752,5.43984729418579e-145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPL,Lipoprotein lipase,42636,-0.115413911811558,0.00447584676817077,-0.124186571477173,-0.106641252145943,3.74508381841407e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.0848038328954487,0.00330936008460502,0.0783174871296228,0.0912901786612745,1.83310538245609e-141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.0654127106974519,0.00257095389807318,0.0603736410572284,0.0704517803376753,1.66953857021966e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN3,Contactin-3,42611,0.0759883568445811,0.00299882905866639,0.0701106518895949,0.0818660617995672,2.06369732446462e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.192269798721749,0.00761841729105704,0.177337700831278,0.207201896612221,2.45176716202032e-137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.251516903828428,0.0100266016916019,0.231864764512888,0.271169043143967,9.62939910453227e-136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA4,Kallistatin,40342,0.0578032111165772,0.0023161326044072,0.0532635912119391,0.0623428310212153,8.14274165050774e-134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH,Parathyroid hormone,40182,0.196248931851454,0.00786424991986004,0.180835002008528,0.21166286169438,9.65669193903029e-134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0757007282210117,0.0030531106468919,0.0697166313531036,0.0816848250889199,9.36829186201734e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCA,Alpha-synuclein,40283,0.273029369645319,0.0110478654973318,0.251375553270549,0.29468318602009,2.63711662655613e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.125738755990474,0.00518621774548016,0.115573769209333,0.135903742771615,4.02657589674297e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.10966475988637,0.00452648000919278,0.100792859068352,0.118536660704388,5.74148325982667e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,P4HB,Protein disulfide-isomerase,42563,0.0885833106356933,0.00368163104307822,0.08136731379126,0.0957993074801266,2.9014454407468e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.129356218456396,0.00538011854792251,0.118811186102468,0.139901250810324,1.2664474458918e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYAP1,Synapse-associated protein 1,40283,0.131420395307663,0.00550317913283528,0.120634164207306,0.14220662640802,5.96590011784206e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.344076870901288,0.0144392469407893,0.315775946897341,0.372377794905235,6.1972351272872e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.260055362107494,0.0109514508307522,0.23859051847922,0.281520205735768,3.90700613059063e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0451979901716409,0.00190710698779479,0.0414600604755631,0.0489359198677187,1.3227669228252e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0562497784772756,0.00237935354973474,0.0515862455197955,0.0609133114347557,4.19895949238918e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBC,Inhibin beta C chain,42611,0.0924635719071878,0.00395442307024685,0.084712902689504,0.100214241124872,1.49472975176796e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0589423363020211,0.00252029845477482,0.0540025513306625,0.0638821212733797,3.52401410618393e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0804048258579719,0.00344893632314518,0.0736449106646073,0.0871647410513364,6.99708499801526e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.17146140286286,0.0073766928503178,0.157003084876237,0.185919720849482,3.18002510275046e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0302021116632168,0.00130550865847024,0.0276433146926152,0.0327609086338185,1.09530106013611e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0821889126734855,0.00356488343199432,0.0752017411467766,0.0891760842001943,5.76580838661804e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0886008098832261,0.0038571327678395,-0.0961607901081915,-0.0810408296582607,1.45254545433872e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRN,"Attractin, Isoform 2",40539,0.0366904156900856,0.0016177715596414,0.0335195834331884,0.0398612479469827,2.09049471472204e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG2,Desmoglein-2,42611,-0.0591995432139921,0.0026301006555536,-0.0643545404988772,-0.0540445459291071,3.71049722591722e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFH,Complement factor H,39956,0.0495168630197627,0.00220926962436363,0.04518669455601,0.0538470314835154,8.81748635091953e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUSB,Beta-glucuronidase,42711,0.12863063242791,0.00586391000869177,0.117137368810874,0.140123896044946,7.86679876692389e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.153449038530769,0.00704528161316857,0.139640286568959,0.16725779049258,2.2565421724152e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.120570753625921,0.00555192324651427,0.109688984062753,0.131452523189088,1.74841571112412e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR5,Cadherin-related family member 5,42636,0.0810157691124696,0.00374803625867538,0.0736696180454658,0.0883619201794733,6.90601049640269e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.286957185244439,0.0133428048479759,0.260805287742406,0.313109082746471,1.40914347123798e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUMB,Protein numb homolog,40199,0.170551071349013,0.00794421729289098,0.154980405454946,0.186121737243079,3.41975750714357e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.10721268997404,0.00501081021417507,0.0973915019542572,0.117033877993824,6.51756766211332e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.226980339982978,0.0106070242110799,0.206190572529262,0.247770107436695,6.82204732067417e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F10,Coagulation factor X,40532,0.0583893901058731,0.00274362754211064,0.0530118801233363,0.06376690008841,1.39832848406507e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0523518594463127,0.00246580077050706,0.0475188899361188,0.0571848289565065,2.05359246489228e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.142973191886549,0.00673438146740459,0.129773804210436,0.156172579562662,2.07928054588323e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADIPOQ,Adiponectin,40539,-0.142044860735131,0.0066934959771151,-0.155164112850276,-0.128925608619985,4.8149915143148e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.236257122001584,0.0111864590562563,-0.258182581751846,-0.214331662251322,1.98139606144773e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB2,Carboxypeptidase B2,40516,0.045203809531541,0.0021503254784455,0.0409891715937878,0.0494184474692942,2.82324788298776e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.140483819732391,0.00668390987146501,0.127383356384319,0.153584283080462,3.11226091293545e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF9,Protein turtle homolog A,40511,0.16784553958352,0.00802434776133877,0.152117817971296,0.183573261195744,2.35744976571338e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.170380742692698,0.0081653934502313,0.154376571530245,0.186384913855152,7.35772473477799e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.24739049210615,0.0119139345562489,0.224039180375903,0.270741803836398,2.73624447576111e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFM,Afamin,40539,0.0399304113061133,0.00193156392982813,0.0361445460036501,0.0437162766085764,3.15940665056099e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCG,Pro-glucagon,42346,0.251849185577714,0.0122295077012127,0.227879350483337,0.275819020672091,9.04935910692069e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN2,Ficolin-2,42597,0.0816952512347409,0.00397917664300476,0.0738960650144515,0.0894944374550302,2.98821206467412e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.0797072923054985,0.00388383877587631,0.072094968304781,0.0873196163062161,3.46139997404377e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.123085307990914,0.00600632286924133,-0.134857700814627,-0.111312915167201,6.12825774420315e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORT1,Sortilin,42613,0.0731481843929433,0.00357864480979128,0.0661340405657524,0.0801623282201342,1.80448663969342e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0614167990953762,0.00300528138674766,0.0555264475773508,0.0673071506134016,1.96970270304656e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO3,Beta-enolase,40223,0.116681302177183,0.00570939258888465,0.105490892702969,0.127871711651397,3.80159435808125e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0379437735808488,0.00187077479508335,0.0342770549824854,0.0416104921792121,3.97110296488607e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFI,Complement factor I,40539,0.0384778410062375,0.00189669752056467,0.0347603138659308,0.0421953681465443,6.55701150162519e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.236457074989896,0.0116588594753396,0.21360571041823,0.259308439561562,8.1921229815719e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FN1,Fibronectin,40539,0.0521495961375437,0.00258440945542593,0.0470841536049089,0.0572150386701785,5.45451727684144e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.114416371945475,0.00572153956956696,0.103202154389124,0.125630589501826,1.15715152207449e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJAP1,Tight junction-associated protein 1,42679,0.159184461068251,0.00796233595041957,0.143578282605428,0.174790639531073,1.19314636879981e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0454805697758692,0.00227736018671605,0.0410169438099058,0.0499441957418327,1.89132232027169e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR3,Anterior gradient protein 3,42326,0.114653396092655,0.00580097979183408,0.10328347570066,0.126023316484649,1.0547821189328e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTD,Biotinidase,40539,0.0395377513747553,0.0019983210384371,0.0356210421394185,0.043454460610092,1.09624270264954e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0450797275176341,0.00228600220509121,0.0405991631956553,0.0495602918396129,2.31076143377633e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0418016630520771,0.00212222718623601,0.0376420977670545,0.0459612283370997,3.75462737128548e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EEF1D,Elongation factor 1-delta,40511,0.173755301377675,0.00885194524336869,0.156405488700673,0.191105114054678,2.19356696118507e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIP2,Cysteine-rich protein 2,42495,0.0696857001884452,0.00355678915612515,0.0627143934424399,0.0766570069344505,2.76195815160264e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.172769133460368,0.00882726523975915,0.15546769359044,0.190070573330295,3.90747785322898e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.07093511649665,0.00364002540204661,-0.0780695662846614,-0.0638006667086387,1.95602289560095e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAT,Tissue-type plasminogen activator,42760,0.0952502894869942,0.00489693382341648,0.0856522991930979,0.104848279780891,3.86132627112346e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTYMK,Thymidylate kinase,40511,0.12774559534525,0.0065840832605094,0.114840792154652,0.140650398535849,1.6078145013637e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREG1,Protein CREG1,42445,0.0724318670918944,0.00373992803342449,0.0651016081463824,0.0797621260374064,2.00434802459422e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.180060701617326,0.00935000243749552,0.161734696839834,0.198386706394817,1.52867817007832e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.126443506216721,0.00658008242165299,0.113546544670282,0.139340467763161,3.50473864344254e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0741577459938581,0.00387110134753885,0.0665703873526819,0.0817451046350342,1.60049530620978e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.076666622793253,0.00401191499437119,-0.0845299761822205,-0.0688032694042854,2.43816497624521e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRP,Gastrin-releasing peptide,40223,0.103951107026151,0.00544575581353478,0.0932774256316227,0.114624788420679,6.08302067544443e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.208954895413476,0.0109720042922091,0.187449767000747,0.230460023826206,8.27173995296075e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FYB1,FYN-binding protein 1,42590,0.168650811910534,0.00890740693088877,0.151192294325992,0.186109329495076,6.42660520200942e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLTP,Phospholipid transfer protein,42752,-0.0658437438912563,0.00347978894237397,-0.0726641302183093,-0.0590233575642033,7.80430242513038e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPIND1,Heparin cofactor 2,40516,0.051641498058163,0.00272983985911091,0.0462910119343056,0.0569919841820204,1.32846266773365e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.199153314541351,0.0105319479629739,0.178510696533922,0.219795932548779,1.5603579852293e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.14458742822825,0.00765623695703572,0.12958120379246,0.15959365266404,2.45128644886129e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0395714767005951,0.00210013837791944,0.035455205479873,0.0436877479213172,5.57727485705864e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.204228864574524,0.0108423343231586,0.182977889301133,0.225479839847915,6.2040825986739e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0765375185406624,0.00409438492672235,0.0685125240842866,0.0845625129970382,5.33811340066904e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH9,Myosin-9,40527,0.20775282511721,0.0111085636230537,0.185980040416025,0.229525609818395,6.80857685911269e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS1,Protein MTSS 1,40449,0.200707965269627,0.010830923005832,0.179479356178196,0.221936574361057,1.5354160091781e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR37,Prosaposin receptor GPR37,42357,0.122745533321585,0.00663549876754239,0.109739955737202,0.135751110905968,1.92055985465398e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0360179871339759,0.00194742276776754,0.0322010385091515,0.0398349357588003,1.95749869080823e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRL,Appetite-regulating hormone,42636,0.152039145310716,0.00826090573061968,0.135847770078701,0.16823052054273,9.95465973626784e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0484388078764174,0.00263186110362169,0.0432803601133189,0.0535972556395159,1.00175145284689e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZN,Kazrin,40449,0.1852186617881,0.0101057932509299,0.165411307016278,0.205026016559923,5.86625253502606e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.157535257007641,0.00864389589642673,0.140593221050645,0.174477292964638,2.55070958371344e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F13B,Coagulation factor XIII B chain,40479,0.0459956135943265,0.00252170192297272,0.0410530778253,0.050938149363353,2.79711287232834e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1S,Complement C1s subcomponent,40539,0.0368967111400041,0.00202515653999826,0.0329274043216075,0.0408660179584007,3.99118676395392e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXIN1,Axin-1,42594,0.16688848122158,0.00918600583079008,0.148883909793231,0.184893052649928,6.95687481120686e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAB2,Stabilin-2,40527,0.0494116146702763,0.00272653530656905,0.044067605469401,0.0547556238711517,2.21768702403125e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.16987950765164,0.00940043814023981,0.15145464889677,0.18830436640651,3.83995605379465e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0445398286027006,0.00246544954850309,-0.0493721097177667,-0.0397075474876346,4.17909065095479e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9,Complement component C9,40532,-0.0933079505119626,0.00515938249396311,-0.10342034020013,-0.0831955608237949,4.28601451786755e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.116938848480035,0.00648038411974803,0.104237295605329,0.129640401354741,6.12407980791901e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA3,Glutathione S-transferase A3,42346,0.133482185167732,0.00741310471976234,0.118952499916997,0.148011870418466,1.2581602279309e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.0932449887960352,0.00519317977533288,0.0830663564363828,0.103423621155688,3.02006198696227e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES3,Carboxylesterase 3,42587,0.122687681378377,0.0068429373330707,0.109275524205558,0.136099838551196,4.72257592965617e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.18392364049443,0.0102673233566309,0.163799686715433,0.204047594273426,6.20449461693716e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.141520847133062,0.00789998172643296,0.126036882949254,0.157004811316871,6.35248677285146e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.168907618364932,0.00943801992290426,0.15040909931604,0.187406137413824,1.18382310585959e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0593218284521708,0.0033190788965563,-0.0658272230894211,-0.0528164338149204,1.22827342892197e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHBP1,EH domain-binding protein 1,40511,0.128782655139956,0.00720810609167584,0.114654767200271,0.14291054307964,1.99163901807534e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0755263565739309,0.00423354260658736,0.0672286130650197,0.0838241000828421,2.25029293080796e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEFTY2,Left-right determination factor 2,42689,0.0865932458707209,0.00486030301024304,0.0770670519706445,0.0961194397707972,3.3493800539989e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.142863315470448,0.00808960948010787,0.127007680889436,0.158718950051459,7.4261185961657e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS2,Protein MTSS 2,40451,0.168919236818078,0.00956743041449688,0.150167073205664,0.187671400430492,7.76714033476727e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOMO1,Nodal modulator 1,42611,0.0396149867676428,0.00224961954655864,0.0352057324563879,0.0440242410788977,1.22718372699524e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0487409664913192,0.00277511402697954,0.0433017429984393,0.0541801899841991,2.811498434163e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.138173447992688,0.00787269667833302,0.122742962503155,0.15360393348222,3.3272266985909e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.102984752009618,0.00587016343189691,0.0914792316831001,0.114490272336136,3.8281096658366e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.209865749685205,0.0119846163138545,0.18637590171005,0.23335559766036,6.62362111840065e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.137052758496003,0.00782129303274048,0.121723024151831,0.152382492840174,7.55666952031801e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.180731542187885,0.0103671565171911,0.16041191541419,0.201051168961579,3.48089655886081e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.181298371820615,0.010414188134296,0.160886563077394,0.201710180563835,5.29001805288986e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.174787824953886,0.0100642596616911,0.155061876016971,0.1945137738908,7.87255264695089e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0512853262837693,0.00295222572430733,0.0454989638641269,0.0570716887034116,9.98484949168871e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPD52L2,Tumor protein D54,40283,0.180487667945323,0.0104118819076126,0.160080379406403,0.200894956484244,1.92431324085909e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.142738990702069,0.00824552970752979,0.126577752475311,0.158900228928828,2.10275950311756e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAB2,Disabled homolog 2,42721,0.183069514321504,0.0105954496404738,0.162302433026176,0.203836595616833,3.52336990392125e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOST,Sclerostin,42613,0.0652573226633253,0.0037930770717189,0.0578228916027563,0.0726917537238944,1.24462379508983e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLN,Promotilin,42594,0.148243734926541,0.00864379823578215,0.131301890384408,0.165185579468674,3.10223716516521e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0492684744315759,0.00287436006787826,0.0436347286985345,0.0549022201646173,4.87106090036338e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.119753988548474,0.00699675967603246,0.10604033958345,0.133467637513498,5.72471458237183e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINK1,Misshapen-like kinase 1,40483,0.154235470308931,0.00900449311959394,0.136586663794527,0.171884276823336,5.9787015465853e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL16,Pro-interleukin-16,42754,0.068700393378381,0.00401837637440518,0.0608243756845468,0.0765764110722151,7.51848724453439e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.129716298722553,0.00759064748515743,0.114838629651645,0.144593967793462,8.99586160486372e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.109400706505823,0.00641087347210773,0.0968353945004918,0.121966018511154,1.34162561708293e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXLNA,Alpha-taxilin,42495,0.145356361646315,0.00853262024525801,0.128632425965609,0.16208029732702,2.15986210014202e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A4,Protein S100-A4,42679,0.0942183984454553,0.00553302325666577,0.0833736728623903,0.10506312402852,2.37729576715208e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH1,Somatotropin,42613,-0.284015911920789,0.0167151403399774,-0.316777586987144,-0.251254236854433,4.43258692368298e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.11260898502407,0.00662373070195641,0.0996264728482354,0.125591497199904,5.36974612996432e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.146060037846009,0.00861966244871972,0.129165499446518,0.1629545762455,1.27807078981159e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.0440652640464388,0.00260031416200187,0.0389686482889152,0.0491618798039625,1.2806433636032e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.138552136479087,0.00818155579515352,0.122516287120586,0.154587985837588,1.5804894096461e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS15,Enteropeptidase,42587,0.150093285023803,0.00887673108615453,0.13269489209494,0.167491677952665,1.76826902811113e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F9,Coagulation factor IX,42663,0.0296794089630556,0.00175716656435498,0.0262353624969198,0.0331234554291913,2.36936157204472e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC5,Glypican-5,42495,0.0927514580063034,0.00549200302763839,0.0819871320721322,0.103515783940475,2.49696526091868e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.138124297273822,0.00820568281907876,0.122041158948428,0.154207435599216,8.21222178233745e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.136678637806887,0.00812850867704245,0.120746760799884,0.152610514813891,1.09966760722116e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.168031434974253,0.0100086952590807,0.148414392266455,0.187648477682051,1.28134531391125e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.111049946915,0.00660688081132643,0.0981004605248006,0.1239994333052,1.29648802557972e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPM,Carboxypeptidase M,42655,0.0551049164104454,0.00328283652163086,0.0486705568280489,0.0615392759928419,1.34183038776619e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.147996766447839,0.00884403902035963,0.130662449967934,0.165331082927744,3.16513994193915e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R9B,Neurabin-2,42754,0.152218765510612,0.0090986165432381,0.134385477085866,0.170052053935359,3.33411170431676e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKB,Creatine kinase B-type,40527,-0.09832199461932,0.00587956706472198,-0.109845946066175,-0.0867980431724649,4.9526669171635e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN1,Dynactin subunit 1,42721,0.104974913885038,0.00628463274177753,0.0926570337111544,0.117292794058922,5.1677293717218e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.101601741327197,0.00608607210154038,-0.113530442646216,-0.0896730400081776,6.11354462919097e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARF6,ADP-ribosylation factor 6,40449,0.173983715599941,0.0104168767312768,0.153566637206638,0.194400793993243,7.01494647197968e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNA4,Plexin-A4,42594,0.132892829356655,0.007971079793049,0.117269512962279,0.148516145751031,8.78902199584377e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0727806742807626,0.00436811111474729,-0.0813421720656673,-0.0642191764958579,1.34807379805638e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.166021994975056,0.00996354653890268,0.146493443758807,0.185550546191306,1.37633897244288e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.119435776945348,0.00718092232438459,0.105361169189554,0.133510384701142,1.69907301595002e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.183144867030588,0.0110197509410331,0.161546155186163,0.204743578875013,2.06229164076703e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL22,C-C motif chemokine 22,42509,0.0856462770235719,0.00515740544587039,0.075537762349666,0.0957547916974779,2.58547615472927e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.101313216507311,0.00610184151195774,0.0893536071438742,0.113272825870749,2.64844235042453e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THPO,Thrombopoietin,42357,0.0630404659354987,0.00379819565160777,0.0555960024583475,0.0704849294126499,3.0427484031616e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BECN1,Beclin-1,40223,0.0968900980432814,0.0058320742188412,0.0854592325743527,0.10832096351221,3.08872986179166e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBIN,Erbin,42587,0.164201417340486,0.00989869244698765,0.14479998014439,0.183602854536582,3.45561993866815e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.092703611342417,0.00559972267500213,0.0817281548994129,0.103679067785421,5.98868968846466e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP10,Stromelysin-2,42608,-0.0946887394332897,0.00572431431938756,-0.105908395499289,-0.0834690833672901,7.37830230859827e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0442389560843411,0.00268052052635891,0.0389851358526776,0.0494927763160045,1.36200665731799e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.168902312577053,0.0102399651838981,0.148831980816613,0.188972644337493,2.09790918082318e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2,Prothrombin,40539,0.0239279169931494,0.00145211044356014,0.0210817805237715,0.0267740534625273,2.64297365465804e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.045198053820341,0.00274710616492329,0.0398137257370913,0.0505823819035906,3.05934987746733e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.181389284457095,0.0110414722276966,0.15974799889081,0.203030570023381,5.99583912482537e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.102099346967197,0.00622044265378232,0.0899072793657838,0.114291414568611,6.03101965646324e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.115721481856908,0.0070456444306518,0.101912018772831,0.129530944940986,6.54902305316592e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.09146406186015,0.00557016687985825,0.0805465347756278,0.102381588944672,7.00651897825877e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.0759547497074312,0.00463012722331534,0.0668797003497332,0.0850297990651293,8.71749854781995e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD63,CD63 antigen,42475,0.081394532718888,0.00497620303192398,0.071641174776317,0.091147890661459,1.4861707700788e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.176224850184657,0.0108075838521243,0.155041985834493,0.197407714534821,3.33865968472373e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.107887245561157,0.00662643013366721,0.0948994424991691,0.120875048623145,5.03969096624222e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0661728475293477,0.00406451267805508,0.0582064026803598,0.0741392923783357,5.05341341029311e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0523193508591663,0.00321521568381092,0.0460175281188969,0.0586211735994357,5.69497158923946e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON2,Spondin-2,42562,-0.0569445056060549,0.00350172363244789,-0.0638078839256527,-0.050081127286457,6.75909884216382e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.114965434322202,0.00707490658265623,0.101098617420196,0.128832251224208,8.11675704250172e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.179058637830403,0.0110233544270966,0.157452863153293,0.200664412507512,1.14532503096666e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.0876500919168213,0.00540194360963628,0.0770622824419342,0.0982379013917084,1.19237037766991e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.16408521155474,0.0101581083706239,0.144175319148317,0.183995103961163,3.79027039551311e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLA,Alpha-galactosidase A,40267,0.0587154672558737,0.00363225110949936,0.051596255081255,0.0658346794304925,4.10728488583454e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.0972178971003926,0.0060242101447446,0.0854104452166932,0.109025348984092,6.13868753031021e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.118353459137449,0.00733417273094723,0.103978480584793,0.132728437690106,6.19779783884124e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0623517166998628,0.00387592364581301,0.0547549063540693,0.0699485270456563,1.09292129329791e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.17049538672012,0.0105959061297029,0.149727410705902,0.191263362734338,1.3068754592764e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.103043949113339,0.00641604849418799,-0.115619404161947,-0.0904684940647304,2.0758257709853e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0624262249579505,0.00389010929194374,0.0548016107457407,0.0700508391701602,2.57161159729251e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HJV,Hemojuvelin,40482,0.0689510071663818,0.00429737050579055,0.0605281609750323,0.0773738533577312,2.66331669974207e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.169666833243873,0.0105830190257322,0.148924115953438,0.190409550534309,3.2788406743329e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.212943802916929,0.0133050164386803,0.186865970697115,0.239021635136742,4.00374007509737e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCR,Breakpoint cluster region protein,42594,0.141886129332538,0.0088654354542563,0.124509875842196,0.15926238282288,4.02388580178285e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMIP,C-Maf-inducing protein,40451,0.129038079931905,0.00805573628742416,0.113248836808554,0.144827323055256,4.07434163491492e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK1,Dickkopf-related protein 1,42711,0.0913931646941289,0.00571339879570272,0.0801949030545516,0.102591426333706,4.52676284801196e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.128304707282708,0.00801663031293321,0.112592111869359,0.144017302696057,5.13454255608385e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLA2,Src-like-adapter 2,40482,0.161433361832705,0.0100960994187803,0.141645006971895,0.181221716693514,6.34875975303887e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.114782472834263,0.00718096801491393,0.100707775525032,0.128857170143494,7.2471019705131e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK2,Docking protein 2,42636,0.186431827802594,0.0117001003657778,0.163499631085669,0.209364024519518,1.20986957845476e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM1,Isthmin-1,42594,0.0597800176135781,0.00375266732841118,0.0524247896498922,0.067135245577264,1.29711133562192e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.147994638198288,0.00929241861531097,0.129781497712278,0.166207778684297,1.36280262964728e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.111300658978458,0.007007663964236,0.0975656376085551,0.12503568034836,3.38513562692984e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.0594954435371272,0.00375132463677564,-0.0668480398252075,-0.0521428472490469,3.88640647219864e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.185725679308251,0.011717597852459,-0.208692171099071,-0.162759187517431,4.46154427978542e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYNU,Kynureninase,42754,0.0686287393923526,0.00433103785427356,0.0601399051979764,0.0771175735867288,4.78202226276986e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.143524074393638,0.00906065476564054,0.125765191052982,0.161282957734293,5.26493286368013e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0539422217605861,0.0034139804881161,0.0472508200038786,0.0606336235172937,1.00460111525797e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.114551420831823,0.00725339330888295,0.100334769946413,0.128768071717234,1.41461378495902e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.146183651632612,0.00926939544180384,0.128015636566676,0.164351666698547,1.54981646172329e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.0977387037420611,0.00619263844519277,0.0856011323894832,0.109876275094639,1.66792381422105e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.148989053653536,0.0094428577744324,0.130481052415649,0.167497054891424,1.78581812677127e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AAMDC,Mth938 domain-containing protein,40223,0.0815467455060823,0.00518241328720814,0.0713892154631543,0.0917042755490102,3.44583292533576e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPHN1,Oligophrenin-1,40483,0.163440877664045,0.0104018255553862,0.143053299575488,0.183828455752602,4.73300245651433e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.063588596777468,0.00404879365783357,0.0556529612081142,0.0715242323468218,5.25780203523558e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.15693989244729,0.00999839296943245,0.137343042227203,0.176536742667378,6.10129541176668e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP20,Centrosomal protein 20,42346,0.114090252070505,0.00727966475897474,0.0998221091429146,0.128358394998096,7.31139215823589e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCTN3,Tectonic-3,40511,0.0457586085084784,0.00292651939788577,0.0400226304886223,0.0514945865283345,1.54134601398319e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.0922894377273149,0.00591844669315048,0.08068928220874,0.10388959324589,2.47492789372928e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.126793729539632,0.00815191928499859,0.110815967741035,0.142771491338229,5.62599145396678e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0748781448414513,0.00482610653235726,0.0654189760380311,0.0843373136448715,8.19887701405976e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.167802265540512,0.0108088020697495,0.146617013483803,0.188987517597221,8.69185914876134e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USO1,General vesicular transport factor p115,42587,0.135578629165044,0.00874695690610061,0.118434593629087,0.152722664701001,1.01354347662481e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.14319165956848,0.00924953793634076,0.125062565213253,0.161320753923708,1.658683470344e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN2,Prorelaxin H2,40257,0.0753436847486045,0.00487230009075308,0.0657939765707284,0.0848933929264805,2.20430960493761e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO1,Forkhead box protein O1,42594,0.127576870317823,0.00826167679340469,0.11138398380275,0.143769756832896,2.45815195861265e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD6,T-cell differentiation antigen CD6,42746,0.0790668450814063,0.0051458480548089,0.0689809828939809,0.0891527072688317,7.81234302672407e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF21,Fibroblast growth factor 21,42689,0.175161041980996,0.0114239873566428,0.152770026761976,0.197552057200016,1.28237010266432e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHBG,Sex hormone-binding globulin,40532,-0.0753620742428096,0.00492959321675606,-0.0850240769476514,-0.0657000715379677,3.06166171478627e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINC1,Antithrombin-III,40516,0.0219596230852573,0.00143914023531919,0.0191389082240317,0.024780337946483,4.73042123303943e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REN,Renin,42636,-0.127134101134788,0.00836432098256846,-0.143528170260622,-0.110740032008954,9.57849852037908e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.144899122188782,0.00954286363433867,0.126195109465478,0.163603134912086,1.19911874771357e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0601227087024654,0.00396037571378285,0.052360372303451,0.0678850451014797,1.25367528831567e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.15916848122946,0.0104792605074868,0.138629130634786,0.179707831824134,1.35369515464863e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.164436729541118,0.0108404258062129,0.14318949496094,0.185683964121295,1.53620900687683e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.102207973881556,0.00673641327900829,0.0890046038547001,0.115411343908413,1.73047436481709e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.136659886344901,0.00901651930334837,0.118987508510338,0.154332264179464,1.8612914428076e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.132633084488949,0.00875884303284073,0.115465752144581,0.149800416833317,2.69523178628891e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0302701537849537,0.0020006894024338,0.0263488025561835,0.034191505013724,2.73135476812334e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11,Coagulation factor XI,40383,0.044547400569377,0.00294863750404221,0.0387680710614543,0.0503267300772998,4.58277570170535e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.132921499022995,0.00880083656231242,0.115671859360863,0.150171138685128,4.86801199895303e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL16,C-C motif chemokine 16,42794,0.0767649777690413,0.00509398884861945,0.0667807596257472,0.0867491959123354,6.59733794213062e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN1,Perilipin-1,42311,0.051349279641473,0.00340881929667508,0.0446679938199898,0.0580305654629561,7.47292361935353e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2AP,CD2-associated protein,42636,0.0932260412980317,0.00620129720356379,0.0810714987790467,0.105380583817017,1.14603730026037e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0458132131476819,0.0030453388304045,-0.0517820772552747,-0.0398443490400891,1.19809932153545e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IST1,IST1 homolog,40375,0.144610386375154,0.00961737015503095,0.125760340871293,0.163460431879014,1.32326008928004e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILPL2,RILP-like protein 2,40511,0.141984809480432,0.00944470559840391,0.12347318650756,0.160496432453303,1.36694320133489e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH2,Neutral ceramidase,42495,0.0784866408298853,0.00523267674392666,0.068230594411789,0.0887426872479815,1.91602866396293e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0635205983955879,0.00423370611645574,0.0552225344073347,0.0718186623838412,2.20774657431003e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK10,Kallikrein-10,42636,0.0594097606318387,0.00396591377840523,0.0516365696261644,0.0671829516375129,2.52249910129954e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.168123178555033,0.0112333880106933,0.146105738054074,0.190140619055992,3.10015370735035e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEG1,Protein HEG homolog 1,40283,0.0394404909980298,0.00263386446434823,0.0342781166479072,0.0446028653481523,3.33727266769808e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.12623314460299,0.0084385296041529,0.10969362657885,0.14277266262713,3.43887540456347e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL17,C-C motif chemokine 17,42604,0.133430004723115,0.00892476178372426,0.115937471627016,0.150922537819215,3.91338952781593e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0375119093235938,0.00251170525458319,0.0325889670246107,0.0424348516225769,6.00981070338833e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2B3,SH2B adapter protein 3,42346,0.141259156869982,0.00947931776568558,0.122679694049238,0.159838619690725,8.17099172413017e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.113435087624858,0.00761740324495839,0.0985049772647392,0.128365197984976,1.12773434040358e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11R,Junctional adhesion molecule A,42611,0.0802831375785478,0.00541124318426362,0.0696771009373911,0.0908891742197045,2.0995517740317e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.128388135722813,0.00866196573302946,0.111410682886075,0.145365588559551,3.06968507434534e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D23,TBC1 domain family member 23,42587,0.128926352700746,0.00870911678111016,0.11185648380977,0.145996221591722,3.39731945313214e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.0800472269140956,0.00540804732092835,0.0694474541650761,0.0906469996631152,3.55817679210391e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0322844440119406,0.00218236948270162,0.0280069998258455,0.0365618881980358,3.92650625773409e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPY30,Protein dpy-30 homolog,42651,0.0868127628386137,0.00587678108554638,0.0752942719109428,0.0983312537662846,5.35716611362547e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0386844282953689,0.0026176249291626,0.0335538834342102,0.0438149731565276,5.83395974872196e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.107093583096357,0.00726274192240201,0.0928586089284493,0.121328557264265,9.49385065521491e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAXX,Protein PAXX,40283,0.0653826933834802,0.00443628779617956,0.0566875693029683,0.0740778174639922,1.05801833143456e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.167482234586021,0.011377081445185,0.145183154953458,0.189781314218584,1.33204200506533e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC1,Stanniocalcin-1,42711,0.0648334943584739,0.00441114587093399,0.0561876484514433,0.0734793402655045,1.57999379568687e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR2,Cadherin-related family member 2,42587,0.101153267677933,0.00688343847143082,0.0876617282739281,0.114644807081937,1.65114380619784e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.10962636314183,0.00746312063672896,0.0949986466938409,0.124254079589818,1.8037870035167e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.129697985640398,0.00882561438472971,0.112399781446328,0.146996189834468,1.91968397263666e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCC,Tubulin-specific chaperone C,42495,0.11485776690301,0.00782312658538606,0.0995244387956528,0.130191095010366,2.01605411461415e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MITD1,MIT domain-containing protein 1,42495,0.137104547430364,0.00934050422929218,0.118797159140951,0.155411935719777,2.11583302441857e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0786807389416016,0.00536802858259013,0.068159402919725,0.0892020749634783,3.35192525572208e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX15,Sorting nexin-15,40283,0.0775966447253733,0.00529495130454296,0.0672185401684691,0.0879747492822775,3.53598820120676e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELP,P-selectin,42689,0.0797191547740402,0.00545579347730338,0.0690257995585256,0.0904125099895548,5.48748599911803e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0346145168288699,0.00236909253523575,0.0299710954598078,0.039257938197932,5.59114461327908e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.0937797839613036,0.00642608577693917,0.0811846558385028,0.106374912084104,8.39616241519039e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BID,BH3-interacting domain death agonist,42594,0.095516719972144,0.00655269575334527,0.0826734362955873,0.108360003648701,9.16504114565517e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.13478797842924,0.00924684481638268,0.116664162589129,0.15291179426935,9.23007150859372e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0417968496481278,0.00286575502122095,0.0361799698065348,0.0474137294897209,9.53966308424269e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.070031185361396,0.00481000574236066,0.0606035741063691,0.0794587966164229,1.19233375866578e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0538229069515705,0.00369817580865177,0.046574482366613,0.061071331536528,1.27337342303459e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.147538672633517,0.0101392455835633,0.127665751289733,0.167411593977301,1.31585394056685e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPK2,SRSF protein kinase 2,42594,0.118026411217001,0.00812573365369052,0.102099973255768,0.133952849178235,1.9284402636931e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINH1,Serpin H1,40302,0.182913003013094,0.0125841159561751,0.158248135738991,0.207577870287197,1.97280063555774e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0616896149270233,0.00424532504536516,0.0533687778381076,0.070010452015939,2.06934764089566e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BACH1,Transcription regulator protein BACH1,42594,0.103294709599777,0.00712000052794054,0.0893395085650131,0.11724991063454,2.47340123361591e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBNL,Drebrin-like protein,42676,0.129363048686766,0.00891741613051169,0.111884913070963,0.146841184302569,2.49301536863054e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.0885640401027395,0.00610598138522026,0.0765963165877077,0.100531763617771,2.63017398002594e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM13A,Protein FAM13A,40449,0.095128850467879,0.00656495714583852,0.0822615344620355,0.107996166473723,3.69946288811843e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEC31A,Protein transport protein Sec31A,40223,0.108450026469712,0.0074846667110054,0.0937800797161419,0.123119973223283,3.81517416734058e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.0954767319600222,0.00659584862789354,0.0825488686493509,0.108404595270694,3.91658285122075e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOL1,Apolipoprotein L1,40532,0.0823150936676622,0.00569045832058387,0.0711617953593178,0.0934683919760066,5.24526305019259e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.097850587244369,0.0067733877034075,0.0845747473456903,0.111126427143048,5.95522601474123e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.0976924419727731,0.00676435927204207,0.0844342977995707,0.110950586145976,6.40110103065543e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRAP,BRCA1-associated protein,40342,0.153365986303542,0.0106210503078302,0.132548727700195,0.174183244906889,7.68362829187768e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.141259538703893,0.00979051695882103,0.122070125464604,0.160448951943182,7.71537779781258e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.10762771806891,0.00745651758811359,0.0930129435962078,0.122242492541613,8.2655918791909e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.111591158723793,0.00775572711190549,0.0963899335844579,0.126792383863127,1.58124547565633e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.0996198298240461,0.00692507035327813,0.086046691931621,0.113192967716471,1.67408260267055e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0770153063806524,0.00536419029340674,0.0665014934055752,0.0875291193557296,2.09813327780786e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.0939112118239451,0.00654562529070337,0.0810817862541665,0.106740637393724,2.82324704811418e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNMBP,Dynamin-binding protein,42495,0.0839618573026871,0.00585671665219761,0.0724826926643798,0.0954410219409944,2.8824477648696e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAMBP,STAM-binding protein,42476,0.0883421426415212,0.00617209230487908,0.0762448417239582,0.100439443559084,3.98859845994085e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.11883495206699,0.00831772356638618,0.102532213876874,0.135137690257107,5.73979262070105e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0586397138165928,0.00410917992330359,0.0505857211669178,0.0666937064662678,8.38685498803566e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.099273482244951,0.00696533451852427,0.0856214265886435,0.112925537901259,1.07917266955683e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRKL,Crk-like protein,42636,0.14494520411814,0.0101841401029118,0.124984289516433,0.164906118719847,1.2360324042224e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC3B,Tetranectin,40269,0.0292776094230717,0.00206005726155717,0.0252398971904196,0.0333153216557237,1.93373235648919e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.0922411735405155,0.00649921885643615,0.0795027045819007,0.10497964249913,2.20399491998439e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY4,Protein canopy homolog 4,42587,0.101737053807389,0.0072077711526311,0.0876098223482317,0.115864285266546,6.44951819620947e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.0946085047731997,0.00670005395375251,0.0814763990238447,0.107740610522555,6.97452438822168e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.116156276487293,0.00823210928287203,0.100021342292863,0.132291210681722,6.98671576787594e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.10161987523579,0.00720162602920109,0.0875046882185558,0.115735062253024,7.82468981570111e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0453981684483946,0.00322017362553966,0.0390866281423369,0.0517097087544523,8.13112432056648e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.0797919935055313,0.00565820323541517,0.0687019151641175,0.090882071846945,8.8674095241513e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.106452197699776,0.00755219561646594,0.0916498942915029,0.121254501108049,9.68504970290432e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP43,Centrosomal protein 43,42255,0.0949297860436297,0.006738914317182,0.081721513981953,0.108138058105306,9.72747066668888e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.11279943384312,0.00800542305834984,0.0971088046487545,0.128490063037486,1.04297721079635e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN2,CCN family member 2,42624,0.0756492502819398,0.0053751223249479,0.0651140105250419,0.0861844900388377,1.14000017592976e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK1,Docking protein 1,40483,0.18638283958295,0.0132497218137592,0.160413384827982,0.212352294337918,1.44157865416404e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA1,Glutathione S-transferase A1,42611,0.113014522362095,0.00804004517066641,0.0972560338275884,0.128773010896601,1.45583521606445e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR,GMP reductase 1,42754,0.0677274026845858,0.00481843128609006,0.0582832773638493,0.0771715280053223,1.45593323959802e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP2,Methionine aminopeptidase 2,42689,0.0780796381777241,0.00555742940400887,0.0671870765458667,0.0889721998095815,1.59499538753899e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0396854536953028,0.0028248607978387,0.0341487265315389,0.0452221808590666,1.6136157363174e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0530157708987002,0.0037739405376024,0.0456188474449994,0.0604126943524009,1.66262077320403e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0525922676518776,0.00375144987876763,0.0452394258894931,0.0599451094142622,2.47971038939079e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEXIM1,Protein HEXIM1,42594,0.10994987536721,0.00786548006795292,0.0945335344340227,0.125366216300398,4.28387921877062e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTPBP2,GTP-binding protein 2,40182,0.109915259216356,0.00788150740455121,0.0944675047034352,0.125363013729276,7.86179300462811e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST13,Hsc70-interacting protein,40283,0.0766713997967297,0.00550919280090178,0.0658733819069622,0.0874694176864972,1.16235397098467e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.121061104451822,0.00870025864489379,0.10400859750783,0.138113611395814,1.20798084237681e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0427052298685026,0.00307577563953922,0.0366767096150058,0.0487337501219995,1.56569970950144e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TWF2,Twinfilin-2,40527,0.112491473427562,0.00809888326409569,0.0966176622299348,0.12836528462519,1.65993604726083e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0368621363131007,0.00265546543330038,0.0316574240638319,0.0420668485623694,1.8554800229338e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0755561662651677,0.00544286280148209,0.0648881551742628,0.0862241773560726,1.89777419878411e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC4,Syndecan-4,42636,0.0638392615715314,0.00460800060922035,0.0548075803774595,0.0728709427656033,2.38854162173046e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.0741761405560172,0.00535422698996225,0.0636818556556912,0.0846704254563432,2.43746244476427e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL13,C-C motif chemokine 13,42734,0.0930373830758359,0.00674670334180019,0.0798138445259075,0.106260921625764,5.70846620301975e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDHD2,Phospholipase DDHD2,40482,0.088285776041162,0.00639814886088966,0.0757454042738183,0.100826147808506,5.7931072203671e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.097391070119704,0.00706438009520318,0.0835448851331057,0.111237255106302,6.13070471287177e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF2,Growth/differentiation factor 2,42636,0.0483302872290393,0.00350871540190418,0.0414532050413071,0.0552073694167715,7.10797703198149e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0696066700906624,0.00505446082531894,0.0596999268730373,0.0795134133082876,7.40052815400135e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPART,Spartin,40283,0.102970101383646,0.00747935626331565,0.0883105631075475,0.117629639659745,9.01284239945475e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM17,Splicing factor 45,40482,0.102607017807613,0.00745370327509959,0.0879977593884173,0.117216276226808,9.04888001103045e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA11,Annexin A11,42570,0.089494331533048,0.00650841358682634,0.0767378409028683,0.102250822163228,9.86575520812388e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0448766112154768,0.00326569952239603,0.0384758401515806,0.051277382279373,1.29742154384252e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNST,Consortin,42636,0.144817728862909,0.0105819382392563,0.124077129913967,0.165558327811852,2.38645656063552e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPB,Natriuretic peptides B,42357,-0.18956360000947,0.0138655970324628,-0.216740170193097,-0.162387029825843,2.91968211362901e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.100392516951215,0.00734200021865429,0.0860021965226528,0.114782837379778,3.16003405936038e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0308379775481131,0.00225976421030729,0.0264088396959108,0.0352671154003154,4.00850859323771e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB3,Plexin-B3,42597,0.0623427050844336,0.00457028610734951,0.0533849443140286,0.0713004658548387,4.36856819009704e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.0954490492472404,0.00700271689896286,0.0817237241252732,0.109174374369208,5.02135975049798e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.165416705240702,0.0121481380591989,0.141606354644672,0.189227055836732,6.92153838054905e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL5,C-C motif chemokine 5,42689,0.13206028117935,0.00971749216628077,0.11301399653344,0.15110656582526,8.65060106832994e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EREG,Proepiregulin,42476,0.106910415806437,0.00787064743803218,0.0914839468278939,0.12233688478498,9.5405045136931e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUCB2,Nucleobindin-2,42683,0.0489974167549394,0.00360838619665487,0.0419249798094958,0.0560698537003829,1.00614556197721e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES2,Cocaine esterase,42587,0.0727499279309712,0.00535794676486232,0.062248352271841,0.0832515035901013,1.02178942307694e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.112617443758145,0.00829174652429648,0.0963656205705242,0.128869266945766,1.10579364321868e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD1,COMM domain-containing protein 1,40223,0.0801010908318918,0.00590354124236543,0.0685301499968556,0.0916720316669281,1.33058939373324e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.124810092436776,0.00920744312242495,0.106763503916823,0.142856680956729,1.40014987072457e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF19,Fibroblast growth factor 19,42676,0.102599033044496,0.00757298505448885,0.0877559823376978,0.117442083751294,1.52176665360922e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORD,Sorbitol dehydrogenase,42658,0.088342488383677,0.00652569856857712,0.0755521191892658,0.101132857578088,1.75140760053753e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.0997702909066801,0.00737219867235095,0.0853207815088722,0.114219800304488,1.88325844669184e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBPL,FK506-binding protein-like,40449,0.0774347079373097,0.00571943239325403,0.0662246204465318,0.0886447954280876,1.94446449056268e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0622948088765397,0.00461333410978282,-0.071336943731714,-0.0532526740213654,2.77225503165832e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.100674750030572,0.00746315288724126,0.0860469703715791,0.115302529689565,3.34902427472123e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD5,Programmed cell death protein 5,42711,0.0757564249687774,0.00561826230677404,0.0647446308475003,0.0867682190900546,3.5870156297229e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0822216614427969,0.00610540956830781,0.0702550586889136,0.0941882641966802,5.1338996934394e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FETUB,Fetuin-B,42663,0.0422525578720674,0.00314218984742306,0.0360938657711182,0.0484112499730166,5.90163718430321e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.103388910020269,0.0076908192053096,0.0883149043778619,0.118462915662675,6.21874549530591e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.057156130438344,0.00425888415180072,0.0488087175008146,0.0655035433758734,8.51275641287443e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.116174424248858,0.00865101276465609,0.0992184392301316,0.133130409267584,8.54774869966611e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.0822119516044839,0.00613065411907892,0.0701958695310892,0.0942280336778786,9.78497065827311e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0459696906871574,0.00343143154436392,-0.0526952965141107,-0.0392440848602042,1.15081089426365e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.118515006673997,0.00884886157050211,0.101171237995813,0.135858775352181,1.22224242338449e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.105420026152516,0.00786759674175848,0.0899995365386695,0.120840515766363,1.24738527415847e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.128040598173369,0.00957683686885101,0.109269997910421,0.146811198436317,1.66809561930903e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.111291993247695,0.00833106423891623,0.094963107339419,0.127620879155971,1.90545727303575e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.0875823274305705,0.00655210491092902,0.0747402018051496,0.100424453055991,1.91131426758803e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.120415387750257,0.00901748112376758,0.102741124747673,0.138089650752842,2.06858798931805e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0689052738434668,0.00515792328806551,0.0587957441988584,0.0790148034880752,2.14714970451379e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.101538616361473,0.00760494137288148,0.0866329312706257,0.116444301452321,2.33850276918281e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.142295919747343,0.0106831515116247,0.121356942784559,0.163234896710127,3.19401712859225e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.117699669398896,0.00884529576028893,0.100362889708729,0.135036449089062,3.81545674321125e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.080658234462968,0.00606089938214236,0.068778871673969,0.092537597251967,4.26740726497888e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGLL,Monoglyceride lipase,42654,0.111196524097247,0.00836331448145735,0.0948044277135906,0.127588620480903,4.38428558707981e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.0988728013741122,0.00743814752411443,0.0842940322268479,0.113451570521376,5.19158721237647e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.101662996848085,0.00765079959817275,0.0866674296356665,0.116658564060504,5.43161510528011e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIFBP,KIF-binding protein,42587,0.105693948334444,0.00795993369022794,0.090092478301597,0.121295418367291,5.53859363257669e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT1,Deaminated glutathione amidase,40223,0.0616872666873952,0.00464404535797779,0.0525849377857587,0.0707895955890316,5.8793856025533e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.103369967011372,0.00778786106516518,0.0881057593236483,0.118634174699096,6.70407978185019e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0726633889531684,0.00548129210184322,0.0619200564335557,0.0834067214727811,7.3636631195179e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS4,Galectin-4,42618,-0.0732465587314251,0.00552895623330301,-0.084083312948699,-0.0624098045141512,8.25725554896212e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYDGF,Myeloid-derived growth factor,40511,0.127024768762,0.00959438683012942,0.108219770574946,0.145829766949053,1.02391888834253e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPC,C-type natriuretic peptide,42594,0.0649127162168517,0.00490768331852093,0.0552936569125507,0.0745317755211528,1.0900356904087e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT2,Omega-amidase NIT2,40462,0.0943463165822197,0.00713906208614238,0.0803537548933806,0.108338878271059,1.40593135709992e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.0815801741941332,0.00617858834072076,0.0694701410463206,0.0936902073419459,1.63617328138599e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.15516816410143,0.011789581117785,0.132060585110572,0.178275743092289,2.60832363386044e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGFR,Opioid growth factor receptor,42587,0.0417400830235288,0.00317571616542958,0.0355156793392868,0.0479644867077707,3.24161366988913e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4D,Semaphorin-4D,42711,0.0383414900299052,0.00292104641991073,0.0326162390468802,0.0440667410129303,4.05611280482794e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7,Interleukin-7,42594,0.0814283650421926,0.0062036432247977,0.0692692243215891,0.0935875057627961,4.07810912491956e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.107387780936216,0.00818211402102781,0.0913508374550016,0.123424724417431,4.14334569790017e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53,Cellular tumor antigen p53,42346,0.0551877273726932,0.00420532282407359,0.046945294637509,0.0634301601078774,4.26215222534396e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.0830244487790435,0.00633073627713594,0.0706162056758571,0.09543269188223,4.70823188058493e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.166442062291514,0.0127016779351693,0.141546773538582,0.191337351044446,5.40963200274627e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5E,5'-nucleotidase,42679,0.0724904474943122,0.0055327700032045,0.0616462182880314,0.083334676700593,5.54623437084863e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLG4,Disks large homolog 4,40483,0.089696936078532,0.00684244007297996,0.0762857535354912,0.103108118621573,5.63590955049039e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0654949182361336,0.0050048824482162,0.0556853486376298,0.0753044878346373,6.91652547711618e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHD3,EH domain-containing protein 3,40223,0.150237787874363,0.0114736854170559,0.127749364456934,0.172726211291793,6.93360191339944e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.0808483658208105,0.0061753658390912,0.0687446487761917,0.0929520828654292,7.01209031314831e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRADD,Death domain-containing protein CRADD,42476,0.0956666640120907,0.00731864857397038,0.0813221128071088,0.110011215217073,8.30039281166114e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GLB2,Endophilin-B2,40483,0.0851378449836985,0.00651700567580968,0.0723645138591115,0.0979111761082855,1.00952977643155e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFR,Epidermal growth factor receptor,42794,0.0208404109402374,0.00159658905896207,0.0177110963846717,0.023969725495803,1.04244732678734e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.107527199073625,0.00824192024492452,0.0913730353935733,0.123681362753677,1.14648752717812e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.111697886252304,0.0085642428002149,0.0949119703638829,0.128483802140725,1.20782809687472e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.112427696352783,0.00861469402840973,0.0955428960570995,0.129312496648466,1.21835281212603e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH9,Protocadherin-9,40449,0.0440462261716158,0.00337616534853912,0.0374289420884791,0.0506635102547524,1.2720814206296e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK13,Kallikrein-13,42381,0.0587583338359188,0.00450770881938812,0.0499232245499181,0.0675934431219195,1.33833978226618e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELN,Elastin,40511,0.046839044513722,0.00359191182718985,0.0397988973324299,0.0538791916950142,1.37137656486419e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.0617350520060467,0.00473873288062811,0.0524471355600157,0.0710229684520778,1.46762109969846e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0917129681577125,0.00704905837303819,0.0778968137465576,0.105529122568867,2.00389496094917e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0389591351490959,0.00299798134511222,0.0330830917126759,0.0448351785855159,2.22030060093042e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0296014676824778,0.00227944753100642,0.0251337505217052,0.0340691848432503,2.49220149029696e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0359382438258302,0.0027663022415736,0.030516291432346,0.0413601962193145,2.57036162821752e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.0763081291596828,0.00587842807800317,0.0647864101267966,0.087829848192569,2.6936162342026e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0255612022116531,0.00196867221862612,0.0217026046631459,0.0294197997601603,2.83368953763006e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.104534188597585,0.00805134952115848,0.0887535435361144,0.120314833659056,2.84918496114017e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2L,Ataxin-2-like protein,40482,0.0612269646989229,0.00471691830953632,0.0519818048122317,0.0704721245856141,2.97168358241301e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTBDN,Retbindin,42587,0.0378715469464749,0.00292247980124793,0.032143486536029,0.0435996073569209,3.55751334952225e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEXN,Nexilin,40532,0.0873415165521859,0.00674229729197492,0.074126613859915,0.100556419244457,4.14062035724637e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.0950981357988327,0.00735058106967394,0.0806909969022717,0.109505274695394,4.64319020834728e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASC3,Protein CASC3,40182,0.0530705015359517,0.00410186177948807,0.0450308524481551,0.0611101506237483,5.19240232757222e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.139952532604225,0.0108255342878611,0.118734485400017,0.161170579808432,5.3374732123756e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0369977961398072,0.00286240418428385,0.0313874839386109,0.0426081083410036,5.414144603664e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.104396358781529,0.0081030095812005,0.0885144600023765,0.120278257560682,9.30603499403204e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.183412253294047,0.0142311601302291,0.155519179438798,0.211305327149296,9.70997567627505e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASHC3,WASH complex subunit 3,40483,0.0937536111230117,0.00731322481960631,0.0794196904765833,0.10808753176944,2.31558346650336e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RWDD1,RWD domain-containing protein 1,42711,0.0786000777410486,0.00613920913577199,0.0665672278349355,0.0906329276471617,2.59914684723145e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGA,Protein O-GlcNAcase,40449,0.0876188646232089,0.00684440400224818,0.0742038327788025,0.101033896467615,2.92319615107994e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.129530518521879,0.0101390252452675,0.109658029041154,0.149403008002603,3.70382808050401e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.0897713344881247,0.00702277348366928,0.076006698460133,0.103535970516117,3.75648794549601e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICA1,Islet cell autoantigen 1,42370,0.0981302532445445,0.00768402518941432,0.0830695638732925,0.113190942615797,3.9676333996545e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.0793588504745592,0.00621451715076714,0.0671783968590556,0.0915393040900628,4.35708376750835e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLG,Plasminogen,40285,0.0268321707662474,0.00210219009202984,0.0227118781858689,0.0309524633466259,4.75031052070498e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.1208102267826,0.00949337328767938,0.102203215138749,0.139417238426452,7.61618351695439e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0758675385839031,0.00596338968649971,0.0641792947983637,0.0875557823694426,8.07161397494306e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDC,Nuclear migration protein nudC,42754,0.0768873636711649,0.00605335025399144,0.0650227971733417,0.0887519301689881,9.37844819999761e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.132294899176339,0.0104193438810472,0.111872985169486,0.152716813183192,1.12567699675345e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPP,Lipoma-preferred partner,40116,0.0817696713849081,0.00644710206300521,0.0691333513414179,0.0944059914283983,1.32758073954997e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.104549906892431,0.0082499447428814,0.0883800151963835,0.120719798588479,1.36903992003198e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSB,Arylsulfatase B,42587,0.0679727062071423,0.00536757170064247,0.0574522656738831,0.0784931467404015,1.52406684394452e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.108376515597256,0.00856103924815643,0.091596878670869,0.125156152523642,1.76159682895514e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.093065856407808,0.00736253503660622,0.0786352877360598,0.107496425079556,2.05557234052372e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBXN1,UBX domain-containing protein 1,40283,0.0845120495074091,0.00668724923222566,0.0714050410122469,0.0976190580025714,2.32635073138702e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.0752795182082964,0.00596162063815207,0.0635947417575183,0.0869642946590744,2.62471880469591e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB9,Serpin B9,42495,0.0405111071473283,0.003217536558502,0.0342047354926644,0.0468174788019922,3.81711413020925e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.121784963705437,0.00967549105704116,0.102821001233636,0.140748926177238,3.98756301691702e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0604308507224761,0.00479889539128743,0.0510250157555527,0.0698366856893995,4.10977686456183e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR2,GMP reductase 2,40283,0.0827057879032487,0.00658504393560819,0.0697991017894566,0.0956124740170407,6.17815162524145e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.121565597422674,0.00968669954848319,0.102579666307647,0.140551528537701,7.04112328707857e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3F,Semaphorin-3F,42636,0.0332897879014859,0.0026552339259707,0.0280855294065833,0.0384940463963884,7.39338499484823e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0846409283501096,0.00675030878671852,0.0714103231281413,0.0978715335720779,7.93189556304278e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1R,Complement C1r subcomponent,40539,0.0239060832476393,0.0019075645249409,0.0201672567787551,0.0276449097165235,8.58018958946728e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD36,Platelet glycoprotein 4,40199,0.0550255745581643,0.0043911305233635,0.0464189587323719,0.0636321903839568,8.85375148816493e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.0966007942909921,0.00771803523303918,0.0814734452342353,0.111728143347749,9.6728197732541e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0575552672771046,0.00459601595378796,0.0485470760076802,0.066563458546529,9.68488275273826e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMVK,Phosphomevalonate kinase,42303,0.132198250591988,0.010563199224365,0.111494380112233,0.152902121071744,9.89203772471048e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.132955917480946,0.0106304960261056,0.112120145269779,0.153791689692113,1.08078747321539e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLK1,Protein delta homolog 1,42794,0.0673361500670424,0.00538552606439134,0.0567805189808353,0.0778917811532494,1.12670720440102e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHK,Ketohexokinase,40223,0.0768334310261461,0.00614193017279788,0.0647952478874623,0.08887161416483,1.15384396828788e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.08705236078151,0.00696348330109797,0.073403933511358,0.100700788051662,1.16144338690789e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.0942651447053437,0.00754893534126868,0.0794692314364571,0.10906105797423,1.39499148020721e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAX,Protein max,42311,0.127904249225418,0.01024352488348,0.107826940453797,0.147981557997038,1.41169191907553e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EZR,Ezrin,42711,0.0291432913892815,0.00233425640074275,0.0245681488438257,0.0337184339347373,1.41533725584523e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0803948343112973,0.00643782647927702,0.0677766944119144,0.0930129742106803,1.50562333292119e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMN,Protein amnionless,42370,0.0574507498343602,0.0046094160931706,0.0484162942917458,0.0664852053769746,1.86408774823783e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED8,Protein TMED8,40449,0.12426765481003,0.00997745488483282,0.104711843235758,0.143823466384302,2.25040639626805e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.127450077274026,0.0102548903970841,0.107350492095742,0.147549662452311,2.87541821525048e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0582893017966598,0.00468869246244139,0.0490994645702747,0.0674791390230449,2.98797121041899e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPB1,Beta-ureidopropionase,40511,0.109410359868534,0.00880128766491674,0.0921598360452975,0.126660883691771,3.00592455978372e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.0799885103095574,0.00645224502036304,0.0673421100696458,0.0926349105494689,4.19756223594583e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.0925184118567376,0.0074627716941937,0.0778913793361179,0.107145444377357,4.20573729972305e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN3,Centrin-3,40449,0.0918031399831006,0.00740562805260275,0.0772881089999992,0.106318170966202,4.62770042251247e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.112844890125303,0.00910563291280323,0.0949978496162092,0.130691930634398,4.82613082280381e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAG1,Dystroglycan,42676,0.0553960480501278,0.00447609719164944,0.0466228975544948,0.0641691985457607,5.46058273419315e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0393697571700446,0.00318143782671577,-0.0456053753104075,-0.0331341390296817,5.53826961053348e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.0781474992731616,0.00631702092503463,0.0657661382600937,0.0905288602862294,5.82634506772208e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0594568644710181,0.00480924399091066,0.0500307462488332,0.068882982693203,7.02170310173762e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF15,Growth/differentiation factor 15,42794,-0.0560403626257996,0.00453672436482761,-0.0649323423808617,-0.0471483828707375,7.25236286374562e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0624359554317103,0.00505329893281778,0.0525314895233874,0.0723404213400331,7.6505793548873e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIN2,Bridging integrator 2,42611,0.108873802730876,0.00882472744837817,0.0915773369320547,0.126170268529697,8.79771087879152e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0400228346948701,0.00324439962256952,0.0336638114346338,0.0463818579551063,8.95295150253844e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0621472709127375,0.00504376171423369,0.0522614979528395,0.0720330438726355,1.15467694210083e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0659123655116571,0.00535827849403474,0.0554101396633491,0.0764145913599652,1.50745152316876e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS8,Galectin-8,42711,0.0718647087604727,0.00584599952111763,0.0604065496990822,0.0833228678218633,1.51099087331371e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.102879295726162,0.00837141820595411,0.0864713160424919,0.119287275409832,1.71773775392677e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.0922385061357353,0.0075100333807336,0.0775188407094975,0.106958171561973,1.87642561073415e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0662012961068024,0.00540152497735283,0.0556143071511909,0.076788285062414,2.57946809058632e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGT1,Protein SGT1 homolog,42346,0.0957747832221759,0.00782612517591787,0.0804355778773769,0.111113988566975,2.99682251151699e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0382513092555076,0.00312832778655066,0.0321197867938683,0.0443828317171469,3.69165714082011e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.0237736536070997,0.00194591687110801,0.019959656539728,0.0275876506744714,3.8213703429706e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXJ3,Forkhead box protein J3,40199,0.0523320865249956,0.00428634907064764,0.0439308423465262,0.060733330703465,4.61947531689994e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY1,Aminoacylase-1,42636,0.0721443401489463,0.00591364268238183,0.0605536004914779,0.0837350798064147,4.72496492115421e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.0896372425556933,0.00735041377881691,0.0752304315492122,0.104044053562174,5.00968405972703e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0679115591715165,0.00557700285721589,0.0569806335713733,0.0788424847716596,6.80119078743294e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACYBP,Calcyclin-binding protein,40267,0.121419060328929,0.00997647033794519,0.101865178466556,0.140972942191301,7.33741625705047e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0696059427971108,0.00572492588169659,0.0583850880689854,0.0808267975252361,8.42976558906648e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.0392241087975561,0.00322807955949429,0.0328970728609473,0.045551144734165,8.50039674501751e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.047983495277423,0.0039496587155353,0.0402421641949738,0.0557248263598722,9.53802301153881e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0362571834873575,0.00298963674037088,0.0303974954762305,0.0421168714984844,1.1352342622471e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0685777836826466,0.00565199489743221,0.0574998736836794,0.0796556936816137,1.14840500087656e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN1,Pantetheinase,40532,0.0864963969839796,0.00713334197979102,0.0725150467035892,0.10047774726437,1.24713106585198e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0431853229375398,0.00356584588605667,0.0361962650008688,0.0501743808742109,1.38623277508203e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.150195981988671,0.0124069016267795,0.125878454800183,0.174513509177159,1.4701869181452e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.100501739688524,0.00831024227947992,0.0842136648207438,0.116789814556305,1.83529868057761e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTF1,Cardiotrophin-1,42357,0.0988787686290807,0.00821557998784988,0.0827762318528949,0.114981305405266,3.45242662947046e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.048472431645348,0.00402829976010748,0.0405769641155373,0.0563678991751587,3.51406946872954e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.139296928428708,0.0115770391672766,0.116605931660846,0.16198792519657,3.8708432879983e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0430984894902028,0.0035859274591759,0.036070071670218,0.0501269073101875,4.54249589014873e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.121801211055708,0.0101367214137559,0.101933237084746,0.141669185026669,4.70515790976385e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0557700363777071,0.00464632356487237,0.0466632421905573,0.064876830564857,5.43649119002496e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.0922315720383038,0.00768824664935026,0.0771626086055773,0.10730053547103,5.46626213087261e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0295953011128129,0.00246861433113829,0.0247568170237819,0.034433785201844,5.99341834875423e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA2,Apolipoprotein A-II,40532,-0.0578386856243897,0.00482457837722824,-0.067294859243757,-0.0483825120050223,6.46567741956861e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YJU2,Splicing factor YJU2,40451,0.038064834097318,0.00317527128447052,0.0318413023797557,0.0442883658148802,6.52095152819166e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0386771828455538,0.00322831346212136,0.0323496884597959,0.0450046772313117,6.59517254452327e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPL,N-acetylneuraminate lyase,40511,0.053480917716786,0.00446361123973053,0.0447322396869142,0.0622295957466578,7.0176531033696e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRY2,Protein sprouty homolog 2,42370,0.107647275007682,0.00899451052796557,0.0900180343728695,0.125276515642495,7.72504330601069e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0242496815169438,0.00203052587232579,-0.0282295122267023,-0.0202698508071852,1.03804880907937e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C4BPB,C4b-binding protein beta chain,42679,0.047125050857641,0.00394674872088868,0.0393894233646992,0.0548606783505828,1.06728510918201e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLUL1,Clusterin-like protein 1,42621,-0.0524591978389156,0.00439555749879844,-0.0610744905365605,-0.0438439051412706,1.14300276530706e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0391062429910075,0.00328093650180705,0.0326756074474657,0.0455368785345494,1.37325174563275e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.085174467640986,0.00715566730111154,0.0711493597308074,0.0991995755511646,1.67662042318805e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.0535773699384704,0.00450293758969924,0.0447516122626599,0.0624031276142809,1.75977231845794e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.0982353519256935,0.00825419317560482,0.082057133301508,0.114413570549879,1.83690014195061e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP5,Retinol-binding protein 5,42587,0.0648797628198059,0.00545534080857492,0.0541872948349991,0.0755722308046128,1.87703916329702e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0442659477464755,0.00372227093393482,0.0369702967159633,0.0515615987769878,1.8844118781508e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.069832701057413,0.0058766617755303,0.0583144439773736,0.0813509581374524,2.12188825093157e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD226,CD226 antigen,40199,0.0494171643956998,0.00416010098590168,0.0412633664633325,0.0575709623280671,2.40284711666604e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0702894565633725,0.00592106883525809,0.0586841616462667,0.0818947514804784,2.42404856850313e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA2,Integrin alpha-2,40283,0.040668045726485,0.00342387106371751,0.0339572584415987,0.0473788330113713,2.42426511598884e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCB,Tubulin-folding cofactor B,42495,0.115475471935269,0.00973870889494854,0.0963876025011695,0.134563341369368,2.865000572958e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0596900845667893,0.0050374010674348,0.0498167784746171,0.0695633906589615,3.16491917332352e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0850314563812943,0.00717687975238879,0.0709647720666122,0.0990981406959763,3.45487908187885e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0441919911874185,0.00373647437018511,0.0368685014218557,0.0515154809529813,4.37295078546774e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0559252489271294,0.0047328345393346,0.0466488932300336,0.0652016046242252,5.01501522099246e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.0973809076038192,0.00824748864288298,0.0812158298637686,0.11354598534387,5.15506662046324e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THOP1,Thimet oligopeptidase,42571,0.0356250182509858,0.00302086431247063,0.0297041241985433,0.0415459123034282,6.10564043321628e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0853239072420974,0.00723529521337788,0.0711427286238768,0.0995050858603181,6.59278615050278e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0580752667110825,0.00494008406993815,0.0483927019340037,0.0677578314881613,9.42273512378384e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.106890584261258,0.00909574947114293,0.089062915297818,0.124718253224698,9.90663062770344e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.019611445886968,0.00166851265634219,0.0163411610805373,0.0228817306933987,1.03025355462165e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YWHAQ,14-3-3 protein theta,40283,0.0844991751368273,0.00719159798582702,0.0704036430846063,0.0985947071890483,1.09188635678164e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLB1,Beta-galactosidase,42495,0.0476162049731377,0.00405511089057859,0.0396681876276037,0.0555642223186718,1.10914879945622e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D5,TBC1 domain family member 5,42594,0.0898624212604653,0.00767032253553362,0.0748285890908194,0.104896253430111,1.51105867675188e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICALL2,MICAL-like protein 2,40182,0.0790027664464364,0.0067420971781611,0.0657882559772406,0.0922172769156321,1.59023235313944e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0632765581741527,0.00540443008785027,0.0526838752019662,0.0738692411463392,1.6612355742663e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0465700474552919,0.00398349798960323,0.0387623913956696,0.0543777035149143,2.02580606130692e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MESD,LRP chaperone MESD,42611,0.137308232127441,0.011757508512224,0.114263515443482,0.1603529488114,2.33226217939799e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0296014693083707,0.00253532806543231,0.0246322263001233,0.034570712316618,2.4063873095645e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP5,Fatty acid-binding protein 5,42678,0.0771187607698537,0.0066154295267931,0.0641525188973392,0.0900850026423682,2.97042864852703e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0676302264949443,0.00581022939477798,0.0562421768811795,0.0790182761087091,3.67374280628624e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0504745673745163,0.00433893725135591,0.0419702503618588,0.0589788843871739,3.9560318267782e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTDH,Protein LYRIC,40199,0.107061767902497,0.00919984204039589,0.0890300775033215,0.125093458301673,4.04825758011457e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F12,Coagulation factor XII,40539,0.0473539713454182,0.00407362728671858,0.0393696618634498,0.0553382808273866,4.63814304248292e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QDPR,Dihydropteridine reductase,42581,0.0482450686281258,0.00415611757095878,0.0400990781890466,0.056391059067205,5.26956046995264e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0790109515582954,0.00680325980211109,0.0656765623461577,0.0923453407704331,5.32604865911771e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0792956314112696,0.00683359407178287,0.0659017870305752,0.092689475791964,5.53477353457277e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.0886546013339703,0.00764042052543008,0.0736793771041274,0.103629825563813,5.58535951236751e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP7,Caspase-7,40483,0.0948887470305033,0.00817773716187103,0.0788603821932361,0.110917111867771,5.9395788005701e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.101422549719218,0.00875139584330857,0.0842698138663336,0.118575285572103,6.97463296133643e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRAS,Ras-related protein R-Ras,40182,0.147008808355767,0.0126869691237242,0.122142348873268,0.171875267838266,7.2157629696411e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADD1,Alpha-adducin,40283,0.0804278013503165,0.00696679747105504,0.0667728783070486,0.0940827243935844,1.17858383988779e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.0972346371421594,0.00843315434116932,0.0807056546334675,0.113763619650851,1.39054551278682e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCXR,L-xylulose reductase,42679,0.0590329900841435,0.0051385779213759,0.0489613773582467,0.0691046028100402,2.0945974899281e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CERT,Ceramide transfer protein,42311,0.0687428818471317,0.00598369123815697,0.057014847020344,0.0804709166739193,2.10939174814399e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB1,Heat shock protein beta-1,42448,0.0759963375917622,0.0066237485706976,0.0630137903931949,0.0889788847903295,2.49791204579697e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PF4,Platelet factor 4,40463,0.110281240329433,0.00962551679209731,0.0914152274169228,0.129147253241944,3.1813889155445e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGF,Pro-epidermal growth factor,42597,0.114789712806233,0.0100270215466002,0.0951367505748969,0.13444267503757,3.32287622395123e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0517533790366253,0.00452185398165003,0.0428905452325912,0.0606162128406593,3.42605175560821e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0635009921942625,0.00555034506636679,0.0526223158641836,0.0743796685243414,3.63117901747194e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP2,Caspase-2,42594,0.0752770070373669,0.00658527603750881,0.0623698660038497,0.0881841480708842,4.03143948483931e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THTPA,Thiamine-triphosphatase,40436,0.0983558865490549,0.00860168939279546,0.0814965753391758,0.115215197758934,4.12429260049741e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.103896519751916,0.0091134017290515,0.0860342523629753,0.121758787140857,5.7108199309489e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2,Microtubule-associated protein 2,40483,0.0519167434464632,0.00455219296135467,0.0429944452422081,0.0608390416507184,5.77321191171188e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0367461040265132,0.00323037366513032,-0.0430776364101686,-0.0304145716428577,7.58263024904253e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTD,Deoxycytidylate deaminase,40283,0.104769249347616,0.00920613922561181,0.0867252164654171,0.122813282229815,7.66705903386994e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.113590162419575,0.00998235236378966,0.0940247517865469,0.133155573052602,7.7942276216321e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.1198282170865,0.0105342434900497,0.0991810998460028,0.140475334326997,8.09169824103409e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FST,Follistatin,42654,0.0546828428199351,0.00481153809112315,0.0452522281613337,0.0641134574785365,8.54499182109776e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1B,Meprin A subunit beta,42636,0.131336747024372,0.0115815224331817,0.108636963055336,0.154036530993408,1.13148738304688e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.0920450003247672,0.0081239304207743,0.0761220967000496,0.107967903949485,1.26954096743417e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFP,Alpha-fetoprotein,42459,0.0745296026454482,0.00657882027471292,0.0616351149070109,0.0874240903838855,1.29368154969508e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOE,Apolipoprotein E,40539,0.0809275781232109,0.00714597701308854,0.0669214631775574,0.0949336930688645,1.42338961060164e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.139216098607467,0.0123032371610385,0.115101753771832,0.163330443443102,1.58747014958959e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH2,Cadherin-2,42636,0.0393299144092828,0.00347978198755452,0.0325095417136759,0.0461502871048897,1.7342491778587e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7,Complement component C7,40251,-0.0365442677694664,0.00324217934955736,-0.0428989392945988,-0.030189596244334,2.62095126157473e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.109104871470276,0.00969978819027387,0.0900932866173395,0.128116456323213,3.38031636225835e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.0730762371411648,0.00650687076962346,0.0603227704327029,0.0858297038496268,3.8817919570865e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0523444742887017,0.00466298482867376,0.0432050240245012,0.0614839245529023,4.12979255406335e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TADA3,Transcriptional adapter 3,40451,0.043483271884589,0.00387238272061088,0.0358934017521917,0.0510731420169863,4.19070952176706e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0369736972953128,0.00329721991696819,0.0305111462580551,0.0434362483325704,4.71068534945008e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0404276439866546,0.00361220396625739,0.0333477242127901,0.0475075637605191,5.98860040744784e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.0755113704230173,0.00675002133676961,0.0622813286029489,0.0887414122430857,6.75314979862549e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIAPIN1,Anamorsin,42679,0.0676666468682659,0.00606051213318209,0.055788043087229,0.0795452506493028,8.07624681426505e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.0944468406662801,0.0084632609200511,0.07785884926298,0.11103483206958,8.59149392528312e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.0950007371806116,0.00851119193260319,0.0783188009927094,0.111682673368514,8.87267397115219e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.128487678333695,0.0115168268667731,0.105914697674819,0.15106065899257,8.89449417279147e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0664112544860128,0.00595957564337474,0.0547304862249983,0.0780920227470273,1.02823400028457e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0520581026254848,0.00467103750267195,0.0429028691202478,0.0612133361307218,1.07011227706011e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POMC,Pro-opiomelanocortin,40223,0.0765584179581505,0.00687283492197611,0.0630876615110773,0.0900291744052236,1.14847778099907e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0565533868667914,0.00508456333978601,0.0465876427208108,0.066519131012772,1.37276225767525e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL8,C-C motif chemokine 8,42706,0.0658127856182283,0.00592154012957694,0.0542065669642575,0.0774190042721991,1.42417010559001e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMTN,Smoothelin,40460,0.100427187325565,0.00903807002854037,0.0827125700696262,0.118141804581504,1.55018554927427e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN3,Ataxin-3,40483,0.0677245960011024,0.0060964629219301,0.0557755286741195,0.0796736633280854,1.596859298874e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMFG,Glia maturation factor gamma,40511,0.0777741221742319,0.00700207578958463,0.0640500536266461,0.0914981907218178,1.62295765419674e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0304347013123294,0.00274381250548754,-0.0358125738230849,-0.0250568288015738,1.81958950658276e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.0961982531639106,0.00867536620597593,0.0791945354001978,0.113201970927623,1.89430198923926e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPACT,Protein IMPACT,40483,0.0608029430815551,0.0054880656202831,0.0500463344658002,0.07155955169731,2.21827347272922e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0377779965499548,0.00341273502094883,0.0310890359088951,0.0444669571910145,2.33478698759151e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB6,Serpin B6,42679,0.062611947418963,0.00565969097448156,0.0515189531089792,0.0737049417289469,2.51656526744796e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRN,Agrin,42676,0.0393646321138746,0.00355940451052474,0.0323881992732461,0.0463410649545031,2.61465040032487e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM3,Dynamin-3,40482,0.059449977980646,0.00537835486454376,0.0489084024461403,0.0699915535151518,2.94120202343538e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.101793042941382,0.0092123058165936,0.0837369235408585,0.119849162341905,3.07252132311784e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOT,Angiomotin,40283,0.0419822327516836,0.00380175427900042,0.0345307943648427,0.0494336711385244,3.32901069319975e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0704797477025798,0.00638417352667833,0.0579667675902903,0.0829927278148693,3.42417634088065e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0635861504602121,0.00576255408179061,-0.0748807564605217,-0.0522915444599026,3.4429889758904e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0569629109477065,0.00516194375691484,0.0468455011841534,0.0670803207112596,3.60525629027676e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0429384746573509,0.0038944973376055,0.0353052598756441,0.0505716894390577,3.82556524713633e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0701163697579655,0.00635713119700923,0.0576563926118275,0.0825763469041036,3.8530918018955e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COCH,Cochlin,40511,0.0507173176477023,0.00460057858698042,0.0417001836172207,0.059734451678184,4.06387928552416e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0494560545811574,0.00449633940205169,0.040643229353136,0.0582688798091787,5.1077321877061e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD276,CD276 antigen,42618,-0.0395529319263339,0.00359855154425685,-0.0466060929530774,-0.0324997708995905,5.53535629400835e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.0971453169692133,0.00884622518226454,0.0798067156119748,0.114483918326452,6.54282598735688e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.102534244427536,0.00934226648061542,0.0842234021255294,0.120845086729542,6.60401306666144e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.0985259831704271,0.00897622592168661,0.0809325803639213,0.116119385976933,6.92341960325439e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.078270238325964,0.00713840154572435,0.0642789712963443,0.0922615053555837,7.79941467830595e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0743213215515841,0.00678427002799752,0.0610241522967089,0.0876184908064592,8.77506985422502e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.118829417878699,0.0108532655492051,0.0975570174022575,0.140101818355141,8.82323985238313e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.097780387627933,0.00893796519603556,0.0802619758437033,0.115298799412163,1.03169449628216e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.080222464889518,0.00734113938039846,0.065833831703937,0.094611098075099,1.17366647282899e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.092812520547831,0.00849782529554991,0.0761567829685531,0.109468258127109,1.18497293275921e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPOCK1,Testican-1,42495,0.0276049959159632,0.00253187420200844,0.0226425224800267,0.0325674693518997,1.45879465559518e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0640824835371906,0.00587934860432496,0.0525589602727136,0.0756060068016675,1.59640958539291e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0292430844049734,0.00268506644936122,0.0239803541642254,0.0345058146457214,1.65365526994838e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO3,Forkhead box protein O3,42346,0.10118697196002,0.00929051807495928,0.0829775565331002,0.119396387386941,1.65957848010639e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0322234769116189,0.00295973119618704,-0.0380245500561455,-0.0264224037670923,1.72687389563515e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARC,SPARC,42679,0.0745158894710764,0.00684683022350081,0.0610961022330148,0.087935676709138,1.80160652772662e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP3,Caspase-3,42794,0.0923339750332997,0.00848458731507509,0.0757041838957525,0.108963766170847,1.81165952258057e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE2,Glia-derived nexin,40511,0.0685322817742027,0.0062967833974219,0.0561905863152558,0.0808739772331496,1.88522330193056e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0824084158880133,0.00757225019532597,0.0675668055051744,0.0972500262708522,1.91607183437907e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0739074787215272,0.00680514775749729,0.0605693891168325,0.0872455683262219,2.30672633628013e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0702100872920418,0.00646624681259919,0.0575362435393473,0.0828839310447362,2.38695816847843e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GET3,ATPase GET3,40511,0.0575408794146205,0.00530330114017383,0.0471464091798798,0.0679353496493612,2.71647581560448e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.0707433633039813,0.00653246751187719,0.057939726980702,0.0835469996272606,3.22440881979714e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.103171586360265,0.00952605231217015,0.0845005238284116,0.121842648892119,3.3617841504637e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0609500353453378,0.00563240140821739,0.0499105285852318,0.0719895421054439,3.554309718506e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBP,Protein AMBP,42706,0.0221999656036985,0.00205197352502464,0.0181780974946502,0.0262218337127468,3.62212245757445e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.0681470958848416,0.00630026391909632,0.0557985786034128,0.0804956131662704,3.72086142553976e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0515011138414575,0.00476553601036799,0.0421606632611363,0.0608415644217788,4.32431813287213e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRGN,Neurogranin,40532,0.0961617140120823,0.00889838821887075,0.0787208731030956,0.113602554921069,4.33819174824412e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0548794863587418,0.00507917439246893,0.0449243045495027,0.0648346681679809,4.43497339163944e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0283846070324321,0.00262738502870753,-0.0335342816886988,-0.0232349323761653,4.49337874950402e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0376272475582362,0.00348650764093896,0.0307936925819958,0.0444608025344765,4.85987600979797e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0628744699652111,0.00582668108462829,0.0514541750393396,0.0742947648910825,5.15826249259893e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0668684034572362,0.00620509731233362,0.0547064127250623,0.0790303941894101,6.02432926442347e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0844323481876532,0.00783595192469089,0.0690738824152591,0.0997908139600474,6.15568042906334e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0796999731424724,0.00740449846221574,0.0651871561565295,0.0942127901284152,6.57096902816591e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RP2,Protein XRP2,42587,0.0441230803493366,0.00410908059909053,0.0360692823751192,0.0521768783235541,8.68001940629994e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0683738550652143,0.00636827922196094,0.0558920277901708,0.0808556823402577,8.79544804369133e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.0819540072719168,0.00763420474723038,0.0669909659673453,0.0969170485764884,8.99625812676017e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD69,Early activation antigen CD69,42585,0.091871665787831,0.00855853871375393,0.0750969299088733,0.108646401666789,9.00699456003117e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0518078273605625,0.00482453843500109,0.0423517320279603,0.0612639226931646,9.12537045658903e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.0891263046864644,0.00830739259764987,0.0728438151950706,0.105408794177858,9.58863797997287e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBN1,Drebrin,40199,0.0526907711724746,0.00491069225037618,0.0430658143617373,0.062315727983212,9.99734324250935e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0541980961601926,0.00505652395122308,0.0442873092157954,0.0641088831045898,1.07478239967649e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0628974905592551,0.00586831691269909,0.0513955894103649,0.0743993917081453,1.12277120464336e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0287305598097494,0.00268163153676941,0.0234745619976814,0.0339865576218175,1.12349731937825e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0474733527186417,0.00443106306470271,0.0387884691118244,0.056158236325459,1.12453655600283e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.0912865122198693,0.00852163330013135,-0.107988913488127,-0.0745841109516119,1.14106618693265e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR4,Complement factor H-related protein 4,40509,0.0786451768523513,0.00734163985600089,0.0642555627345896,0.0930347909701131,1.1969902798644e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLB,Beta-klotho,42311,-0.0784547230519753,0.00732744858077412,-0.0928165222702926,-0.0640929238336581,1.21630368406695e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLM2,Protein GOLM2,42711,0.024196923284204,0.00226052498265869,0.0197662943181929,0.028627552250215,1.24462954230148e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0464954521646909,0.00434475853422691,0.0379797254376062,0.0550111788917757,1.35226946678064e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.103555778121488,0.00969292978365958,-0.122553920497461,-0.0845576357455153,1.55201280827326e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RFC4,Replication factor C subunit 4,40451,0.0221330273116157,0.00207182556417073,0.0180722492058411,0.0261938054173903,1.64009944208423e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0416049106472447,0.00389627060990119,0.0339682202518383,0.049241601042651,1.65349809944319e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMT,Catechol O-methyltransferase,42214,0.0867002835001338,0.00813004967024223,0.070765386146459,0.102635180853809,1.92480258048245e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0842519575966479,0.00789929873081442,0.0687693320842516,0.0997345831090442,1.98217673674529e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIAE,Sialate O-acetylesterase,42646,0.0478334734774562,0.00448749133518625,0.0390379904604912,0.0566289564944213,2.01154473917489e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0696841770643673,0.00654056644831256,0.0568646668256746,0.0825036873030599,2.12521358141912e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPY,Pancreatic prohormone,42600,0.108026007612644,0.0101489144099891,0.0881341353690652,0.127917879856223,2.36699726833771e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL24,C-C motif chemokine 24,42654,0.0862867243284003,0.00810845954234351,0.0703941436254071,0.102179305031394,2.42918225593145e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.0880601872871536,0.0082816089956678,0.0718282336556448,0.104292140918663,2.67141188330659e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0561263829746183,0.00527787747225265,0.0457817431290031,0.0664710228202335,2.76280399958436e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0702827569065094,0.00662565921851782,0.0572964648382145,0.0832690489748043,3.48721968847132e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0638570048615808,0.00602177451121655,0.0520543268195964,0.0756596829035652,3.62998698529505e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEP,Leptin,42636,0.0689310170505717,0.00650161891491795,0.0561878439773325,0.0816741901238108,3.69470254468083e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0587131293873384,0.00554438030812459,0.0478461439834142,0.0695801147912626,4.21785031645452e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0520235777788192,0.0049144499937969,0.0423912557909773,0.0616558997666612,4.62540333627224e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0632587217229339,0.00597598721653502,0.0515457867785252,0.0749716566673425,4.644826715803e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.069203513557075,0.00654229550632788,0.0563806143646723,0.0820264127494776,4.77166001159162e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.0966887197398238,0.00914507845189213,0.0787643659741153,0.114613073505532,5.05550818584467e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0544131588200442,0.0051612524365905,0.0442971040443268,0.0645292135957615,7.24544362868068e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN9,Septin-9,42587,0.0293929707884217,0.00278934767392651,0.0239258493475257,0.0348600922293176,7.31833753190836e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCLY,Selenocysteine lyase,42674,0.0481781336990779,0.00457668723647638,0.0392078267155842,0.0571484406825716,8.18152117711772e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0685165323773605,0.00651102664052755,0.0557549201619265,0.0812781445927945,8.55569925675681e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA5,Integrin alpha-5,42611,0.0257911280046201,0.00245383084397413,0.0209816195504308,0.0306006364588094,9.7233034089825e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0489608124073852,0.00465710321594452,0.039832890104134,0.0580887347106365,9.96478046818479e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0857188711077256,0.00816065229466194,0.0697239926101882,0.101713749605263,1.04135815087144e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0517556410027652,0.00492784653032995,0.0420970618033185,0.0614142202022119,1.05655365776632e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0680830019248936,0.00648411445164694,0.0553741375996656,0.0807918662501216,1.14004482457407e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTF2,Transcription termination factor 2,40182,0.0504273665543101,0.00480423878008931,0.041011058545335,0.0598436745632851,1.18612228742134e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD22,B-cell receptor CD22,42754,0.0447803998205229,0.00427499631871453,0.0364014070358424,0.0531593926052034,1.40968778242681e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0295778896986795,0.00282391960146839,0.0240430072798015,0.0351127721175576,1.43384996963886e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.122398568040807,0.0117092391134289,0.0994484593784866,0.145348676703128,1.77585312583258e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA3,Annexin A3,42681,0.071033203077435,0.00679904597517344,0.0577070729660951,0.084359333188775,1.88097329360376e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.10160178825023,0.00972506764143148,0.082540655673024,0.120662920827435,1.96651883337314e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.0590519090029233,0.00565772111803607,0.0479627756115726,0.070141042394274,2.09391561006594e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.0380088228921905,0.00364193472465946,0.0308706308318579,0.045147014952523,2.11917408492505e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0633291796623282,0.00607101353094939,0.0514299931416674,0.075228366182989,2.32402054814756e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP10,Caspase-10,42311,0.0730437956545129,0.00700732623424519,0.0593094362353923,0.0867781550736334,2.42199911389228e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0662128502454581,0.0063646513163894,0.0537381336653349,0.0786875668255813,3.00336991866813e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD2,Polycystin-2,40116,0.0596281757158361,0.00573149057903038,0.0483944541809365,0.0708618972507356,3.13123337847165e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0397488464682057,0.0038266752799325,0.032248562919538,0.0472491300168734,3.52949470411193e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0403776158050752,0.00389694734433152,0.0327395990101854,0.0480156325999649,4.62174867084112e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0277565301194249,0.00268138369563467,0.0225010180759809,0.0330120421628688,5.09852422219463e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0186451521159693,0.00180105506728665,0.0151150841840875,0.0221752200478512,5.2784944320869e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0535570303341321,0.0051801450931463,0.0434039459515654,0.0637101147166989,5.83227729932058e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0668829910160728,0.00646964828850137,0.0542024803706101,0.0795635016615354,5.87382266433178e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0504051411630462,0.00487395061784138,0.0408521979520771,0.0599580843740153,5.92218201040813e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARK7,Parkinson disease protein 7,42611,0.0524043460673085,0.00507208327752238,0.0424630628433646,0.0623456292912523,6.26722921846815e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0347871463295463,0.00336719732756755,-0.0413868530915787,-0.0281874395675139,6.31404283256108e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0497337212958133,0.00481369739150138,0.0402988744084706,0.059168568183156,6.57828852324612e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB1,Beta-crystallin B1,40511,0.0646543297060017,0.00625896686835732,0.0523867546440213,0.076921904767982,6.66008822901863e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.0556180240350928,0.00539214570057309,0.0450494184619696,0.0661866296082161,7.80457506780835e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0477463305931126,0.00463149778102705,0.0386685949422996,0.0568240662439256,8.26159611661478e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.0805877712505511,0.00782437436129508,0.0652519975024127,0.0959235449986894,9.16501026777352e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP5,Platelet glycoprotein V,40283,0.0364978222052129,0.00354899279405961,0.0295417963288561,0.0434538480815697,1.07406837019191e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0584746551146483,0.00568991316575035,0.0473224253097776,0.069626884919519,1.11034258839184e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM106A,Transmembrane protein 106A,40451,0.0705683270995877,0.00686818685197945,0.0571066808697079,0.0840299733294674,1.17768009067701e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0562373009053246,0.00547872745713381,0.0454989950893423,0.0669756067213069,1.31177290479384e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0691343556964742,0.00674403624838495,0.0559160446496397,0.0823526667433086,1.5099918901324e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK7,Kallikrein-7,40009,0.0393611787796294,0.00384763940419468,0.0318198055474078,0.0469025520118509,1.88125938241762e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0705616901527191,0.0068979450288448,0.0570417178961833,0.0840816624092549,1.88767329036701e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0866340576480388,0.00848326029015956,0.070006867479326,0.103261247816752,2.23075197925213e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TALDO1,Transaldolase,40499,0.0441256791035291,0.00432153592592525,0.0356554686887156,0.0525958895183426,2.26655701049754e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0531612729084302,0.00521237745377972,0.0429450130990219,0.0633775327178384,2.46562645196085e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXN,Paxillin,42311,0.0511053299778899,0.00501487408010595,0.0412761767808822,0.0609344831748975,2.68604218883751e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0469224449682736,0.00460329534543285,0.0378999860912253,0.055944903845322,2.70553323528066e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESYT2,Extended synaptotagmin-2,40483,0.0821463944053185,0.00806135693310952,0.0663461348164238,0.0979466539942131,2.79486356813582e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0657007269773249,0.00644869832740816,0.0530612782556049,0.0783401756990449,2.87346682674669e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0761607590247734,0.00748135846921628,0.0614972964251094,0.0908242216244373,3.11447439450115e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN2,Centrin-2,42311,0.0670132699012963,0.00658961083649719,0.0540976326617618,0.0799289071408307,3.33473530551919e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE4,Ribonuclease 4,40169,0.0291810908968001,0.00287206394618139,0.0235518455622846,0.0348103362313156,3.81195003913391e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0275362610565383,0.00271169165308026,0.022221345416501,0.0328511766965756,3.86134061484195e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0458425961694812,0.0045181546341807,0.036987013086487,0.0546981792524754,4.19819802716615e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLMH,Bleomycin hydrolase,42794,0.0311380125428519,0.00306953063963673,0.0251217324891639,0.0371542925965399,4.28289417831739e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6AP2,Renin receptor,42346,0.0401429811133026,0.00395758530931058,0.0323861139070538,0.0478998483195513,4.3523382963667e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0197690268156945,0.00195099460514258,0.0159450773896151,0.023592976241774,5.00285411460787e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.0538419633249891,0.00532577247790993,0.0434034492682857,0.0642804773816926,6.0982296418815e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0685629422689819,0.00678265847713351,0.0552689316538002,0.0818569528841636,6.4489870088296e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0805711908516943,0.00797706196026137,0.064936149409582,0.0962062322938066,6.70225823407478e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0475273752746729,0.00470473504479852,0.0383060945868678,0.056748655962478,6.83590564211765e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0685366484472913,0.00678657666052717,0.0552349581926581,0.0818383387019246,7.06675246920427e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.089182044290915,0.00884931605868198,0.0718373848158984,0.106526703765932,8.72127351275321e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0312303566450555,0.00310192948702617,0.0251505748504842,0.0373101384396268,9.27504203063319e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGLAP,Osteocalcin,40527,0.0894441228966475,0.00889818677092265,0.0720036768256391,0.106884568967656,1.13167101875026e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PENK,Proenkephalin-A,40283,0.0323755462048217,0.00322082056831328,0.0260627378909277,0.0386883545187158,1.13726169044481e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0246087612898223,0.00244941844553081,0.0198079011365819,0.0294096214430627,1.15346415205435e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0599725872335157,0.00596996987864399,0.0482714462713735,0.0716737281956579,1.20534019707122e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0522238458606048,0.0051989107511298,-0.0624137109328192,-0.0420339807883904,1.21174210891438e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDUA,Alpha-L-iduronidase,42721,0.0455647580647111,0.00454116926574984,0.0366640663038414,0.0544654498255808,1.31058619392798e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0513927217290665,0.00512747741002775,0.0413428660054121,0.0614425774527209,1.46155568103638e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPBP,Platelet basic protein,40471,0.082746423117582,0.00825909714826283,0.0665585927069868,0.0989342535281771,1.58017609818209e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0231913416225204,0.00231616209338655,0.0186516639194827,0.027731019325558,1.61475199217031e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.107259086868365,0.0107244748825641,0.0862391160985397,0.128279057638191,1.82331437828321e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0849105713466459,0.00850552953589594,0.0682397334562899,0.101581409237002,2.2744961043959e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.0726547138850599,0.00728340048667317,0.0583792489311805,0.0869301788389393,2.43858989538129e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0368107033699447,0.00369906097632583,0.029560543856346,0.0440608628835433,2.99170127069954e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0720023964940635,0.00723861188361364,0.0578147172021808,0.0861900757859462,3.13967895295863e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.05185204933443,0.00521851972307297,0.041623750677207,0.062080347991653,3.48569564770524e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.115434272691464,0.0116223647546075,0.0926544377724334,0.138214107610495,3.62641231901653e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.0575440765144936,0.00579912048588949,0.0461778003621502,0.0689103526668371,3.97769755700221e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA13,Carbonic anhydrase 13,42483,0.0998511394219644,0.0100642499740512,0.0801252094728241,0.119577069371105,4.04440279334745e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.0945909518067882,0.00953921026011219,0.0758940996969683,0.113287803916608,4.40424511360818e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0453694829113885,0.00457716476068384,0.0363982399804481,0.0543407258423288,4.44168802546213e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.036776300710256,0.00371398669451297,0.0294968867890105,0.0440557146315014,5.07815509464832e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP6,Platelet glycoprotein VI,42590,0.0841033502050421,0.00852479757602954,0.0673947469560242,0.10081195345406,7.0133362293134e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX2,Heme oxygenase 2,42311,0.0442225392801363,0.00448325041674047,0.035435368463325,0.0530097100969477,7.16536933794168e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0241208167453995,0.00245084501543235,0.0193171605151521,0.0289244729756469,8.88136849796792e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.0620520882153106,0.00631279297055341,0.0496790139930259,0.0744251624375952,1.00554031303182e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FADD,FAS-associated death domain protein,42636,0.0724810584031076,0.00739732399557095,0.0579823033717885,0.0869798134344267,1.36303890018561e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",42618,-0.0906155005012467,0.00924942260298633,-0.1087443688031,-0.0724866321993935,1.38222973421361e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.061180224867247,0.00624726322195007,0.0489355889522248,0.0734248607822691,1.44003779091792e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0564155489809522,0.00576572634635956,0.0451147253420875,0.0677163726198169,1.56440331056207e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL1,Growth-regulated alpha protein,42607,0.0915502341910604,0.00935732257556617,0.0732098819429507,0.10989058643917,1.57183373674541e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0640470109717829,0.00654589870791762,0.0512170495042643,0.0768769724393014,1.62708799353154e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP2,Retinol-binding protein 2,42587,-0.0741554513481449,0.0075822490387049,-0.0890166594640065,-0.0592942432322833,1.62984505455441e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.027076089422299,0.00277233834321727,0.0216423062695931,0.0325098725750048,1.866241080596e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.114553330971329,0.0117368522579025,0.0915491005458404,0.137557561396818,1.98256524192038e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0420467595589939,0.00430888681637616,0.0336013413988966,0.0504921777190912,2.02178549161243e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0931825434445466,0.00956516629007964,0.0744348175159905,0.111930269373103,2.36815573214125e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0254785877953101,0.0026164073906855,0.0203504293095665,0.0306067462810537,2.45786501934285e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2,Complement C2,42663,0.0218873481848767,0.00224849926506662,0.0174802896253461,0.0262944067444073,2.55270529493472e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS1,Galectin-1,42636,0.0334066712733492,0.0034415439572762,0.0266612451170878,0.0401520974296105,3.3331527551982e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0679502819440277,0.0070240827526978,0.0541830797487401,0.0817174841393154,4.58469679664147e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP3,Stromelysin-1,42611,-0.0479600363421679,0.00496003907942639,-0.0576817129378436,-0.0382383597464922,4.80538360393434e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C3,Complement C3,39989,0.0446734218893083,0.00462745231482497,0.0356036153522513,0.0537432284263652,5.79902006907733e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0242736196663375,0.00251890054340477,0.0193365746012642,0.0292106647314109,6.79451036248766e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.0812964508323219,0.00844107692614333,0.064751940057081,0.0978409616075629,7.17490965706529e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARFIP1,Arfaptin-1,40482,0.0645920660081581,0.00670805495472367,0.0514442782968997,0.0777398537194164,7.31628168308973e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0613519033600867,0.00637454793005764,0.0488577894171737,0.0738460173029996,7.40402359389285e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0571778231893292,0.00594036394136299,0.0455347098642578,0.0688209365144007,7.58799717091118e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0547380963970081,0.00569220209772051,0.0435813802854759,0.0658948125085403,8.04824115849507e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0662998957830311,0.00689310573731119,0.0527894085379011,0.079810383028161,8.11090536160748e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABHD14B,Protein ABHD14B,42460,0.0538060518809853,0.00559758517228083,0.0428347849433148,0.0647773188186557,8.35005212585632e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.0460845314281422,0.00480711062695387,-0.0555064682569718,-0.0366625945993126,1.06712694693905e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTC,Probetacellulin,42346,0.0703090229568765,0.00733443255842095,0.0559335351423714,0.0846845107713816,1.07638646745563e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX4,Syntaxin-4,42587,0.0557617598939397,0.00581870999596628,0.0443570883018458,0.0671664314860336,1.10440169989077e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0490115529585628,0.00511993818408885,0.0389764741177486,0.0590466317993769,1.22524736109117e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0556781700896593,0.00582533879806153,0.0442605060454587,0.0670958341338599,1.44964371441679e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0356766398067925,0.00373954626768327,0.0283471291221333,0.0430061504914517,1.71508893564849e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0556128054765829,0.00583217537254532,0.0441817417463941,0.0670438692067718,1.74317910181158e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL32,Interleukin-32,42594,-0.0414122575416184,0.00434839989584819,-0.0499351213374808,-0.032889393745756,1.95621150828283e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0572392568514275,0.00601229505652,0.0454551585406483,0.0690233551622067,2.01394963238751e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LARP1,La-related protein 1,40451,0.0570165050306917,0.00600743359603528,0.0452419351824625,0.0687910748789208,2.74859665782063e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1A,Meprin A subunit alpha,40449,0.0675007915147803,0.00711726634109692,0.0535509494862304,0.0814506335433303,2.93526588582606e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0505506203955544,0.00533553417223526,0.0400929734179733,0.0610082673731355,3.23385192439918e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0281450838484606,0.00297515376058375,0.0223137824777164,0.0339763852192047,3.69018621298477e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DXO,Decapping and exoribonuclease protein,40483,0.0423688338806806,0.00448096856707496,0.0335861354892137,0.0511515322721475,3.85675756320231e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA12,Serpin A12,42249,0.0959923599440354,0.0101611112433309,0.0760765819071069,0.115908137980964,4.07100080070687e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPSE,Heparanase,40408,0.0868713782999916,0.00919607976446256,0.068847061961645,0.104895694638338,4.19404389209793e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM1,Dynamin-1,40449,0.105624184869752,0.0111895378516672,0.0836926906804847,0.12755567905902,4.47937138465096e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.037103066137691,0.00393338709974741,0.029393627422186,0.0448125048531959,4.64344006300626e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.0974720606153776,0.0103456668174088,0.0771945536532565,0.117749567577499,5.30871609146161e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGLN1,Egl nine homolog 1,42594,0.0511762440921219,0.00543648474127585,0.0405207339992212,0.0618317541850225,5.57167572267921e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUS,RNA-binding protein FUS,42336,0.0366759214553924,0.00389972925658573,0.0290324521124844,0.0443193907983004,6.06933754032152e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0401204892656268,0.00426589146966216,0.0317593419850889,0.0484816365461646,6.21195238181896e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0451692204275793,0.00482210743033929,0.0357178898641143,0.0546205509910443,8.62601342976307e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0533884115446806,0.00571744088457486,0.0421822274109139,0.0645945956784473,1.13556061024264e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0443844546494662,0.0047551036651146,0.0350644514658416,0.0537044578330908,1.20895064113012e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRD2,Protein ZNRD2,40449,0.0638309079038713,0.0068445799787161,0.0504155311455878,0.0772462846621549,1.30737954099147e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLNK,B-cell linker protein,40199,0.0374602898854469,0.00401852116098184,0.0295839884099224,0.0453365913609713,1.36057571987995e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0363365630319764,0.00389864212712276,0.0286952244628158,0.043977901601137,1.3750710899886e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0314379596606707,0.00337528906312326,0.0248223930969492,0.0380535262243923,1.45724264585285e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT1,Angiopoietin-1,42554,0.0763438413058989,0.00820723701048514,0.060257656765348,0.0924300258464498,1.58948114288223e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0424580180032626,0.00456453085721627,0.0335115375231187,0.0514044984834065,1.64093821736824e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0396508120385489,0.0042800749552178,0.031261865126322,0.0480397589507758,2.26643527470791e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0514906690105363,0.00555905269371929,0.0405949257308465,0.0623864122902261,2.29672109874372e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0385636540217472,0.00416269076647882,0.0304047801194487,0.0467225279240457,2.32577638322388e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL7,C-C motif chemokine 7,42594,0.0536871377410422,0.00580486876500594,0.0423095949616305,0.0650646805204538,2.61298293177209e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCG,Gamma-synuclein,42495,0.0625105716456717,0.00676709493721844,0.0492470655687236,0.0757740777226198,2.90269811936264e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0367444338780148,0.00398308654953907,0.0289375842409182,0.0445512835151113,3.2592785390695e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL26,C-C motif chemokine 26,42594,0.0844789838628633,0.00916524923095495,0.0665150953701916,0.102442872355535,3.49447305451917e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0519848473983599,0.00564571107313995,0.0409192536950056,0.0630504411017142,3.81014444440757e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO1A,Coronin-1A,42353,0.0804957173521741,0.00875031446515113,0.0633451010004779,0.0976463337038703,4.14339622086472e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX8,Syntaxin-8,42594,0.0431267957008901,0.00468970059289887,0.0339349825388083,0.0523186088629718,4.25384532450463e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0547583211373523,0.00595763835777753,-0.0664352923185963,-0.0430813499561083,4.44058458413487e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0428162355699402,0.00467015874846709,-0.0519697467169357,-0.0336627244229448,5.50831676746888e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN6,Dynactin subunit 6,42311,0.0645689604983078,0.00704271946304913,0.0507652303507315,0.0783726906458841,5.51823250154442e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSTN,Growth/differentiation factor 8,42357,0.0479709670014187,0.00523763366961226,0.0377052050089787,0.0582367289938588,6.00809901012836e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSHB,Thyrotropin subunit beta,42636,0.0711959624910115,0.00779354121172211,0.0559206217160361,0.0864713032659868,7.44678705935603e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCA,Tubulin-specific chaperone A,40283,0.0758964656759829,0.00831473637746027,0.0595995823761608,0.0921933489758051,8.18791999551677e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0783274593706585,0.00860555287814333,0.0614605757294975,0.0951943430118194,1.013222286764e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0384343122387839,0.00422142348895994,0.0301603222004224,0.0467083022771454,1.01549757172778e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0613814130842046,0.00675580376440681,0.0481400377059672,0.0746227884624419,1.20634875732867e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0215945887607937,0.00237923664430735,0.0169312849379513,0.0262578925836361,1.27731404065735e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0463424068070446,0.00510830696817161,0.0363301251494282,0.0563546884646609,1.33287057827237e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0746030792334526,0.00823977591455219,0.0584531184409303,0.0907530400259748,1.60281192102277e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0315961475704443,0.00349687511738514,-0.0384500228005192,-0.0247422723403694,1.89785682733668e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2R,Proteinase-activated receptor 1,42654,0.0494683079456506,0.0054777442387994,0.0387319292376038,0.0602046866536974,1.93348031152369e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0356301687566844,0.00394871737853232,0.027890682694761,0.0433696548186077,2.12038844568125e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH7,Protocadherin-7,40449,0.0321967535689436,0.00356944845505934,0.0252006345970273,0.0391928725408599,2.18327052844455e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXT,Oxytocin-neurophysin 1,42711,0.122050879537677,0.0135664904892343,0.0954605581787779,0.148641200896576,2.63707037753098e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.030097575028607,0.00334706922777716,0.0235373193421637,0.0366578307150502,2.74441550974618e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0698448995598222,0.00777447148263368,-0.0850828636657842,-0.0546069354538602,2.95791338340497e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0533621359628885,0.00594125146727228,0.0417172830870348,0.0650069888387422,3.02248387767382e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0309844463182805,0.00345653111283141,-0.0377592472994301,-0.024209645337131,3.53979697813984e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0471035742294801,0.00525643376501902,0.0368009640500429,0.0574061844089174,3.63307655474514e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0361952804477779,0.00404347443616026,0.0282700705529038,0.044120490342652,3.9585236463445e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.0749855649000827,0.00840410445337495,0.0585135201714678,0.0914576096286976,5.16321689860446e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40LG,CD40 ligand,42754,0.0677190065013574,0.00760284674921679,0.0528174268728925,0.0826205861298223,5.89963761443223e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.024902861534793,0.0027956411901499,0.0194234048020992,0.0303823182674868,6.00215351860937e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0242334261667396,0.00272257608646357,0.018897177037271,0.0295696752962082,6.24257577337381e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1F,Protein phosphatase 1F,40511,0.0455225872909068,0.0051150442481892,0.035497100564456,0.0555480740173576,6.44778167898006e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0464770861078482,0.00522354556390333,0.0362389368025976,0.0567152354130987,6.61056192626206e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0507773049675243,0.00570898667251868,0.0395876910893877,0.0619669188456609,6.62467806944824e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRN1,Secernin-1,42594,0.0482456941429068,0.00542473217522055,0.0376132190794746,0.0588781692063391,6.66164801375138e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0399564992362839,0.00449379261061362,0.0311486657194812,0.0487643327530866,6.96740241097162e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0668456790894412,0.00753287044431183,0.05208125301859,0.0816101051602924,8.13124196406493e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0206828842942172,0.00233447996304016,0.0161073035666585,0.0252584650217759,9.01797537684437e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0632399728398689,0.00715845094741308,0.0492094089829393,0.0772705366967986,1.13232156263104e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANG,Angiogenin,42618,0.0290685618206851,0.00329304997385395,0.0226141838719313,0.0355229397694388,1.20421858213209e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSC2,Desmocollin-2,42488,-0.0307465240556207,0.00348421486593253,-0.0375755851928484,-0.0239174629183929,1.23512617656988e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0351579631855459,0.00398707136151019,0.0273433033169859,0.0429726230541059,1.34212027688574e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACYP1,Acylphosphatase-1,40250,0.0567039294461121,0.00643724722344321,0.0440869248881634,0.0693209340040608,1.4545310429932e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM3,Junctional adhesion molecule C,40283,0.0438373303545062,0.00498477377497504,0.0340671737555551,0.0536074869534573,1.65267739243669e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0389840480915041,0.00443502569025686,0.0302913977386006,0.0476766984444075,1.67888266559168e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0551575102030395,0.00628046107825936,0.0428478064896512,0.0674672139164279,1.83143537285913e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0439194047380664,0.00500866846519438,0.0341024145462854,0.0537363949298474,2.02774279758359e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0372402757641222,0.00425146750598282,0.0289073994523959,0.0455731520758485,2.20087859813493e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID1,Nidogen-1,42652,0.0329592179183469,0.00376507885013132,0.0255796633720895,0.0403387724646042,2.30362493932489e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF7,SLAM family member 7,42594,-0.0511911647401757,0.00585295860482155,-0.0626629636056259,-0.0397193658747254,2.46700241808616e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0329110141942005,0.00376423495318017,0.0255331136859673,0.0402889147024336,2.58890203923919e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBI,Acyl-CoA-binding protein,42562,0.0653580237766417,0.00748249393247915,0.0506923356689825,0.0800237118843008,2.72839373411374e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0288140222677906,0.00329906235766764,-0.0352801844888192,-0.022347860046762,2.74450368320356e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOA,Elongin-A,42587,0.0458218609439309,0.00524910003422272,0.0355336248768544,0.0561100970110075,2.85851385698112e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.022055791593806,0.00252813835874723,0.0171006404106614,0.0270109427769505,3.05932023731964e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.056301156978563,0.00646649410163041,0.0436268285393674,0.0689754854177586,3.50057930365242e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.0259083348079364,0.00297853548247162,-0.0317462643535807,-0.020070405262292,3.75257005216624e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB10,Ras-related protein Rab-10,40511,0.0456862003783203,0.00525446354057464,0.035387451838794,0.0559849489178466,3.95485638224346e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD84,SLAM family member 5,42594,0.0267384588375125,0.00308044373492006,0.0207007891170692,0.0327761285579558,4.40776430071901e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSO,Cathepsin O,42754,0.0261531358552381,0.00301575110738089,0.0202422636847716,0.0320640080257047,4.71632841793336e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.102150138374045,0.0117811934929981,-0.125241277620321,-0.0790589991277687,4.79132829588951e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4R,Reticulon-4 receptor,42721,0.0292538550485939,0.00337840093373984,0.0226321892184638,0.035875520878724,5.28894136495865e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.032332845417878,0.00373738238086645,0.0250075759513797,0.0396581148843762,5.6817907186096e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL3,C-C motif chemokine 3,42594,0.0488277127440911,0.00564567085320389,0.0377621978718115,0.0598932276163708,5.79585046499989e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0631694961017003,0.00730990992880648,0.0488420726412396,0.077496919562161,6.30048170098077e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0699750479716759,0.00810553233271804,0.0540882045995485,0.0858618913438032,6.77974537783873e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAN,Aggrecan core protein,42488,0.0235736873397404,0.00273286118488113,0.0182172794173733,0.0289300952621074,7.06692241022893e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMNL1,Formin-like protein 1,42311,0.0523471232874855,0.00607536589083014,0.0404394061414585,0.0642548404335126,7.70030847774811e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0509846055310568,0.00591868960531908,0.0393839739046314,0.0625852371574822,7.84109185138585e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGF,Hepatocyte growth factor,42754,0.029410333689439,0.00341557574370081,0.0227158052317854,0.0361048621470926,8.058352955928e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0181363668117356,0.00210670372759592,0.0140072275056476,0.0222655061178236,8.18953410684019e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0458590666175023,0.00532752171449804,0.0354171240570861,0.0563010091779185,8.44662579955785e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSNAX,Translin-associated protein X,40116,0.0334546593128108,0.00388890068749007,0.0258324139653303,0.0410769046602914,8.8584800440562e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.0613260010717215,0.00713459514463233,0.0473421945882422,0.0753098075552009,9.19469079713328e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0609187864071304,0.00714531165546904,0.0469139755624111,0.0749235972518497,1.68333017694471e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0298235291835833,0.00350108932728015,0.0229613941021142,0.0366856642650524,1.79340696504952e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0480777751826779,0.00565838589801356,0.0369873388225713,0.0591682115427844,2.15580592324925e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL2,C-C motif chemokine 2,42475,0.0444415165471353,0.00523080635936943,0.0341891360827712,0.0546938970114993,2.1675665576747e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C5,Complement C5,40539,0.0126008352442325,0.00148359898057448,0.0096929812423065,0.0155086892461585,2.25616237062712e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA6,Integrin alpha-6,42594,0.042415258274738,0.00499644663663388,0.0326222228669356,0.0522082936825405,2.29993089602077e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.019565937328566,0.00230601446723615,0.0150461489727832,0.0240857256843489,2.38711707672774e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.047411678915536,0.00558854438394955,0.0364581319229949,0.0583652259080771,2.41230546231336e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAV,Integrin alpha-V,42721,0.0136419999564842,0.00161126623565895,0.0104839181345926,0.0168000817783757,2.78389598191132e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML2,Trem-like transcript 2 protein,42611,0.0288714838029635,0.00341794927623851,0.022172303221536,0.0355706643843909,3.29327346700715e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0366354019885657,0.00434900183928321,0.0281113583835707,0.0451594455935608,4.01462575922006e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0431667140851552,0.00513227411188599,0.0331074568258587,0.0532259713444517,4.48770214124974e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0226326213646814,0.00269422644038933,0.0173519375415183,0.0279133051878445,4.97945982375438e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSPN,Persephin,42594,0.0768236178293038,0.00915583332107433,0.0588781845199981,0.0947690511386095,5.31401766543414e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUOM,Fucose mutarotase,40283,0.0520759941959813,0.00622020417607613,0.0398843940108721,0.0642675943810905,6.34138499148903e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL,Podocalyxin,42587,0.0125607069108273,0.00150124833599635,0.00961826017227443,0.0155031536493801,6.49999522154679e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0564297567123488,0.0067474237871511,0.0432048060895326,0.0696547073351649,6.83509179050565e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN2,Matrilin-2,42638,0.0242831978057516,0.00290452920373071,0.0185903205664394,0.0299760750450638,6.85713185678835e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN4,Cerebellin-4,42721,0.0267211590399804,0.00319808303123225,0.0204529162987652,0.0329894017811956,7.15382128480152e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0299947456599738,0.00359213883652377,0.0229541535403872,0.0370353377795604,7.48967313294431e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0433292183880919,0.0051883236886774,0.0331601039582842,0.0534983328178996,7.55909795181099e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0322035919814189,0.00386345273545743,0.0246312246199224,0.0397759593429155,8.46283499216546e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.050112634651494,0.00601493883207353,0.0383233545406298,0.0619019147623581,8.76312646050299e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX16,Syntaxin-16,42346,0.0473145811930801,0.00568007605858653,0.0361816321182505,0.0584475302679097,8.8853249527575e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0550968023663803,0.00661357639916649,0.0421341926240139,0.0680594121087466,8.98501563383139e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR2,Folate receptor beta,42711,-0.0242225640947511,0.00291102959332522,-0.0299281820976686,-0.0185169460918337,9.55559638948681e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO2,Gamma-enolase,42711,0.0525609759888702,0.00632252980717834,0.0401688175668006,0.0649531344109397,1.01915614039644e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLU,Clusterin,40539,0.0258480341666789,0.00310981207920375,0.0197528024914395,0.0319432658419182,1.05015780256747e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX9,Sorting nexin-9,42636,0.0545535405869843,0.00656947278544074,0.0416773739275204,0.0674297072464481,1.10128295908458e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SWAP70,Switch-associated protein 70,40449,0.0291306989656841,0.00350782198006554,0.0222553678847556,0.0360060300466125,1.11703099147892e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WDR46,WD repeat-containing protein 46,40451,0.0293319239307426,0.00353217701460237,0.0224088569821219,0.0362549908793632,1.11974292182429e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APP,Amyloid-beta precursor protein,42592,0.0540941340557958,0.00651645269320813,0.0413218867771079,0.0668663813344838,1.12902454396094e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA4,Carbonic anhydrase 4,42794,-0.0196239441607571,0.00237094182997361,-0.0242709901475054,-0.0149768981740089,1.38169724659613e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0461001572510059,0.00557285122312003,0.0351773688536907,0.0570229456483212,1.43988367358665e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.022667388618622,0.00274000730503377,0.0172969743007558,0.0280378029364882,1.46008609835574e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMA,Granzyme A,42754,0.0288369507411596,0.00348894158018826,0.0219986252439906,0.0356752762383286,1.52272169822352e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDS,Iduronate 2-sulfatase,42754,0.00709440321513519,0.00085915469321621,0.00541046001643142,0.00877834641383897,1.62531579574122e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL11,Eotaxin,42754,0.0297438306143918,0.00360231094702087,0.0226833011582309,0.0368043600705527,1.6327489183305e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0208450111971194,0.00252740423295492,0.0158912989005278,0.0257987234937111,1.76547193067982e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0710108821645027,0.00862592246969627,0.054104074123898,0.0879176902051073,2.03960588159573e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0353381099074496,0.00429467778559398,0.0269205414476855,0.0437556783672138,2.11146529864892e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0416977470131701,0.00506768035177172,0.0317650935236976,0.0516304005026427,2.11677076776349e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.03898729415651,0.00474476628955127,0.0296875522289895,0.0482870360840305,2.28236817886683e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL18,C-C motif chemokine 18,42477,0.0561842111050151,0.00684143916924606,0.0427749903332928,0.0695934318767374,2.36837563866804e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS27,Serine protease 27,42603,0.0325386497923651,0.00396341474431778,0.0247703568935023,0.040306942691228,2.41770579682629e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL4,C-C motif chemokine 4,42642,0.0550662006560911,0.0067077279503553,0.0419190538733947,0.0682133474387875,2.42480975912291e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0352550744091688,0.00430721662862297,-0.0436972190012698,-0.0268129298170678,2.96456398854856e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0388366089776359,0.00474732817789767,0.0295318457489565,0.0481413722063154,3.12565418812162e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0267880450546888,0.00327879751887749,0.0203616019176889,0.0332144881916887,3.3527850279097e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TST,Thiosulfate sulfurtransferase,42277,0.0598115755601926,0.00732419849645674,0.0454561465071374,0.0741670046132478,3.46983320317291e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0536203652359573,0.00657159477413815,0.0407400394786465,0.0665006909932681,3.72319942402386e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0275392495381,0.00339366659606145,0.0208876630098196,0.0341908360663804,5.37919383174843e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0238498097133346,0.00294886530217606,0.0180700337210696,0.0296295857055997,6.70791085056669e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0415264537894583,0.00513721892661358,-0.0515954028856209,-0.0314575046932956,6.83351174945912e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSD,Cathepsin D,41747,0.0333290762256994,0.00414410429013845,0.0252066318170281,0.0414515206343708,9.58674344729424e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0245590687293617,0.00305634438159924,-0.0305495037172962,-0.0185686337414271,1.01147310952403e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0318813926756737,0.00397243548087889,0.0240954191331511,0.0396673662181963,1.11248474098091e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGA,Chromogranin-A,40527,-0.0773712444158361,0.00965135271838199,-0.0962878957438648,-0.0584545930878074,1.19355027379099e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0276813991190922,0.00346343087098161,0.0208930746119682,0.0344697236262162,1.4547585558942e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0376100768281696,0.00471132967261643,0.0283758706698414,0.0468442829864978,1.54719711177333e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MME,Neprilysin,42587,0.063518720539422,0.00796416366159088,0.0479089597627039,0.0791284813161401,1.6392917076915e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0286589131191741,0.00359559574234968,0.0216115454641687,0.0357062807741795,1.70514270740915e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0495650372664912,0.00622090728171112,0.0373720589943374,0.061758015538645,1.77411727335157e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD27,CD27 antigen,42679,-0.0346345563381251,0.00435450523733318,-0.0431693866032982,-0.0260997260729521,1.95325838971795e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0412271729658371,0.0051951468258341,-0.0514096607444719,-0.0310446851872023,2.25758792140656e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.0205830362390239,0.0025967495415844,-0.0256726653405294,-0.0154934071375185,2.42948849900973e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL2,Chordin-like protein 2,42636,0.0367127225562327,0.00464332397222172,0.0276118075706781,0.0458136375417873,2.85137179170622e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0454102467903895,0.00574436528569972,0.034151290830418,0.0566692027503609,2.88171490339314e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0433032354711195,0.00548468402957117,0.03255325477316,0.054053216169079,3.12049564985802e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0357535686405063,0.00453413168437359,0.026866670539134,0.0446404667418785,3.42396953607245e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0377674341785128,0.0047936785188756,0.0283718242815166,0.047163044075509,3.6154335719875e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0230842647107163,0.00293536389997329,0.0173309514667686,0.0288375779546639,4.00089403819121e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCA,Calcitonin,42476,0.048947007800134,0.00622520828210307,0.036745599567212,0.061148416033056,4.04791804347406e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0707675097489792,0.00902314408751689,0.0530821473374461,0.0884528721605123,4.79933675873336e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0390842775578097,0.00499237207293869,0.0292992282948498,0.0488693268207695,5.30081756471723e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELE,E-selectin,42794,0.0389592474367519,0.00498173331858097,0.0291950501323332,0.0487234447411706,5.65087276815665e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0219618140868705,0.002807735434797,0.0164586526346684,0.0274649755390727,5.68278371927478e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA4,Annexin A4,42584,0.0547658394881555,0.00701210241417763,0.0410221187563674,0.0685095602199437,6.13360527204088e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0332102220939877,0.00425256293040952,0.024875198750385,0.0415452454375903,6.16958489951893e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0674868951787137,0.0086721621565779,0.0504894573518211,0.0844843330056064,7.77176573391283e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT2,Angiopoietin-2,42721,-0.0289104599873878,0.00371759003909305,-0.0361969364640102,-0.0216239835107654,7.98279119080353e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.0663109433144071,0.00853118035438807,0.0495898298198065,0.0830320568090077,8.36098402846594e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC79,Protein unc-79 homolog,40080,0.0425694841515117,0.00547859109113638,0.0318314456128844,0.053307522690139,8.54450189001537e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0171926866319124,0.00221530507889905,0.0128506886772703,0.0215346845865546,9.16184713835838e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0289524466722174,0.00373405194763164,-0.0362711884895754,-0.0216337048548594,9.57269860761842e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C8B,Complement component C8 beta chain,40539,0.0232233387081728,0.00299586678899436,0.0173514398017439,0.0290952376146018,9.83380241483967e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17D,Interleukin-17D,42370,0.0262603369422131,0.00339177425008844,0.0196124594120398,0.0329082144723865,1.04687849970104e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.0217450613942325,0.00281308235456431,0.0162314199792865,0.0272587028091786,1.16665973096158e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0211338306106879,0.00273470054539991,0.015773817541704,0.0264938436796717,1.18530725770655e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0190735473325684,0.0024688336670609,0.0142346333451291,0.0239124613200078,1.19044867674333e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRBP,Acrosin-binding protein,40451,0.0297197494986884,0.00385415499664454,0.0221656057052651,0.0372738932921117,1.35249989769052e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0264379114752483,0.00343089632832497,0.0197133546717313,0.0331624682787652,1.39270160276043e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAP3,Cytosol aminopeptidase,42370,0.036668605967056,0.00476068274546081,0.0273376677859528,0.0459995441481591,1.43064369060579e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0180260100423784,0.00234696354229867,0.013425961499473,0.0226260585852838,1.69194329235612e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAD,Chondroadherin,40283,0.0393310104650445,0.00512258858389277,0.0292907368406146,0.0493712840894743,1.75233053851237e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0243590461368161,0.00317263836553211,0.0181406749403731,0.030577417333259,1.75727772454707e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C19orf12,Protein C19orf12,42311,0.0479832650955665,0.00625147323658858,0.0357303775518529,0.0602361526392801,1.76382236970375e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM3,Myomesin-3,40283,-0.0700227769445737,0.00912862623323871,-0.0879148843617216,-0.0521306695274259,1.85409936976213e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0204050883589121,0.00266241066470408,0.0151867634560922,0.0256234132617321,1.92344657390377e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0492963703933624,0.0064369060018441,-0.0619127061569768,-0.0366800346297479,2.00952648071517e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0285008803502531,0.00372156929138323,0.0212066045391419,0.0357951561613642,2.03799137209242e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0283746809197377,0.00371614151195456,0.0210910435563067,0.0356583182831686,2.4338685004268e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0497720466564129,0.00652296649635522,0.0369870323235566,0.0625570609892691,2.50309107428691e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0542097175690637,0.00710535751918913,0.040283216831453,0.0681362183066744,2.5151234961158e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0358508760956272,0.00470474974531636,0.0266295665948071,0.0450721855964472,2.73724722981238e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF3,Trefoil factor 3,42613,-0.0322878179035482,0.00423838365573112,-0.0405950498687812,-0.0239805859383152,2.74952700634498e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0567936095302921,0.00745604658815381,0.0421797582175107,0.0714074608430736,2.80178423545922e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.0608122441711634,0.00800201902316175,0.0451282868857664,0.0764962014565604,3.17090667512316e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0182983868088995,0.0024115163977412,0.0135718146693268,0.0230249589484723,3.46529324905672e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0381262045353069,0.00502707072886821,0.0282731459067252,0.0479792631638886,3.56489876041996e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.0175531839995752,0.00231901842867537,-0.022098460119779,-0.0130079078793715,3.99937642825589e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0264626407627663,0.00349811824446552,-0.0333189525219187,-0.0196063290036139,4.14138003766479e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMS,Spermine synthase,40136,0.0473629303527429,0.00628338286534859,0.0350474999366597,0.0596783607688261,5.15717048917173e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPN,Asporin,40511,0.0208873027228277,0.00277244575366052,0.0154533090456531,0.0263212964000023,5.30020903182737e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDHB,Succinate dehydrogenase,40449,0.0492308966095717,0.00653706323692084,0.0364182526652069,0.0620435405539366,5.41873985450356e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXN,"Frataxin, mitochondrial",42721,0.0539975893036424,0.00718231099112182,0.0399202597610436,0.0680749188462411,5.90546186234347e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF2,Fibroblast growth factor 2,42594,0.0504365613038007,0.00672293411301815,0.0372596104422852,0.0636135121653163,6.67214786843828e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0413281898447368,0.00551319322805019,-0.0521340485717151,-0.0305223311177584,7.07625162473121e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRIB,Protein scribble homolog,40223,0.0669891585537312,0.00894201984372568,0.0494627996600289,0.0845155174474336,7.32957488929548e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0209443952532594,0.00279753768318373,0.0154612213942193,0.0264275691122996,7.49762653022261e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0184294234994772,0.00246320950796659,0.0136015328638626,0.0232573141350917,7.78319758264931e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18,Interleukin-18,42566,0.033998304736571,0.00455310594659514,0.0250742170812445,0.0429223923918975,8.70811052158452e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.05182657167949,0.00694028457008853,0.0382236139221165,0.0654295294368635,8.78663823791837e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0444761033966662,0.00595691888158744,0.0328005423887548,0.0561516644045775,8.8768909415399e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.0766536744145633,0.0102725378150315,0.0565195002971015,0.0967878485320251,9.14977706826739e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0286943946101926,0.00385178663572215,-0.036243896416208,-0.0211448928041772,1.00429868939119e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEPR,Leptin receptor,42636,-0.0227993652044713,0.00306377537929841,-0.0288043649478962,-0.0167943654610464,1.05516571856052e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.051662789282628,0.00694527067608486,-0.0652755198077544,-0.0380500587575017,1.07993753002868e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.024400647008414,0.00328403202027639,-0.0308373497681558,-0.0179639442486723,1.15083108538146e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0494957662842617,0.00666050641144268,0.0364411737178341,0.0625503588506894,1.15361836512038e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPLAH,5-oxoprolinase,40223,0.0494611402980291,0.00665753919896417,0.0364123634680594,0.0625099171279989,1.17204746132005e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFB,Complement factor B,40344,0.023643326294066,0.0031912086339889,0.0173885573714477,0.0298980952166842,1.36560577820634e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0622274529003745,0.00840870474849078,0.0457463915933326,0.0787085142074164,1.43873847478941e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB6,Integrin beta-6,42370,0.0227481327608476,0.00307501087156972,0.0167211114525709,0.0287751540691243,1.46899474209459e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRG,Histidine-rich glycoprotein,40479,0.0225328608286407,0.00304549453578863,0.016563691538495,0.0285020301187865,1.4722685863882e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0165611237808288,0.00224044003968512,0.012169861303046,0.0209523862586116,1.54968915873714e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.0254049590375104,0.00343682603976781,0.0186687799995655,0.0321411380754553,1.55052562758149e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0381527688487494,0.00516215608761965,0.0280349429170149,0.0482705947804839,1.56142963275807e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0346362939048405,0.00469396847636923,0.0254361156911568,0.0438364721185242,1.69183169344498e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0552224551555832,0.00750237192967156,0.0405178061734269,0.0699271041377394,1.95922965447127e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0418105867236946,0.00568501883052208,-0.0529532236315179,-0.0306679498158713,2.02738369103029e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTNB,Dystrobrevin beta,40430,0.0309333476705025,0.00420676813676903,0.0226880821224352,0.0391786132185697,2.06921259052645e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.0402256866838833,0.00547323440018186,0.0294981472595268,0.0509532261082397,2.10626015216805e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP8,Caspase-8,42674,0.0440894340739359,0.00601891542489856,0.0322923598411347,0.0558865083067371,2.52188518098464e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0276015999787567,0.00377088158262995,-0.0349925278807114,-0.020210672076802,2.62725518977309e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0255083800315927,0.00348464858068749,-0.0323382912497402,-0.0186784688134452,2.64802422869976e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0655083630867861,0.00894967146073992,0.0479670070237359,0.0830497191498363,2.65811250409865e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL3,Myosin light chain 3,40223,-0.0529873115163419,0.00724231881930561,-0.0671822564021809,-0.0387923666305029,2.72509973441689e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBN,Nibrin,42370,0.0384416394218675,0.00526242650631169,0.0281272834694966,0.0487559953742384,2.93363629562989e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0497762157427796,0.00682508012276061,0.0363990587021688,0.0631533727833904,3.19716290584094e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMSB10,Thymosin beta-10,42611,0.0530167576161063,0.00726939135497852,0.0387687505603484,0.0672647646718642,3.19764617680447e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0251264767890722,0.00344769850635145,0.0183689877166234,0.031883965861521,3.32580488760982e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.0581234246968644,0.00798222732677893,-0.0737685902573511,-0.0424782591363777,3.48279033759833e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0394153615818176,0.0054301081932776,0.0287723495229935,0.0500583736406417,4.16658906815737e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0445563651458216,0.00614453241294046,0.0325130816164583,0.0565996486751849,4.40165998031335e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.0257373023044003,0.00355301347115228,0.0187733959009418,0.0327012087078587,4.60139781397798e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCA2A,Guanylin,42563,-0.0259628182830162,0.00358735057398719,-0.032994025408031,-0.0189316111580013,4.82585310249936e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0397466913393344,0.00549540099757377,0.0289757053840898,0.050517677294579,5.04492116351834e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0298437630140833,0.00412705453340356,0.0217547361286123,0.0379327898995543,5.1008858241818e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS9,Galectin-9,42620,0.0228668647100238,0.00316348467133914,0.0166664347541991,0.0290672946658485,5.1520830748389e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP9,Caspase-9,40199,0.044362335225082,0.00616939208946172,0.032270326729737,0.056454343720427,6.86355044148845e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRB1,Chymotrypsinogen B,42611,0.0408890077311099,0.00570386610848108,0.029709430158487,0.0520685853037328,7.97033595107867e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.0155347359716024,0.00216755280109066,-0.0197831394617401,-0.0112863324814647,8.06683681168344e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0242794474538743,0.00339099803270044,0.0176330913097814,0.0309258035979671,8.5791229906602e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0572602857154953,0.00801056920653894,0.041559570070679,0.0729610013603116,9.25473564709532e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0226952478240877,0.00317668943720976,0.0164689365271566,0.0289215591210189,9.60201181589996e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0323984191332998,0.00453669715571812,0.0235064927080922,0.0412903455585073,9.72246201049364e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH17,Cadherin-17,42636,-0.0488645924005273,0.0068446302785553,-0.0622800677464957,-0.0354491170545589,9.87574254291803e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0480423866141954,0.0067380935391432,0.0348357232774747,0.0612490499509161,1.05499926772887e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOB,Apolipoprotein B-100,40532,0.0156835251509829,0.00220027014227033,0.0113709956721331,0.0199960546298328,1.08023721979773e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0170027382431573,0.00238954247062165,0.0123192350007389,0.0216862414855757,1.17158871739983e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0211483784333561,0.00297405358732078,-0.0269775234645049,-0.0153192334022074,1.21037695871116e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164,Sialomucin core protein 24,42611,0.0190983907851315,0.00268925082873228,0.0138274591608162,0.0243693224094467,1.29389975279254e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0420781994005272,0.00592661621388119,0.0304620316213201,0.0536943671797343,1.32354367759803e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ING1,Inhibitor of growth protein 1,42292,0.0328340013335388,0.00463648423125315,0.0237464922402826,0.0419215104267949,1.49708003057519e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0228161249504799,0.0032217176271852,0.0165015584011969,0.0291306914997629,1.50539478597672e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0399543461791458,0.00564291305231615,0.0288942365966061,0.0510144557616854,1.52224393107581e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0505802967236068,0.00715289652461048,0.0365606195353702,0.0645999739118433,1.61261659672764e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGF,Placenta growth factor,42754,0.0184751929956188,0.00261410762074144,0.0133515420589656,0.023598843932272,1.6546387659423e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0467103515434238,0.00661027607223237,0.0337542104418484,0.0596664926449993,1.68787421238717e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0290096827041969,0.00410853390826165,0.020956956244004,0.0370624091643897,1.73536803259558e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0265215427213355,0.00376010563315511,0.0191517356803515,0.0338913497623195,1.83348977472762e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0325829320239467,0.00462536054552562,0.0235172253547165,0.0416486386931769,1.97085736773626e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0461499236928179,0.00655334140948979,0.0333053745302179,0.0589944728554178,1.98660720720882e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRH,Corticoliberin,42322,0.0595014391327507,0.00845226875759406,0.0429349923678664,0.0760678858976351,2.02231593626167e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS2,Trypsin-2,42689,0.0386159644259819,0.00548823524817835,0.0278590233395523,0.0493729055124114,2.07179100935366e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FEN1,Flap endonuclease 1,42346,0.0439844686438028,0.00625546111971163,0.031723764849168,0.0562451724384376,2.14614153986875e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBKS,Ribokinase,42317,0.0343632124133113,0.00488870412105813,0.0247813523360373,0.0439450724905852,2.18138901777792e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMM2,Phosphomannomutase 2,40116,0.0416543932936884,0.00592548086335187,0.0300404508015187,0.0532683357858581,2.19319621461614e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN1,Ficolin-1,40515,0.0384204551774177,0.00548582817227639,0.027668231959756,0.0491726783950794,2.63635438337694e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMB1,Laminin subunit beta-1,40223,0.0208528885256554,0.00299689823328741,0.0149789679884121,0.0267268090628988,3.6430025120971e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA12,Carbonic anhydrase 12,42587,-0.0226392614656797,0.00325737712909347,-0.0290237206387029,-0.0162548022926565,3.81781602673696e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENR,Density-regulated protein,40199,0.0390030298151591,0.00562025183744679,0.0279873362137634,0.0500187234165548,4.14937629935064e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF6,SLAM family member 6,42346,0.0264609058787841,0.00381659621171614,0.0189803773038205,0.0339414344537478,4.30884895082507e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP7,Matrilysin,42333,0.0343959157482014,0.00496300061645431,0.024668434539951,0.0441233969564519,4.3902018100597e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0191188631705416,0.00276316167520762,-0.0245346600539485,-0.0137030662871347,4.74708855347937e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0196907775657512,0.00284735131870681,-0.0252715861504165,-0.0141099689810858,4.87380132888862e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLF4,Krueppel-like factor 4,40136,0.0273225904990101,0.00395322209749002,0.0195742751879296,0.0350709058100905,5.06329219557566e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0291011108429271,0.00421110757238774,0.0208473400010472,0.0373548816848071,5.09590185516631e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPQ,Carboxypeptidase Q,40516,0.0243246222583944,0.00352102804850656,0.0174234072833215,0.0312258372334672,5.16485010968308e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0231988540780198,0.00336439466732252,0.0166046405300677,0.0297930676259719,5.61484628084633e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0379866194644054,0.00551285492490079,0.0271814238115998,0.0487918151172109,5.80590814368037e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0304066483209015,0.00441274486239691,0.0217576683906036,0.0390556282511995,5.85756721858352e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0767027621306883,0.0111328617234216,0.054882353152782,0.0985231711085947,5.88687179380731e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0320605419942911,0.00465645988956013,0.0229338806107532,0.0411872033778289,6.03097597095771e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0252466195447938,0.00367307546711277,0.0180473916292527,0.0324458474603348,6.60940389833917e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0253147397863868,0.00368426568232498,0.0180935790490299,0.0325359005237438,6.70992146419422e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN2,Dynactin subunit 2,42587,0.0631049005301335,0.00919320104793481,0.0450862264761813,0.0811235745840857,6.9759344971899e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MILR1,Allergin-1,42370,-0.0348298049360236,0.0050751334841322,-0.0447770665649227,-0.0248825433071245,7.05265626533216e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0258832482859633,0.00377239994891188,0.018489344386096,0.0332771521858306,7.19158488259044e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0323041940177308,0.00471618272546322,-0.0415479121596387,-0.0230604758758229,7.72227843030854e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0166195405410669,0.00242701162250167,-0.0213764833211701,-0.0118625977609636,7.82921308042148e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR1,Complement receptor type 1,40509,0.0244047555202305,0.00356418773992802,0.0174189475499716,0.0313905634904895,7.92011096728659e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.02983645263985,0.00435880803528057,0.0212931888907,0.0383797163889999,8.04574685185398e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSV,Cathepsin L2,42677,0.0282093689169912,0.00412397848147583,0.0201263710932986,0.0362923667406838,8.24186144446523e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBI3_IL27,Interleukin-27,42689,-0.0207655741838948,0.00303727649998617,-0.0267186361238677,-0.0148125122439219,8.44010004254898e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0316143833649713,0.00462738981752491,0.0225446993226225,0.0406840674073201,8.73040135977691e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.0762846917845128,0.01116339387207,-0.09816494377377,-0.0544044397952556,8.74181280279648e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYAL1,Hyaluronidase-1,42544,-0.0155668282313061,0.00228330791732124,-0.0200421117492558,-0.0110915447133565,9.65095795998805e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNMT,Histamine N-methyltransferase,42439,0.0322251710171041,0.00472707232077887,0.0229601092683776,0.0414902327658307,9.6885593994535e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0305633902566969,0.0044948955206944,-0.039373385477258,-0.0217533950361359,1.09366276174784e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0263180328912031,0.00388112637259202,0.0187110252009228,0.0339250405814835,1.24248180479843e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AREG,Amphiregulin,42587,-0.02838495852761,0.00418914786954756,-0.0365956883519232,-0.0201742287032968,1.28863800659041e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0352922615102991,0.00521147994891632,0.0250777608104231,0.0455067622101751,1.32389694294993e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0276427883464494,0.00408192146979966,0.0196422222656421,0.0356433544272567,1.3334839136459e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLTA,Clathrin light chain A,42357,0.0317175239779633,0.00468690908729552,0.0225311821668641,0.0409038657890625,1.36801639383762e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD93,Complement component C1q receptor,42141,-0.0214125078439923,0.00317646983603106,-0.0276383887226132,-0.0151866269653715,1.63994543274644e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0201408238100994,0.00299030043683309,0.0142798349539065,0.0260018126662922,1.71419997242751e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.0532356022205096,0.00791434021766659,0.0377234953938831,0.0687477090471361,1.80881202177813e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREH,Trehalase,40527,0.0491689253672064,0.00731377938040603,0.0348339177816105,0.0635039329528022,1.86853620612092e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDT,D-dopachrome decarboxylase,40527,0.0274432440043858,0.00409146049710672,0.0194239814300566,0.0354625065787149,2.07488593608164e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0525587041452425,0.00784247347861304,0.0371874561271609,0.0679299521633241,2.14024563756288e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA1,Carboxypeptidase A1,42794,0.0411368874099438,0.00613876474454101,0.0291049085106434,0.0531688663092442,2.14902887800221e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY75,Lymphocyte antigen 75,42594,0.0256794070307848,0.00383459376430918,0.0181636032527388,0.0331952108088308,2.21565876836117e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MVK,Mevalonate kinase,42370,0.0525497077181229,0.00784940532920054,0.0371648732728898,0.067934542163356,2.24811582258645e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR3,Toll-like receptor 3,42754,0.0401377408861359,0.00600217497754057,0.0283734779301564,0.0519020038421154,2.36391372856988e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA1,BolA-like protein 1,40136,0.0356716654528009,0.00534013773461969,0.0252049954929463,0.0461383354126555,2.50682235495784e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0342009754844341,0.00512950333195689,0.0241471489537986,0.0442548020150696,2.70610980043766e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0458067688315466,0.00688083437047783,0.0323203334654101,0.0592932041976832,2.92341438079322e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0608118784553919,0.00914313455699385,0.0428913347236839,0.0787324221870998,3.02111779657928e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0244881017831581,0.00368440316540449,0.0172666715789653,0.0317095319873509,3.11882305650087e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.0259562778795649,0.00391396650455939,0.0182849035306285,0.0336276522285014,3.44795926795092e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0432584824023256,0.00653595992666408,0.030448000946064,0.0560689638585872,3.7690000399846e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0309319540730202,0.00467527532908579,0.021768414428012,0.0400954937180283,3.83152201288861e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0359354272398068,0.00543499198188757,0.0252828429553071,0.0465880115243064,3.97111508401993e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.0175424217168888,0.0026565725042583,0.0123355396085426,0.0227493038252351,4.19779116417764e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAL,Integrin alpha-L,40199,0.0289475764623496,0.00440330072105543,0.020317107049081,0.0375780458756183,5.11762058403596e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0103075584134081,0.00157023387580321,0.00722990001683384,0.0133852168099824,5.41572122436409e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.017660561532862,0.00269614683192353,0.0123761137422918,0.0229450093234321,5.9926295502224e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX6,Syntaxin-6,42346,0.0425231483597549,0.00650133686108919,0.0297805281120201,0.0552657686074897,6.35059544261269e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAN,Brevican core protein,42495,0.0222493375615896,0.00341550704541975,0.0155549437525669,0.0289437313706123,7.57015054511137e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0403142427863883,0.00619381751167396,0.0281743604635074,0.0524541251092693,7.84478425678652e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSZ,Cathepsin Z,42648,0.0205921862376256,0.00316717962553564,0.0143845141715757,0.0267998583036754,8.21973896528162e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.015236600364412,0.00234430185429245,0.0106417687299988,0.0198314319988252,8.41093357927122e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0539332528433265,0.0083076209029666,0.0376503158735119,0.070216189813141,8.77414559965664e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPA,Apolipoprotein(a),40324,-0.116393119295459,0.0179383368369778,-0.151552259495936,-0.0812339790949827,9.03687201101047e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0216566538595073,0.00334233867670355,0.0151056700531683,0.0282076376658462,9.52518420007072e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH5,Cadherin-5,42794,-0.019169500621766,0.00296550090498408,-0.0249818823955348,-0.0133571188479972,1.05331775376106e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0325026565213768,0.00503045821603776,0.0226429584179428,0.0423623546248108,1.07486819173321e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.0228876163952774,0.00354535520005195,0.0159387202031756,0.0298365125873792,1.11427633669307e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP6,Gastrotropin,42334,0.0373376410186943,0.00578445997357741,0.0260000994704826,0.048675182566906,1.12154536474072e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VGF,Neurosecretory protein VGF,40482,0.0200714987809334,0.00311036537967334,0.0139751826367737,0.0261678149250932,1.14072560259619e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0377005671492633,0.00584592398747714,0.0262425561338082,0.0491585781647185,1.16373324412521e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0275950643305305,0.00427925624370608,0.0192077220928666,0.0359824065681944,1.17538432757026e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0399321674683971,0.00620030149907791,0.0277795765302044,0.0520847584065898,1.23246463006066e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.018992088044726,0.00295506091148824,0.0132001686582091,0.024784007431243,1.34573115159803e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0208903533743859,0.00325322104438914,0.0145140401273832,0.0272666666213886,1.39519903116517e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAN,Neurocan core protein,42711,0.0240060912583196,0.00374109508169403,0.0166735448981993,0.0313386376184399,1.43750338363045e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0343949769920986,0.00538473861406909,0.0238408893085231,0.044949064675674,1.75442226701932e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0369213858971634,0.00578100001059588,0.0255906258763955,0.0482521459179314,1.76364396967913e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GC,Vitamin D-binding protein,40539,0.016275148279292,0.00255368520786208,0.0112699252718823,0.0212803712867017,1.92300599212394e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1A,Protein phosphatase 1A,42346,0.019923187967537,0.00313427070954967,0.0137800173768197,0.0260663585582544,2.1313142974589e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL1,Follistatin-related protein 1,40223,-0.0141926109336624,0.00223663157763061,-0.0185764088258184,-0.00980881304150643,2.30354645784329e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0285766916064078,0.00450713547485496,-0.0374106771371235,-0.0197427060756921,2.36548125358101e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE,Angiotensin-converting enzyme,40532,-0.0167798103360032,0.00264877481812952,-0.0219714089795371,-0.0115882116924694,2.46438306773121e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0236056711496819,0.00373182339048597,0.0162912973043294,0.0309200449950344,2.60410782716379e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.0572581043290847,0.00906982732943117,0.0394812427633996,0.0750349658947698,2.82407219524753e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0331358508565061,0.00524801851857857,0.0228497345600921,0.0434219671529201,2.82438924093106e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0365864699657603,0.00579560277162149,0.0252270885333822,0.0479458513981384,2.82739610526208e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1B,Lithostathine-1-beta,42794,-0.0363744617545953,0.00576755472995363,-0.0476788690253044,-0.0250700544838862,2.93792855970457e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0174214611763774,0.00276321867470589,0.0120055525739539,0.0228373697788009,2.9935140431402e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAYN,Layilin,42476,-0.0235229490040757,0.00373489946957001,-0.0308433519644329,-0.0162025460437185,3.10717471912981e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB1,Carboxypeptidase B,42794,0.0375636388781399,0.0059645581765143,0.0258731048521719,0.049254172904108,3.11172935698553e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0258386982258736,0.00410688409122278,-0.0338881910446702,-0.0177892054070769,3.24130518937371e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0299951861544129,0.00477064552154994,0.020644720932175,0.0393456513766508,3.3297450133112e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0358920806203083,0.00571815951546216,0.0246844879700025,0.0470996732706142,3.58153381767855e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0144089066201329,0.00229595618241745,0.00990883250259475,0.0189089807376711,3.60595296570023e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICOSLG,ICOS ligand,42587,0.0118923851200622,0.00190486536032437,0.00815884901382639,0.0156259212262979,4.4175411202038e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0346372322510735,0.00556244481852551,0.0237348404067635,0.0455396240953835,4.89983648537734e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.0221908597833693,0.00356668900308485,0.015200149337323,0.0291815702294156,5.09222913065493e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0171640179357854,0.00276232894107681,-0.0225781826602959,-0.0117498532112749,5.33217320190345e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0237358923361058,0.00383486751805659,0.0162195520007149,0.0312522326714967,6.25061530086362e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0272403703520863,0.00440487134082788,-0.0358739181801089,-0.0186068225240636,6.42455289420503e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF22,Kinesin-like protein KIF22,40116,0.0762475281371093,0.0123295474285423,0.0520816151771665,0.100413441097052,6.46783616656209e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0298637927333062,0.00483497842660619,0.020387235017158,0.0393403504494543,6.73791148988279e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDK2,Protein sidekick-2,40283,0.02462170024916,0.00398882812664754,0.0168035971209308,0.0324398033773892,6.94950346581538e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH1,Acid ceramidase,40418,0.0277812822166711,0.00450264257971972,0.0189561027604204,0.0366064616729217,7.06456482515459e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP2,Neuropilin-2,42611,-0.017441007085315,0.00282752575659163,-0.0229829575682346,-0.0118990566023954,7.10143428949011e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0329488503098178,0.00534339700397471,0.0224757921820274,0.0434219084376083,7.23701877880101e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTPN,Myotrophin,42357,0.0201584778117822,0.00327053498297857,0.0137482292451442,0.0265687263784202,7.31565876596202e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0313544104018769,0.00508663772270688,0.0213846004653715,0.0413242203383824,7.3330627442779e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN4,CCN family member 4,42721,0.0242542996592018,0.00393885353614329,0.016534146728361,0.0319744525900427,7.58951545168784e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0382070968098273,0.00620635391510041,0.0260426431362305,0.0503715504834242,7.71435442153952e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN2,Alpha-actinin-2,40116,-0.0361192598072374,0.00588323642901196,-0.0476504032081008,-0.0245881164063739,8.57370082017369e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.0706215244517246,0.0115179875457098,0.0480462688621335,0.0931967800413158,9.00225052885989e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXN,Thioredoxin,40384,0.0267973931696265,0.00438727905998054,0.0181983262120647,0.0353964601271884,1.04254011839937e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0148952384431899,0.00243916236775774,0.0101144802023848,0.0196759966839951,1.05117118592052e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST3,Cystatin-C,42659,0.0181235432090173,0.002969656511541,0.0123030164463969,0.0239440699716376,1.07013688880637e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECM1,Extracellular matrix protein 1,40269,0.0224750931226936,0.00368938975605756,0.0152438892008208,0.0297062970445665,1.15342746558592e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0153095763122035,0.00251938519973967,0.0103715813207137,0.0202475713036933,1.25988094493072e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0203948741049961,0.0033578996567111,-0.0269763574321498,-0.0138133907778423,1.284044683737e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYY,Peptide YY,40116,0.0614224532815485,0.0101147084253642,0.0415976247678346,0.0812472817952624,1.3005223928949e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.0183278776488054,0.00302089671204022,0.0124069200932066,0.0242488352044042,1.34450782920289e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.020275984211367,0.00334421716755047,0.0137213185629681,0.0268306498597659,1.37163221868943e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAL,Galanin peptides,42676,0.0382752987248607,0.00631937608739799,0.0258893215935607,0.0506612758561608,1.42535555463495e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFAP1,Actin filament-associated protein 1,40283,0.049474319575527,0.00819385449733971,0.0334143647607412,0.0655342743903128,1.61054174378259e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMD,Dystrophin,40223,0.0306421402834233,0.00508238992160535,0.0206806560370768,0.0406036245297698,1.70173544733014e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG3,Desmoglein-3,42651,0.0208470732032933,0.00346367370520261,0.0140582727410962,0.0276358736654904,1.80310543210057e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCT,Secretin,40182,0.0296489766405544,0.00493201066987754,0.0199822357275945,0.0393157175535144,1.89607516101536e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0214134008263766,0.00356677287740532,0.0144225259866622,0.0284042756660911,1.99152164110549e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFAP,Glial fibrillary acidic protein,42326,0.0288663199920921,0.00481765105777874,0.0194237239188457,0.0383089160653384,2.12986285724196e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO2,Roundabout homolog 2,42711,0.013792068502754,0.00230507757854714,0.00927411644880159,0.0183100205567064,2.2413185963551e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0390220859512706,0.00652222256874269,0.0262385297165349,0.0518056421860063,2.25788925433216e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.034358864708125,0.00576065594037992,0.0230679790649803,0.0456497503512696,2.53064676302533e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.034157922332709,0.00572915926834985,0.0229287701667433,0.0453870744986747,2.55366435287734e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0241178798513639,0.00404980509647726,-0.0320554978404594,-0.0161802618622685,2.66003512835028e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0244627257339441,0.00410801088273681,0.01641102440378,0.0325144270641082,2.68191148169737e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.042853734471674,0.00721490015043961,0.0287125301768124,0.0569949387665356,2.94250111369155e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0269043809889949,0.00453392917708738,0.0180178798019036,0.0357908821760861,3.02858733869734e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.0347525849798381,0.00586004040397631,0.0232669057880445,0.0462382641716316,3.09580044468756e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDM1,Nuclear protein MDM1,40182,0.0183193271993367,0.0030903384239296,0.0122622638884347,0.0243763905102387,3.15987053433327e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0180060531055771,0.00304061675985161,-0.0239656619548863,-0.012046444256268,3.27975022604954e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN2,Transcobalamin-2,42771,-0.0179781177796832,0.00303775826014153,-0.0239321239695606,-0.0120241115898059,3.33293439157895e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0252268236730778,0.004262945958972,0.0168714495934926,0.0335821977526629,3.34590773487046e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0385656797035396,0.00651979006535727,0.0257868911754394,0.0513444682316399,3.39544571839918e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.0179451449079834,0.00303601141810041,0.0119945625285066,0.0238957272874602,3.48732004861107e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRL,Prolactin,42711,-0.0435450276005684,0.00737053695058522,-0.0579912800237155,-0.0290987751774214,3.54645938413428e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSNL1,Visinin-like protein 1,40483,0.0223312347605039,0.00378091783931442,0.0149206357954477,0.0297418337255602,3.59962362970247e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.0304462548288099,0.00516879788473379,0.0203154109747316,0.0405770986828881,3.96527278129402e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0561700923547492,0.00955220950134316,0.0374477617321166,0.0748924229773817,4.21339387847098e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0395585456500787,0.00673924201736139,0.0263496312960504,0.052767460004107,4.46430990807287e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID2,Nidogen-2,42611,0.04262999599717,0.00727201584396443,0.0283768449429997,0.0568831470513403,4.67516161792825e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPPK1,Epiplakin,40223,0.041920595703333,0.00715595517764661,0.0278949235551456,0.0559462678515203,4.81452556352446e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHPS,Deoxyhypusine synthase,40451,0.0233248011826729,0.00398345462471518,0.0155172301182311,0.0311323722471146,4.89098809076632e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.0673304580624565,0.011509804073302,0.0447712420787847,0.0898896740461284,5.06181486036937e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWF,von Willebrand factor,42794,-0.0412594574665395,0.0070762572942673,-0.0551289217633034,-0.0273899931697756,5.64517980014835e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLO1,Lactoylglutathione lyase,42357,0.0332239377873367,0.00569882071130902,0.0220542491931711,0.0443936263815024,5.67381731210954e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0249668676011603,0.0042834584996832,0.0165712889417813,0.0333624462605394,5.74393452363619e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.0138663817274192,0.0023793968661268,-0.0185299995850278,-0.00920276386981072,5.74928930682974e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA2,Adenosine deaminase 2,42572,-0.0254574011384628,0.0043712470656933,-0.0340250453872217,-0.016889756889704,5.88351773992992e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNLY,Granulysin,42611,0.0306999808992447,0.00527311381034503,0.0203646778309684,0.0410352839675209,5.94836466562476e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN3,Calsyntenin-3,40483,0.0176101276796659,0.0030247801976794,0.0116815584922143,0.0235386968671176,5.97481792274946e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX,Glutaredoxin-1,42546,0.0320793312599373,0.00551222729938139,0.0212753657531498,0.0428832967667249,6.03181130929231e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0252300003113777,0.00433614863522217,-0.0337288516364132,-0.0167311489863423,6.10364015933144e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTB,Lymphotoxin-beta,40451,0.020534336395349,0.00353263309450967,0.0136103755301101,0.0274582972605879,6.31205528870331e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0209986363003564,0.00361914826069766,-0.0280921668913238,-0.013905105709389,6.69702232702821e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST5,Cystatin-D,42357,0.03264856893776,0.00562700293544556,0.0216196431842867,0.0436774946912333,6.69868219356295e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CABP2,Calcium-binding protein 2,40182,0.036950905270695,0.00637518922683019,0.0244555343861078,0.0494462761552821,6.97631189166356e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0211372534212095,0.00365205828837696,-0.0282952876664284,-0.0139792191759906,7.3222815118189e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0161649941831228,0.00279385846922867,-0.021640956782811,-0.0106890315834346,7.37260480995869e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0200501374102497,0.00346667660576178,0.0132554512629567,0.0268448235575428,7.47208435369577e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0214718304459172,0.00371413135917952,0.0141921329819254,0.0287515279099091,7.61775130749524e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0185547334172921,0.00321297413525508,-0.0248521627223921,-0.0122573041121922,7.90483135398612e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0245086061744316,0.00426840054945126,0.0161425410975072,0.0328746712513561,9.56779070519e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0155578163359784,0.00270921889454641,0.0102477473026674,0.0208678853692893,9.57383258974831e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDA,Cytidine deaminase,40494,0.026541002752343,0.00462447184902893,0.0174770379282463,0.0356049675764396,9.7542320725605e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0122358559978383,0.00213789684334406,0.00804557818488395,0.0164261338107927,1.06704204496242e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0482285683687027,0.00842576343361363,0.03171407203882,0.0647430646985854,1.06732847835645e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0183095178643862,0.0032085111940708,0.0120208359240075,0.024598199804765,1.18193795427623e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR15L,Protein GPR15L,40449,0.0342364696540756,0.00599951801278206,0.0224774143490227,0.0459955249591284,1.18209347355767e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.0331302085024223,0.00580900541128181,-0.0445158591085346,-0.02174455789631,1.20024463989573e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0471568162846513,0.00826896299729093,0.0309496488099611,0.0633639837593416,1.20865806215491e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGN,Secretagogin,42370,-0.0253691547352026,0.00445973084542963,-0.0341102271922447,-0.0166280822781605,1.30890162444456e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0262859268066035,0.00462768900775011,0.0172156563514133,0.0353561972617937,1.37372876455353e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0360583730451457,0.00635160138478396,0.0236092343309692,0.0485075117593223,1.40496240344557e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.0202481241366684,0.00357728664194088,0.0132366423184642,0.0272596059548725,1.54276184507306e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0195912400349578,0.00347254595571035,0.0127850499617655,0.0263974301081501,1.72486429090481e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENAH,Protein enabled homolog,42370,0.0262134811783577,0.0046489927891531,0.0171014553116176,0.0353255070450978,1.75032657859736e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0252917803536515,0.00448591538611128,0.0164993861968734,0.0340841745104296,1.75469229139947e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0321801769639508,0.00571398442196835,0.0209807674968928,0.0433795864310087,1.82583936096506e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVALB,Parvalbumin alpha,42654,0.0607894757042055,0.010808650565206,0.0396045205964017,0.0819744308120092,1.90134683511994e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI1,Neuroserpin,40267,0.0167826814518914,0.00298447117154766,0.010933117955658,0.0226322449481248,1.91843996626147e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM2,Myomesin-2,40116,-0.0280336400775707,0.00498681697795325,-0.0378078013543591,-0.0182594788007823,1.93895742900649e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0447995269702457,0.0079750956196188,0.0291683395557929,0.0604307143846985,1.98516475714418e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN5,CCN family member 5,42611,0.0213368899979521,0.00380288985266843,0.013883225886722,0.0287905541091822,2.05492046054073e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIT2,Slit homolog 2 protein,42311,0.0290411055472055,0.0051769122079427,0.0188943576196378,0.0391878534747732,2.06735851931272e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0343216556803037,0.00612088922750427,0.0223247127943953,0.046318598566212,2.10337791510891e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0315084818105013,0.0056232118912807,0.0204869865035911,0.0425299771174115,2.15317556552259e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0317256943098551,0.00568133764318125,0.0205902725292198,0.0428611160904903,2.39438704652882e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0252370437278633,0.00451958999819432,0.0163786473314025,0.0340954401243242,2.40772502334031e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF5,Fibroblast growth factor 5,42370,-0.01817873735558,0.00325891199440125,-0.0245662048646064,-0.0117912698465535,2.47861890404007e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0176224654325187,0.00317527837896798,0.0113989198097414,0.0238460110552959,2.92273805305253e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0216738933257149,0.00391002813107098,-0.0293375484626141,-0.0140102381888158,3.03715174627015e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM,Paralemmin-1,40384,0.0171452413577898,0.00311072305891467,0.0110482241623171,0.0232422585532626,3.63346602445774e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0206940032315255,0.00376600222776047,0.013312638865115,0.0280753675979361,3.99437622358922e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PER3,Period circadian protein homolog 3,40199,0.0668065746663128,0.0121605723022332,0.0429718529539357,0.0906412963786898,4.02349230489818e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL3,Insulin-like 3,40483,0.0423778280070188,0.00771840989705902,0.0272497446087831,0.0575059114052545,4.09499459406915e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA,Lymphotoxin-alpha,42594,0.022047504526806,0.00402066097891939,0.014167009008124,0.0299280000454879,4.24419287490223e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0293801246125918,0.00536596112126451,0.0188628408149134,0.0398974084102703,4.44696478758285e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0309472450639985,0.00565735387351622,0.0198588314719067,0.0420356586560903,4.57569044370471e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0359856626665833,0.00659929044395928,0.0230510533964231,0.0489202719367435,5.05818771970843e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYGD,Gamma-crystallin D,40483,0.052262390367495,0.00959535802298315,0.033455488642448,0.0710692920925419,5.24085989246093e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0128559139795011,0.00236276918614549,-0.0174869415843462,-0.0082248863746559,5.3896126849393e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0490570023366652,0.00901814538383825,0.0313814373843422,0.0667325672889882,5.44765695979365e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0510360096726288,0.00939386363891951,0.0326240369403466,0.0694479824049111,5.64196365194406e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0273356508685028,0.00503959981966684,0.0174580352219558,0.0372132665150498,5.92197829121306e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.00438243066578476,0.000809022616071704,-0.0059681149932853,-0.00279674633828422,6.18879560247884e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TF,Serotransferrin,40539,0.0113818878691024,0.00210396168286758,0.0072581229706819,0.0155056527675228,6.43981533080542e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0289222686954469,0.005354533176589,0.0184273836693325,0.0394171537215613,6.7239775033141e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.012579184681456,0.00233156500474646,-0.017149052090759,-0.00800931727215291,6.98754383607972e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0168445890358747,0.00312757569028136,0.0107145406829233,0.0229746373888262,7.3324786889286e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA2,Annexin A2,40054,0.0384833910153376,0.00716001713292807,0.0244497574347986,0.0525170245958766,7.82709604462344e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0474371562585237,0.00882858229028768,-0.0647411775474876,-0.0301331349695599,7.87073932581203e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX7,Syntaxin-7,40199,0.0265095775336431,0.00493757840480121,0.0168319238602328,0.0361872312070535,8.08100871514521e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPT,Dermatopontin,42794,0.013364632702609,0.00248992957064777,0.0084843707441394,0.0182448946610787,8.11574465447255e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL1,Delta-like protein 1,42679,-0.0166231695127306,0.00309865250189516,-0.0226965284164451,-0.010549810609016,8.24486423564854e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0251220174491908,0.00468637148020533,0.0159367293479883,0.0343073055503932,8.45549232241185e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KITLG,Kit ligand,42636,-0.0197742535880013,0.003694615593286,-0.0270157001508418,-0.0125328070251607,8.83273045659448e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0227709083254028,0.00425690062887333,0.0144273830928111,0.0311144335579945,9.00821280186924e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD72,B-cell differentiation antigen CD72,40283,0.023378387834322,0.00437082574261968,0.0148115693787874,0.0319452062898566,9.033258378648e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHCY,Adenosylhomocysteinase,42636,0.0352295492826497,0.006598764849186,0.0222959701782452,0.0481631283870543,9.50804390895365e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0357034308346907,0.0067048342215989,-0.0488449059090246,-0.0225619557603569,1.02569173438298e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0206120526286079,0.00388156010974796,0.0130041948135019,0.0282199104437139,1.11224386873971e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGRN,Neugrin,40483,0.0121073055953064,0.00228353149191628,0.00763158387115053,0.0165830273194623,1.16696581981524e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0222108328936361,0.00420377927620569,0.013971425512273,0.0304502402749992,1.28682737700093e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARCO,Macrophage receptor MARCO,42636,0.0136432077894031,0.00258226821901286,0.00858196208013788,0.0187044534986683,1.28774171464588e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA9,Carbonic anhydrase 9,42721,-0.0252230937738947,0.00477540073492997,-0.0345828792143574,-0.015863308333432,1.29846751372006e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0286502158636028,0.00542463997891352,0.0180179215049323,0.0392825102222733,1.30595776366084e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0458330332935813,0.00868334641456517,0.0288136743210335,0.062852392266129,1.32436330633959e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0283247187987821,0.00537010008358472,0.0177993226349561,0.0388501149626082,1.35649821053855e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0394176099765688,0.00748206575107208,0.0247527611044675,0.0540824588486701,1.40324838665962e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0173059896534979,0.00328657387649331,0.010864304855571,0.0237476744514248,1.4224463200514e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0208333476856289,0.0039656160185553,0.0130607402892605,0.0286059550819973,1.51511634688524e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POF1B,Protein POF1B,40199,-0.0242397105164807,0.00461493004558797,-0.0332849734058332,-0.0151944476271283,1.52887229601991e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0155279323467947,0.00296138873714325,-0.0213322542715954,-0.00972361042199389,1.59984067394899e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0370592572697111,0.00706954490609869,0.0232029492537576,0.0509155652856645,1.61189909163447e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS1,Nephrin,40199,0.017403760012733,0.00332387789821255,0.0108889593322364,0.0239185606932296,1.67137522658099e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX5,Sorting nexin-5,40223,0.0150069183103825,0.00286831019317946,0.00938503033175075,0.0206288062890142,1.70787943979931e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0226062491758119,0.00432563302420201,0.014128008448376,0.0310844899032479,1.76278948506126e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBD,Thrombomodulin,42636,0.0155269170259465,0.00297402788233478,0.00969782237657035,0.0213560116753227,1.80770826982155e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0228022502247941,0.00436879632776189,-0.0313650910272074,-0.0142394094223808,1.82221375243575e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF16,Fibroblast growth factor 16,40199,0.0244398070931414,0.00468376833268082,0.015259621161087,0.0336199930251958,1.84176610089527e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSA,Arylsulfatase A,42611,0.0227617450242799,0.00437866780050329,0.0141795561352934,0.0313439339132663,2.0404397367003e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,0.0223068882274201,0.00430645644084964,0.0138662336033548,0.0307475428514854,2.2523942370994e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0515566350554904,0.00996445258861879,0.0320263079817976,0.0710869621291833,2.32399930740337e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,40539,0.00802414224920212,0.00155112458967647,0.00498393805343624,0.011064346444968,2.3415412661048e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0187698571935415,0.00363014199968111,0.0116547788741665,0.0258849355129164,2.36831241092549e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0418145089626781,0.00808787850401005,0.0259622670948184,0.0576667508305378,2.38070732775911e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LF,CMRF35-like molecule 1,42721,0.0310177150583215,0.0060009178786934,0.0192559160160824,0.0427795141005605,2.38922221797091e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0311034829887473,0.00601699397630337,0.0193101747951927,0.0428967911823019,2.3913554024659e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPB2,Coatomer subunit beta',40116,0.0221304875612336,0.0042848128844227,0.0137322543077651,0.0305287208147021,2.4484918648555e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.0633959152356488,0.0122824960238426,0.0393222230289174,0.0874696074423803,2.48470295360762e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0268265567676881,0.00519928638359289,0.016635955455846,0.0370171580795301,2.51665178570434e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17C,Interleukin-17C,42370,-0.0379490717523195,0.00736776701520668,-0.0523898951021246,-0.0235082484025144,2.63277349133791e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XCL1,Lymphotactin,42721,0.0284267910236884,0.00552310431843278,0.0176015065595602,0.0392520754878167,2.68556947936703e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0150233189492275,0.00292404066889908,0.0092921992381853,0.0207544386602697,2.81757962647798e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENSA,Alpha-endosulfine,40451,0.0268865326040543,0.00523683171395432,0.0166223424447038,0.0371507227634047,2.88197228720369e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.02479454881379,0.00484774668018477,0.0152929653206278,0.0342961323069521,3.19487932188675e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH1,Protocadherin-1,42721,0.0109014200146917,0.00213823945699003,0.0067104706789912,0.0150923693503921,3.47317408901098e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0358349415415724,0.00704029574635398,0.0220359618787186,0.0496339212044262,3.63042446387077e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG4,Desmoglein-4,42543,0.0250806721408559,0.00493108160546782,0.0154157521941389,0.0347455920875728,3.70182250371407e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0257467696704791,0.00512148820969551,0.0157086527794759,0.0357848865614823,5.04051134502175e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0157892171191003,0.00314056226057512,-0.0219447191498275,-0.00963371508837307,5.04183450955992e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRELP,Prolargin,42618,0.0120049153431139,0.0023958135484378,0.00730912078817581,0.016700709898052,5.48972831888488e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOB,Elongin-B,40116,0.0198636120269262,0.00396375812474247,0.012094646102431,0.0276325779514215,5.49082996568809e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTN,Pleiotrophin,42357,0.0243915226420435,0.00487099660404477,0.0148443692981157,0.0339386759859712,5.585504243042e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC13,Mucin-13,42311,0.0257227987433632,0.00513991259131975,0.0156485700643765,0.0357970274223499,5.67271305614601e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.00967785005226779,0.0019365553741755,-0.0134734985856518,-0.00588220151888381,5.88250183776001e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSR,Insulin receptor,40199,0.00858484566497825,0.00171771425575819,0.00521812572369219,0.0119515656062643,5.88707849489857e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0284020651166372,0.00570126602016711,0.0172275837171097,0.0395765465161647,6.38239988863512e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAC1,Cartilage acidic protein 1,42794,0.0146518380507676,0.00294349597274191,0.00888258594419348,0.0204210901573418,6.51322146449056e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0196940628839311,0.00396246919238198,0.0119276232668625,0.0274605025009998,6.78861071924797e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD109,CD109 antigen,42611,-0.0163683101158243,0.0033153796117345,-0.0228664541548239,-0.00987016607682466,8.02523783380137e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0199009198394232,0.00404343441716576,-0.0278260512970681,-0.0119757883817783,8.67783891669673e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.0235255988095816,0.00479162913737929,0.0141340057003182,0.0329171919188451,9.22770082997511e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0195219957775419,0.00397764503501621,-0.0273181800461737,-0.0117258115089101,9.31559862045615e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIT,Vitrin,40511,0.0186708195433264,0.00380543737579364,0.0112121622867709,0.0261294767998819,9.40774357619431e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0102425555611665,0.00208981003241974,0.0061465278976238,0.0143385832247092,9.63733103183927e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0139330333162369,0.00284407476765419,-0.0195074198608391,-0.00835864677163464,9.74649886896199e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0161812878145249,0.003304186667862,0.0097050819455154,0.0226574936835345,9.85592249793138e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0275458396366148,0.00563516903015706,0.0165009083375069,0.0385907709357226,1.02965770166492e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK6,Kallikrein-6,42656,0.015235156931163,0.00312378397755226,0.00911254033516054,0.0213577735271654,1.08860730569092e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN1,Tetraspanin-1,42357,0.0326239515425257,0.00669013666230529,0.0195112836844073,0.045736619400644,1.09287621099979e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0267878904484587,0.0054986608502193,0.0160105151820289,0.0375652657148885,1.12142706034406e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MB,Myoglobin,42794,-0.0254207206661778,0.00523057832884378,-0.0356726541907116,-0.015168787141644,1.18683092230856e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDHB15,Protocadherin beta-15,40451,-0.019241115493156,0.00397780945820156,-0.0270376220312311,-0.011444608955081,1.33483786104906e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGN,Biglycan,42328,-0.0571621773621599,0.011829793875713,-0.0803485733585575,-0.0339757813657624,1.36660325060728e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0156819357342617,0.00324672848720503,0.00931834789933982,0.0220455235691835,1.38020951192227e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSH,Pro-cathepsin H,42332,0.0354421936151316,0.00733807670498783,0.0210595632733554,0.0498248239569077,1.38140785231272e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX1,Heme oxygenase 1,42500,-0.0229259979455459,0.00476361911312479,-0.0322626914072705,-0.0135893044838213,1.50519994285041e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA14,Carbonic anhydrase 14,42721,0.0170051580527488,0.00354389889838152,0.0100591162119211,0.0239511998935766,1.61620437734219e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPP1,Osteopontin,42771,-0.0222935636740124,0.00465460167973932,-0.0314165829663014,-0.0131705443817233,1.68900739389087e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.029602246486068,0.00618779613123501,0.0174741660688474,0.0417303269032886,1.73735438736314e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0338445312911626,0.00708232511613268,-0.0477258885187826,-0.0199631740635425,1.78622673751122e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0144389138516328,0.00302363960950829,-0.020365247486269,-0.00851258021699654,1.81694214224525e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0218895672632647,0.0045861167982556,-0.0308783561878457,-0.0129007783386837,1.83395998360852e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0141205065590941,0.00295942195989621,0.00832003951769752,0.0199209736004907,1.84892571116367e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0186380412958433,0.00390810270299545,0.0109781599979722,0.0262979225937144,1.8700256983049e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA9,Serpin A9,42538,0.0336542015327748,0.00705742343313784,0.0198216516038246,0.0474867514617249,1.87448708454371e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POSTN,Periostin,40527,-0.0181460497591334,0.00380524402976832,-0.0256043280574793,-0.0106877714607875,1.87732254237403e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL4,Delta-like protein 4,40223,0.0404180816700235,0.00847624562345601,0.0238046402480498,0.0570315230919973,1.88076467697831e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.0124416340327522,0.00260967544122799,0.0073266701679453,0.017556597897559,1.88843676006656e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPR,Nucleoprotein TPR,40116,0.0227343488096367,0.00479528794500106,0.0133355844374346,0.0321331131818387,2.15378396913202e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1,Integrin beta-1,42638,0.00998130523327623,0.00210600451927709,0.00585353637549314,0.0141090740910593,2.16493606636515e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0263356321397992,0.00555780122790533,0.0154423417331048,0.0372289225464937,2.17995479610697e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0208949100116252,0.00442085477495288,0.0122300346527176,0.0295597853705328,2.31294653658514e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB1A1,Uteroglobin,42646,0.0259109126977297,0.00548636767860672,0.0151576320476606,0.0366641933477989,2.34991309054515e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0129842908041286,0.00275153376866484,-0.0183772969907117,-0.00759128461754555,2.39930071875067e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN1,Nectin-1,40199,0.0152516251777201,0.00323622091279746,0.00890863218863706,0.0215946181668031,2.47344646013114e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0286273796732347,0.00608433261529957,0.0167020877472475,0.0405526715992218,2.56858606640732e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH1,Neurexophilin-1,42311,0.0180268735452681,0.0038382137433795,0.0105039746082443,0.0255497724822919,2.67101717706894e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0228218172145762,0.00486172296146991,-0.0323507942190572,-0.0132928402100952,2.70315944352285e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPL14,60S ribosomal protein L14,40223,0.0185471943085408,0.00395269554430083,0.0107999110417111,0.0262944775753704,2.7341271341493e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP1,Guanylate-binding protein 1,40466,0.0303223327652249,0.00646424977640253,0.017652403203476,0.0429922623269739,2.75372283497995e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0229765170317882,0.00489971442283661,0.0133730767630284,0.0325799573005479,2.76818212486501e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA7,Carbonic anhydrase 7,40302,-0.0163116035893987,0.00348125311172281,-0.0231348596883754,-0.00948834749042205,2.82517427975705e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD1,Leiomodin-1,40482,-0.0165262128611688,0.00352977381873551,-0.0234445695458904,-0.00960785617644718,2.87473775719284e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0351766798342934,0.00751699108740233,0.0204433773029848,0.049909982365602,2.90837142849248e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0470043596921856,0.0100461821895484,0.0273138426006706,0.0666948767837005,2.91881558380961e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2,Ataxin-2,40136,0.0509599434942228,0.0109137857332507,0.0295689234570514,0.0723509635313942,3.05795016270428e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0316875688882093,0.00680467361703533,0.0183504085988201,0.0450247291775986,3.24370548715349e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.0181990241212719,0.00391370929332328,0.0105281539063583,0.0258698943361856,3.35675499731044e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0106373947082724,0.00228855804111659,0.00615182094768385,0.0151229684688609,3.38907137996935e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0183033560959911,0.00394331984108525,-0.0260322629845182,-0.010574449207464,3.4897661990205e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.00845217559540693,0.00182471896671688,0.00487572642064184,0.012028624770172,3.66102923035785e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0259149437865467,0.00559585388594733,0.01494707017009,0.0368828174030035,3.6780679698578e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAA4,Serum amyloid A-4 protein,40539,0.0147848090062927,0.00320050351828745,0.00851182211044935,0.0210577959021361,3.88851074739918e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0275925147953748,0.00598170410509303,-0.0393166548413571,-0.0158683747493925,4.01718310324583e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0359511482881451,0.00781140760294183,0.0206407893863791,0.0512615071899111,4.22237239250265e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCOR1,REST corepressor 1,42357,0.0200804070724874,0.0043649648020337,0.0115250760605014,0.0286357380844735,4.25697658188539e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17A,Interleukin-17A,42347,-0.0195978163836258,0.00426017720293572,-0.0279477637013798,-0.0112478690658718,4.25954611533552e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNF,Tumor necrosis factor,42339,0.017427886856467,0.00378887364271194,0.0100016945167516,0.0248540791961824,4.26940081252932e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0207427678754538,0.00451767779056936,0.0118881194059379,0.0295974163449698,4.45057645943082e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRSF1,G-rich sequence factor 1,40014,0.0364919519976784,0.00796209830192537,0.0208862393259047,0.0520976646694522,4.63023510056956e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM25,Transmembrane protein 25,40482,-0.0206413935929874,0.00450477682351716,-0.0294707561670811,-0.0118120310188938,4.65237438175829e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCOF1,Treacle protein,40511,0.0145507353805495,0.00317774036315516,0.00832236426876536,0.0207791064923336,4.72284937527015e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSE,Cathepsin E,40283,0.0230755470041861,0.00505561520523477,0.013166541201926,0.0329845528064463,5.06455727481502e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PZP,Pregnancy zone protein,40539,0.0229615387490233,0.00503507043581879,0.0130928006948185,0.0328302768032282,5.16103477207444e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0384811192947247,0.00844027448924881,0.021938181295797,0.0550240572936524,5.18068845371419e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,42416,-0.0370177938155671,0.00812079419797971,-0.0529345504436073,-0.0211010371875269,5.2008038424931e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAT,Catalase,40361,0.0243838564053857,0.00534972600449751,0.0138983934365706,0.0348693193742008,5.22005166977151e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0281128564842583,0.00617517091451019,0.0160095214918183,0.0402161914766982,5.35656168472988e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0161787960345896,0.0035586894362468,0.0092037647395459,0.0231538273296333,5.51916247578426e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROK1,Prokineticin-1,42594,0.0247044112931427,0.00544822477301166,0.0140258907380398,0.0353829318482456,5.82692515107708e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.0239154258488202,0.0052812898193349,0.0135640978029237,0.0342667538947166,5.99735788594278e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0309506828576274,0.00684049390854728,-0.0443580509183801,-0.0175433147968747,6.10223382044719e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOSB,Protein fosB,42311,0.0170911029230547,0.00378337644450113,0.00967568509183252,0.0245065207542769,6.31439810216977e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0233962948777456,0.00518131688638509,0.0132409137804308,0.0335516759750604,6.38026524964767e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.0264231243880668,0.00585252647499635,0.014952172497074,0.0378940762790597,6.3904748539906e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLC,Galectin-10,42611,-0.0292214111944206,0.00649012858252204,-0.0419420632161638,-0.0165007591726774,6.77439623066476e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0231776274033264,0.00514995971822121,0.0130837063556128,0.03327154845104,6.84735015976435e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPS,Colipase,42590,0.0322612248430434,0.00718448970353964,0.0181796250241057,0.0463428246619811,7.16837501919388e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0133176596432683,0.00297358748969584,-0.0191458911230722,-0.00748942816346449,7.57281944825706e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY96,Lymphocyte antigen 96,42495,-0.0157804497854417,0.00352445149649146,-0.022688374718565,-0.00887252485231849,7.6179115415231e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0163530442901159,0.00366062898254475,0.00917821148432814,0.0235278770959036,8.00117440840636e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTL1,Cytokine-like protein 1,40527,0.011282318958424,0.00252588752378147,0.00633157941181234,0.0162330585050357,8.02137260814526e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0183404131486758,0.00411406068856187,0.0102768541990945,0.026403972098257,8.34154538134025e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0295013905437183,0.00664667982311944,0.0164738980904041,0.0425288829970324,9.14431950543416e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0245700578345976,0.00554722839865758,0.0136974901732288,0.0354426254959665,9.54772580448473e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0178336204206803,0.00403475070075943,0.00992550904719181,0.0257417317941688,9.96224991072583e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0154383724098605,0.00351688181470173,0.00854528405304515,0.0223314607666759,1.14318580529885e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0236874234849059,0.00539639972128458,0.0131104800311881,0.0342643669386237,1.14488744425883e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAP,Prosaposin,40440,0.0125457736851742,0.0028602889868576,0.00693960727093334,0.0181519400994151,1.16402432258871e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL19,C-C motif chemokine 19,42711,0.056572577306947,0.0129034223225303,0.0312818695547875,0.0818632850591064,1.17233935626237e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0282968405366091,0.00645496519494556,0.0156451087545158,0.0409485723187024,1.17757391968116e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QL2,Complement C1q-like protein 2,40199,0.0191141749817032,0.00436171353011537,0.0105652164626771,0.0276631335007294,1.18541426569638e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12A_IL12B,Interleukin-12,42587,0.0352359397065492,0.00806085488352706,0.0194366641348361,0.0510352152782622,1.24473428120855e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A12,Protein S100-A12,42434,0.032329482541613,0.00739839239428759,0.0178286334488093,0.0468303316344167,1.25308301243094e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.0112516738822929,0.00257550563306755,0.00620368284148052,0.0162996649231053,1.25914287794293e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL3,Fc receptor-like protein 3,42370,0.0242488347470143,0.0055674598824231,0.013336613377465,0.0351610561165635,1.33792644764185e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO4,Roundabout homolog 4,40223,-0.00783929257218167,0.00179978828639042,-0.0113668776135069,-0.00431170753085644,1.3385594128741e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF1,Trefoil factor 1,42556,-0.0355244258533531,0.00817522815152701,-0.051547873030346,-0.0195009786763601,1.40065162449747e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0111568739463171,0.00258745608099723,-0.0162282878650717,-0.00608546002756253,1.63276582068076e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0182592349057532,0.00424427485760415,0.00994045618484909,0.0265780136266573,1.70424545461834e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELL,L-selectin,40539,0.0101425261316771,0.00235840429499352,0.00552005371348984,0.0147649985498645,1.71769914274116e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI2,Serpin I2,40449,0.0237625459409747,0.00552682962278002,0.0129299598803259,0.0345951320016235,1.72633848593663e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.101765089702396,0.0236693300040712,0.0553732028944162,0.148156976510375,1.72660579289702e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0174694690000047,0.00406364436533828,-0.0254342119560677,-0.00950472604394167,1.73085570983645e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLASP1,CLIP-associating protein 1,40080,0.0308905895543367,0.0071869095962468,0.0168042467456929,0.0449769323629804,1.73708796942794e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A13,Protein S100-A13,40199,0.0151031855584025,0.00351999711170472,0.0082039912194612,0.0220023798973437,1.79648313319758e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F3,Tissue factor,42636,-0.0114962487694276,0.00268963821372164,-0.016767939668322,-0.00622455787053321,1.93083320939839e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC16,Mucin-16,42587,0.0807902010442212,0.0189082405943956,0.0437300494792059,0.117850352609236,1.94409885672268e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0160967339984251,0.003772000317791,0.00870361337555473,0.0234898546212955,1.99099669538419e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX2,Sorting nexin-2,40451,0.0344299990607461,0.00809586385219726,0.0185621059104394,0.0502978922110527,2.12829874774625e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,42679,0.0122475075467879,0.00288391430111269,0.00659503551660703,0.0178999795769688,2.18265013835859e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LUZP2,Leucine zipper protein 2,40451,0.0192609279110613,0.00453699952858798,0.0103684088350289,0.0281534469870938,2.20051652197997e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.0168160946652986,0.00396598595291186,0.00904276219759131,0.0245894271330058,2.24964558090297e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0134886095799243,0.00318379281927903,-0.0197288435057112,-0.0072483756541374,2.28395929121204e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGMN,Legumain,42676,0.0148543926655247,0.00350660473449262,0.0079814473859192,0.0217273379451303,2.289270271806e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB2,Calretinin,42311,0.0133281086098161,0.00315940601841607,0.00713567281372063,0.0195205444059116,2.47531530533997e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0137952241983465,0.00327302389789081,-0.0202103510382125,-0.0073800973584805,2.51909395298765e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0271185359170041,0.00643847751833423,0.014499119981069,0.0397379518529392,2.55133993155262e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0401810038466402,0.00955876995845834,0.0214458147280619,0.0589161929652186,2.64434588774815e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.0320374761845004,0.00762891958714912,-0.0469901585753127,-0.0170847937936881,2.69654134850862e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCC,Netrin receptor DCC,40182,0.00961711233366029,0.00229122122208402,0.00512631873837562,0.014107905928945,2.72153188554379e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0105079305322133,0.00250423335814693,-0.0154162279141813,-0.00559963315024535,2.73661543891568e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0159117832237498,0.00379277347286882,0.00847794721692688,0.0233456192305727,2.74671317347209e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0341189221985759,0.00815998929751727,0.0181253431754421,0.0501125012217098,2.91761206536853e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APLP1,Amyloid-like protein 1,42636,-0.0212368675042312,0.00508230549735012,-0.0311981862790375,-0.011275548729425,2.95177051661695e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGA,Fibrinogen alpha chain,40284,0.0127749673383861,0.00306089364614338,0.0067756157919451,0.0187743188848272,3.0210262548902e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSS,Cathepsin S,39872,0.0100863023874286,0.00241827667560216,0.00534648010324832,0.0148261246716088,3.05846596142157e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP1,Interstitial collagenase,42136,0.037460703495654,0.00898735991601134,0.0198454780602718,0.0550759289310362,3.09073208527841e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOF,Apolipoprotein F,40532,0.00978536784479598,0.00234978202730476,0.00517979507127865,0.0143909406183133,3.14520621145585e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0116243500262164,0.00279362392052151,0.0061488471419942,0.0170998529104385,3.19220207223108e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMB,RGM domain family member B,42711,0.0116451162775005,0.00280611522329527,0.00614513043984173,0.0171451021151592,3.34647645716649e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0109406852469828,0.00264030016762026,0.0057656969184471,0.0161156735755185,3.44191452908162e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0198607219606779,0.00480024136168608,0.0104522488917732,0.0292691950295826,3.53805656099934e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2,Brorin,42456,0.0167578598643704,0.0040649749532042,0.00879050895609014,0.0247252107726506,3.77063341185668e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0299926712396022,0.00727558414272448,0.0157325263198622,0.0442528161593422,3.77664619155287e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,40283,-0.0168136849632116,0.00408014612566362,-0.0248107713695123,-0.00881659855691094,3.80215734587235e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0128686684963434,0.00312793047526829,-0.0189994122278692,-0.00673792476481751,3.91500402200511e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.0228282346228421,0.00555159152903036,0.0119471152259426,0.0337093540197416,3.94612418459136e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0182800404952517,0.0044482683722919,0.00956143448555957,0.0269986465049438,3.99437396354178e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0136036503839128,0.00331266394854608,0.00711082904476244,0.0200964717230631,4.04493988588481e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCP1,Plastin-2,40527,0.0194122928219706,0.00473725994146635,0.0101272633366965,0.0286973223072446,4.20019395598025e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0237150025434733,0.00578746826073898,0.0123715647524249,0.0350584403345217,4.20357239571426e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0209472657473598,0.00513585602032293,0.0108809879475268,0.0310135435471927,4.55654549217844e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0175334382721963,0.00430157267105488,0.00910235583692873,0.0259645207074639,4.61213386984158e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0183634217071158,0.0045108488757673,0.00952215791061194,0.0272046855036198,4.7142779247741e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA2,Carbonic anhydrase 2,42573,0.0278406860817051,0.00684001467554375,0.0144342573176393,0.0412471148457708,4.7229170566101e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS53,Serine protease 53,40483,0.014956519077765,0.00368540309787408,0.00773312900593182,0.0221799091495982,4.97615567062881e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,42638,0.00956045968857364,0.00235844168942595,0.00493791397729878,0.0141830053998485,5.06936662761916e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSAP,Gamma-secretase-activating protein,42346,0.0342125910259842,0.00843992909991999,0.0176703299901411,0.0507548520618274,5.07130498315904e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSL,Cathepsin L1,42636,0.00989490074554857,0.00244312399378877,0.00510637771772257,0.0146834237733746,5.14827445696009e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0138212492212751,0.00341483374774992,0.00712817507568528,0.020514323366865,5.20763466340727e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0123585494561342,0.00305333748382943,-0.0183430909244399,-0.0063740079878285,5.21018421047351e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD46,Membrane cofactor protein,42580,0.0115074765648807,0.00284802091130001,0.00592535557873272,0.0170895975510287,5.36314653086746e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0134812077442246,0.00334036547750733,-0.020028324080139,-0.00693409140831027,5.47078405219628e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0195887719305071,0.0048604516341737,0.0100622867275266,0.0291152571334875,5.6098640461749e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE3,Eosinophil cationic protein,42578,0.0435592448480421,0.010819688674063,0.0223526550468785,0.0647658346492056,5.70647634049944e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0166324539745387,0.00413397524190076,0.00852986250041324,0.0247350454486642,5.76898883616873e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0135320539475595,0.00336907791814218,0.00692866122800081,0.0201354466671182,5.93802651414404e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0105810908359323,0.00264012619671559,-0.0157557381814948,-0.00540644349036971,6.16885598232399e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0116353808690912,0.00290594601430467,0.00593972668105407,0.0173310350571284,6.26158133300378e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0210422102709611,0.0052636617820526,0.010725433178138,0.0313589873637842,6.43175378806043e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0273138162178581,0.00683532154128216,0.0139165859969451,0.0407110464387711,6.48458558166023e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0257437121260778,0.00646260712896685,0.0130770021533027,0.0384104220988528,6.83420539600529e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0113808109800503,0.00286444991237903,-0.0169951328083132,-0.00576648915178739,7.13106395257928e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF23,Fibroblast growth factor 23,42711,0.0212254273613421,0.00536015635023506,0.0107195209148814,0.0317313338078029,7.5380470711277e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0143215211252687,0.00361647343555419,0.00723323319158252,0.021409809058955,7.53968280293089e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0163071421615551,0.00413202396201061,0.00820837519601432,0.0244059091270959,7.970659559199e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0203851908161192,0.00516909988105052,0.0102537550492602,0.0305166265829782,8.06500758506632e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB8,Serpin B8,42754,0.022384337397991,0.00567796210739886,0.0112555316674893,0.0335131431284928,8.11029408197289e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSB,Cathepsin B,42659,0.0208406491803508,0.00529311919867489,0.010466135550948,0.0312151628097536,8.28150979247006e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTG,Protogenin,42721,0.00965565182961423,0.0024528543325611,0.00484805733779448,0.014463246321434,8.30939331465417e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0204511670956188,0.00520618150237607,0.0102470513509617,0.0306552828402759,8.6095721703033e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0153257666287413,0.00390467833259986,0.00767259709684561,0.0229789361606371,8.71815753519909e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN2,Calsyntenin-2,42754,-0.0153220374022099,0.00390818687615325,-0.0229820836794702,-0.0076619911249495,8.8800960071949e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0158650666627075,0.00405469602869241,0.00791786244647036,0.0238122708789446,9.17052065633125e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0414864471730396,0.0106231528600133,0.0206650675674136,0.0623078267786657,9.46772888957479e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00830737586740556,0.00213189855655923,0.00412885469654948,0.0124858970382616,9.7986575035148e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0295678650381775,0.00761616059209182,0.0146401902776775,0.0444955397986774,0.000103998738630587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0121724300856848,0.00313563046683227,0.00602659437069355,0.018318265800676,0.000104217933960701
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.0207661251486461,0.00535412572423419,-0.0312602115681451,-0.0102720387291471,0.000105603631896951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0148295212665454,0.00382389200020743,0.00733469294613882,0.0223243495869519,0.000105879231448809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN5,Contactin-5,42640,0.0145659162056433,0.00375617640867927,0.00720381044463188,0.0219280219666546,0.000105882049083376
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.016200262257437,0.00418964458817941,0.00798855886460534,0.0244119656502686,0.000110821450948293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0121381138583098,0.00314473867671354,-0.0183018016646683,-0.00597442605195127,0.000114115912410554
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK4,Kallikrein-4,42721,-0.0241655447610701,0.00626715567648144,-0.0364491698869738,-0.0118819196351665,0.000115837098428567
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0202547898916008,0.00526096811312699,-0.0305662873933297,-0.00994329238987185,0.000118668424866074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN4,Nectin-4,42679,-0.0130964837428687,0.0034019396419938,-0.0197642854411766,-0.00642868204456091,0.000118803360802254
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0221416035090008,0.00575464571118358,0.010862497915081,0.0334207091029206,0.000119830191484015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0225156682527992,0.00586919641807937,0.0110120432733636,0.0340192932322348,0.000125616637944277
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH3,Neurexophilin-3,40199,0.0116483666733024,0.00304212809280698,0.00568579561140072,0.0176109377352041,0.000129368440304055
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP9,Matrix metalloproteinase-9,42594,-0.0226729420275167,0.00592177804287731,-0.0342796269915562,-0.0110662570634772,0.000129387785479699
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0204473262048175,0.00535369004564595,0.0099540937153514,0.0309405586942835,0.000134448042058918
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.023556392573761,0.00618089579381885,-0.0356709483296459,-0.011441836817876,0.000138944543586462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0139434849244356,0.00365891264710979,0.00677201613610041,0.0211149537127708,0.000139132261586054
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0121569477105386,0.00319648886723576,0.00589182953075655,0.0184220658903207,0.000143452424855339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.030303865685591,0.00797842429882529,0.0146661540598934,0.0459415773112885,0.000146377553521578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0161574865468875,0.00425711518846273,0.00781354077750053,0.0245014323162744,0.000148061360690985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS2,Thrombospondin-2,42611,-0.0145203747763339,0.00382673203840657,-0.0220207695716107,-0.00701997998105698,0.000148616362635601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0165067721035522,0.00435037303339315,0.00798004095810157,0.0250335032490027,0.000148831249565021
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0247275611374784,0.00652072859670131,0.0119469330879438,0.037508189187013,0.000150006393390887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171B,Protein FAM171B,40451,0.00986752264718933,0.00260914560972019,0.00475359725213776,0.0149814480422409,0.000156442305016359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0112724548371929,0.00298120421563759,0.00542929457454322,0.0171156150998426,0.000156915360553233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA1,Carbonic anhydrase 1,42362,0.022408508949739,0.0059285942708399,0.0107884641788928,0.0340285537205852,0.000157688702592013
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,40527,-0.00870181627546733,0.00230740166884244,-0.0132243235463985,-0.00417930900453615,0.000163249853889758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0156297293433897,0.0041629059865947,0.00747043360966411,0.0237890250771153,0.000174401125145353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300A,CMRF35-like molecule 8,40283,0.0115282130052438,0.00307771648368992,0.00549588869721151,0.017560537313276,0.000180800200472925
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.0099164937092794,0.00265169347887214,-0.0151138129278688,-0.00471917449069001,0.00018500839034186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEO1,Neogenin,40482,0.00819733964809518,0.00219527263635956,0.00389460528083044,0.0125000740153599,0.000189323644959706
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_DRA,,42549,-0.0135994640807778,0.00364267570800553,-0.0207391084684686,-0.00645981969308692,0.00018971766779719
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTN,Titin,40116,-0.0241897921597031,0.00649958491071161,-0.0369289785846979,-0.0114506057347083,0.000198844625957481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR4,Proline-rich protein 4,40198,-0.0255780706012634,0.00687434455520211,-0.0390517859294596,-0.0121043552730673,0.00019958012316432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC1,Glypican-1,42721,0.0109398273040711,0.00294607024618295,0.00516552962155257,0.0167141249865897,0.000205345162478744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,42464,-0.0131073239175233,0.00353014564237297,-0.0200264093765743,-0.00618823845847227,0.000205679999397961
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0146907032261308,0.00396758780725499,-0.0224671753283506,-0.006914231123911,0.00021435122511577
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD6,Programmed cell death protein 6,42636,-0.0256813886237298,0.00694410115870834,-0.0392918268947982,-0.0120709503526615,0.000217910119432994
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00811193116111819,0.00219593559035005,0.0038078974040321,0.0124159649182043,0.000221573293580705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNU13,NHP2-like protein 1,40116,0.0231271197961096,0.00627144067861162,0.0108350960660308,0.0354191435261884,0.000227397817332619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0161327484652024,0.00438403092715064,0.00754004784798717,0.0247254490824177,0.00023442431053358
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSTB,Cystatin-B,42437,0.0154278557934163,0.00419561380981716,0.00720445272617469,0.023651258860658,0.000236797338783899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAP,Cartilage-associated protein,40182,0.0173970912589714,0.00473669985081436,0.0081131595513753,0.0266810229665676,0.000241018310503545
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.0222398059560879,0.006064190169193,0.0103539932244696,0.0341256186877062,0.00024619781968481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100P,Protein S100-P,42357,0.0196573346687932,0.00536616838896677,0.00913964462641832,0.0301750247111681,0.000250063526282472
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0271005925912039,0.00740149653817077,-0.0416075258060186,-0.0125936593763891,0.000251886480976678
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00715440758778888,0.00195470658187936,-0.0109856324882724,-0.00332318268730534,0.000253268078068151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0160748056889292,0.0043940398227367,0.00746248763636523,0.0246871237414931,0.000255065989414308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0104728863191734,0.00286313224045746,0.00486114712787678,0.01608462551047,0.00025554768844893
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0105030630592367,0.00287204215259332,0.00487386044015378,0.0161322656783196,0.000256159763367467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NADK,NAD kinase,42636,0.0196754634430567,0.00538406251159584,0.0091227009203289,0.0302282259657846,0.00025877573131345
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0112310255932639,0.00309915273582194,-0.0173053649554748,-0.00515668623105286,0.000291249801344846
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0107581989375787,0.00296904250387228,0.00493887562998904,0.0165775222451684,0.000291789659022439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0240941988182769,0.00665523038767749,0.0110499472584291,0.0371384503781248,0.000295303223007574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0192645752611812,0.00532283204924122,0.00883182444466839,0.029697326077694,0.000296584093211377
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAM,Integrin alpha-M,42611,-0.0112796381391726,0.00311825339316707,-0.0173914147897801,-0.00516786148856516,0.000298792342555186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.0103579848863912,0.00286403607362624,0.00474447418208372,0.0159714955906986,0.000299642742057669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGF,Beta-nerve growth factor,42495,0.00428438826246901,0.00118512673473217,0.00196153986239396,0.00660723666254406,0.000301305037433026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0140696459482074,0.00389962448777832,0.00642638195216187,0.0217129099442529,0.00030977187548599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK8,Kallikrein-8,42154,0.0132882252911199,0.00368746886441494,0.00606078631686666,0.0205156642653732,0.000314995305466411
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1B,Interleukin-1 beta,42293,0.0201061291693719,0.00560713648191045,0.0091161416648274,0.0310961166739164,0.000337255651214322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMCN2,Hemicentin-2,40269,-0.0206977650520702,0.00577977169961424,-0.0320261175833141,-0.00936941252082627,0.000343656216774826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC1,Sialoadhesin,42676,-0.0152193849218037,0.00425286686038511,-0.0235550039681585,-0.00688376587544884,0.000346628264556985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXTL1,Exostosin-like 1,40116,0.0167708403314443,0.0046874451809411,0.00758344777679975,0.0259582328860889,0.0003479702987867
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0120946397809551,0.00338141352343627,0.00546706927502002,0.0187222102868902,0.000349052426067604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0185961979379661,0.00520164379163039,-0.0287914197695616,-0.00840097610637049,0.000351376779693102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0135837638396014,0.00379980596606772,0.00613614414610864,0.0210313835330941,0.000351651984735051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0145050188469681,0.00405977691884278,0.00654785608603629,0.0224621816079,0.000354573415079476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0354265433784633,0.00994139898280001,0.0159414013721753,0.0549116853847513,0.000367451438630056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIT,Citron Rho-interacting kinase,40182,0.0159204442539899,0.00447646814760272,0.0071465666846886,0.0246943218232913,0.000377446614918669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN2,Prefoldin subunit 2,42311,0.0194241889492089,0.00546323665949214,0.00871624509660431,0.0301321328018135,0.000378680923710329
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XG,Glycoprotein Xg,42734,0.0120628146902749,0.00339854928601342,0.00540165808968857,0.0187239712908612,0.000387416693943766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0140020159371306,0.00395680791144908,0.00624667243069041,0.0217573594435708,0.00040373736749368
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LXN,Latexin,42461,-0.0235929482516359,0.00668439533419452,-0.0366943631066571,-0.0104915333966146,0.000417667079007882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0120107001599179,0.00341293175601557,0.00532135391812741,0.0187000464017084,0.000434311491023113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVR,Poliovirus receptor,42711,0.0127288210185505,0.00361700868245963,0.00563948400092959,0.0198181580361713,0.000434343739699651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.015910303957857,0.00452122193751513,0.0070487089603273,0.0247718989553866,0.000434563518556471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0100155594633519,0.00284928012625675,0.00443097041588862,0.0156001485108151,0.00044128450407625
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY2,Protein canopy homolog 2,42357,0.0213406841294844,0.00608467605904445,0.00941471905375733,0.0332666492052116,0.000454215571551457
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0131074515651969,0.0037406392137874,0.00577579870617364,0.0204391044242202,0.0004597329878262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99,CD99 antigen,42611,-0.00696913387052244,0.00199214097561743,-0.0108737301827326,-0.00306453755831228,0.000469726831957005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.0191497003044765,0.0054804958478769,0.00840792844263777,0.0298914721663152,0.00047743839192036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPJ,Centromere protein J,40302,0.0244451218409718,0.00700666319495255,0.0107120619788648,0.0381781817030788,0.000487002010518448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0629481659170608,0.0180599179534785,0.0275507267282429,0.0983456051058786,0.000492759710808442
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0128581977623015,0.00369904011710046,0.00560807913278459,0.0201083163918184,0.000510758134452028
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0200866708575627,0.00577924263360976,0.00875935529568755,0.0314139864194378,0.000511226902546017
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNC,Tenascin,42689,-0.0165275718613228,0.00476029661671842,-0.0258577532300909,-0.00719739049255465,0.000518285871563811
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.0153752573171,0.0044319599430306,0.00668861582876003,0.02406189880544,0.000523700864663223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0137358237073879,0.00395955397076615,-0.0214965494900896,-0.00597509792468626,0.000524349817414562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0166667906249589,0.0048222912377845,0.00721509979890132,0.0261184814510165,0.00054987013653502
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A11,Protein S100-A11,42531,0.0154710936070256,0.00448855654999153,0.00667352276904223,0.024268664445009,0.000569046924104238
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH6,Cadherin-6,42636,-0.0131042201712332,0.00381605840879958,-0.0205836946524804,-0.00562474568998606,0.000596610194098853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0121799884576826,0.00354766718437284,-0.0191334161390534,-0.00522656077631184,0.000598207463314324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0127047521775285,0.00370568722067161,0.0054416052250121,0.0199678991300448,0.000608865503955963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEK,Angiopoietin-1 receptor,42679,0.00738644639546838,0.00216145463206322,0.00314999531662446,0.0116228974743123,0.000634207468591261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.0110867163662607,0.00324616198452847,-0.0174491938559365,-0.00472423887658486,0.000639280576520495
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0151493714740836,0.00445318344124371,0.00642113192924593,0.0238776110189213,0.000671471770841477
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00508794505699061,0.00150263222142131,0.00214278590300483,0.00803310421097638,0.00071155204950453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,0.0165169856254065,0.00488617451994543,0.00694008356631348,0.0260938876844996,0.000726381246004097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERC2,ERC protein 2,40182,0.0253593975075175,0.00750384647715334,0.0106518584122969,0.040066936602738,0.000728651481861072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPS10,40S ribosomal protein S10,40116,-0.0136019447680242,0.00403252907156421,-0.02150570174829,-0.00569818778775833,0.000745972269160093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS4,Thrombospondin-4,42652,0.0152092980920552,0.00450998143115662,0.0063697344869882,0.0240488616971222,0.000747358790924976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0108426964081714,0.00321644520073742,-0.0171469290016168,-0.00453846381472608,0.000751504383575526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0117500016876611,0.00349370961089423,0.00490233085030837,0.0185976725250138,0.000772677812392924
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA10,Annexin A10,42311,-0.028598323088982,0.00851618909203942,-0.0452900537093793,-0.0119065924685848,0.000786998809147996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.022442149292055,0.00669448348102026,0.00932096166925525,0.0355633369148547,0.000803541375061198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.00964238475891255,0.00288188301375889,0.00399389405194513,0.01529087546588,0.000822539633611138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0147742150054438,0.00441668289545958,0.00611751653034306,0.0234309134805446,0.000825299841007825
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0144034373238736,0.00430962938608834,0.00595656372714043,0.0228503109206067,0.000833632259233673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB37,Ras-related protein Rab-37,42370,0.0265425064861461,0.00797331323446938,0.0109148125465861,0.042170200425706,0.000874231191382594
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPL,Periplakin,40199,0.010933797368896,0.00329557161592419,0.00447447700168458,0.0173931177361074,0.000910483848182478
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.0069575257991787,0.00209861623164506,0.00284423798515438,0.011070813613203,0.00091790649754328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0375185998906017,0.0113262317799073,0.0153191856019834,0.0597180141792201,0.000927003381390381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0160775585546421,0.00486256326159751,-0.0256081825473732,-0.00654693456191097,0.000947517270596258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO1,R-spondin-1,42495,0.011071551013591,0.00334904041381787,0.00450743180250792,0.017635670224674,0.000949267142267028
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0127767501872794,0.00386825415717418,0.00519497203921803,0.0203585283353408,0.000959720831248192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN4,Contactin-4,42611,-0.00781039267154623,0.00237136125287901,-0.0124582607271891,-0.00316252461590338,0.000991577026832883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEG1,Protein LEG1 homolog,39926,-0.02272659052616,0.00692232049656925,-0.0362943386994357,-0.00915884235288423,0.00103004863936217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0106443715963525,0.00324836706682091,0.0042775721453835,0.0170111710473215,0.0010530184220426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0113295361583022,0.00346298060228271,-0.0181169781387763,-0.0045420941778281,0.00107210666104353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.0132038661570848,0.0040519881192225,0.00526196944340871,0.0211457628707609,0.00112288921000706
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00839279534897461,0.00258187012668743,-0.013453260797282,-0.00333232990066725,0.00115472823993862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0141461610748017,0.0043529937811871,0.00561429326367495,0.0226780288859284,0.00115848391989148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0180245815404484,0.00556442613723102,0.00711830631147564,0.0289308567694212,0.00120202981693854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR2,Complement receptor type 2,42689,0.0152991211705385,0.00472340517625251,0.00604124702508357,0.0245569953159934,0.00120238702609209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0121420714636144,0.00374859951141687,-0.0194893265059915,-0.00479481642123731,0.00120265821841412
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0139887520656307,0.00433292704823015,0.00549621505109961,0.0224812890801618,0.00124750687535219
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.029513995590077,0.00914255170577315,0.0115945942467616,0.0474333969333924,0.00124939214640141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP4,Guanylate-binding protein 4,42311,0.0157172089558777,0.00487210695885292,0.00616787931652599,0.0252665385952294,0.00125859963798726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL4,Myosin light chain 4,40223,-0.016612147181254,0.00516052518534521,-0.0267267765445306,-0.00649751781797736,0.00128974434182323
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF2,Trefoil factor 2,42654,-0.0184549520036416,0.00573342269164576,-0.0296924604792673,-0.00721744352801592,0.00129016786114705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0134835213133459,0.00419659930925168,-0.0217088559594792,-0.00525818666721261,0.00131680276519851
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0137434583083598,0.00427778829859941,-0.0221279233736147,-0.005358993243105,0.00131846982705794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUK1,Guanylate kinase,40116,-0.0122149411367502,0.00380544356938326,-0.0196736105327414,-0.00475627174075904,0.00133183618722746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0178987641218781,0.00558423357894627,0.00695366630714344,0.0288438619366128,0.00135275946634812
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0102354939001805,0.00320516021886209,-0.0165176079291502,-0.00395337987121083,0.00140912093368541
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0165777584927913,0.00519154010945656,0.00640233987825643,0.0267531771073261,0.00141092097361307
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELENOP,Selenoprotein P,40539,0.00724996710716245,0.00227591950383063,0.00278916487965441,0.0117107693346705,0.00144889587607263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC1,Hamartin,40199,0.0231273867973979,0.00726764574657633,0.00888280113410832,0.0373719724606875,0.00146547312716499
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0169401905667428,0.00532464527876515,0.00650388582036306,0.0273764953131225,0.0014686425368148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0220019053437046,0.00692738271585598,0.00842423522062683,0.0355795754667823,0.00149614324019575
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0263083784329315,0.00829411298042622,0.0100519169912961,0.0425648398745668,0.00151765769488876
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH3,Cadherin-3,42711,0.011677741802626,0.00369595823367721,0.00443366366461871,0.0189218199406334,0.00158335226640611
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0218174399111473,0.00692372721187441,-0.0353879452464211,-0.00824693457587342,0.00163017964194573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0220495404402569,0.00700186652024681,0.00832588206057318,0.0357731988199407,0.00164211093928847
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.0111900927082157,0.00355972258504935,0.00421303644151895,0.0181671489749124,0.00167294718521734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0197619662784232,0.00628861349059568,-0.0320876487199907,-0.00743628383685566,0.00167953655024789
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA2,Ephrin type-A receptor 2,42125,-0.0104363331485161,0.003321260807465,-0.0169460043311475,-0.00392666196588474,0.00168015835205882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASS1,Argininosuccinate synthase,40116,0.0241023363702863,0.00768236295285094,0.0090449049826985,0.0391597677578742,0.00170929947812622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0175651760271221,0.00560891123021046,0.00657171001590962,0.0285586420383346,0.00174204278635288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0242204742579132,0.00774045988428058,0.0090491728847233,0.0393917756311032,0.00175812595217669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00790522027822299,0.00253593377242639,-0.0128756504721787,-0.00293479008426727,0.00182996240431566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX5,Syntaxin-5,40199,0.0126659169510885,0.00406363775281563,0.00470118695556983,0.0206306469466071,0.00183239663898232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0108949803450127,0.00349728520012468,0.00404030135276835,0.0177496593372571,0.00184162449880404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG1,Arginase-1,42488,0.0158817330399661,0.00510866352724759,0.00586875252656079,0.0258947135533714,0.00188255431714331
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5L,CD5 antigen-like,40479,0.0146518950960835,0.00472065797292123,0.00539940546915789,0.0239043847230091,0.00191536259849161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD302,CD302 antigen,42587,0.00979423511294062,0.00315679758951404,0.00360691183749309,0.0159815583883881,0.00192237082702258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0146537058140659,0.00473134783597916,0.00538026405554677,0.0239271475725851,0.00195868572335647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSN,Gelsolin,40488,0.00592979311577013,0.00191740773108105,0.00217167396285127,0.009687912268689,0.00198888881768874
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12B,Interleukin-12 subunit beta,42754,0.0172655618716649,0.00558638989883798,0.00631623766994242,0.0282148860733873,0.00200125205570232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0306039854459203,0.00992808462523206,0.0111449395804654,0.0500630313113751,0.00205640493169434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.0182659405528419,0.00593605490741817,0.0066312729343023,0.0299006081713815,0.00209435658765512
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0155901962589958,0.00506689243133476,0.00565908709357969,0.025521305424412,0.00209697325974622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.018174296689391,0.00591034826272319,0.00659001409445358,0.0297585792843285,0.00210934001384634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.012415802886234,0.00404046534558059,-0.020335114963572,-0.0044964908088961,0.00212536833056172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRC,Chymotrypsin-C,42626,0.0199555148956261,0.00651808216461143,0.00718007385298773,0.0327309559382646,0.00220620117373923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.017047217281571,0.0055714235778328,0.00612722706901874,0.0279672074941233,0.00221959806286294
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMP,Cartilage oligomeric matrix protein,42511,0.010131268297539,0.00331918053342866,0.0036256744520188,0.0166368621430591,0.00227512043687856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGB,Secretogranin-1,42664,-0.0129346425339435,0.00424036922177553,-0.0212457662086236,-0.0046235188592635,0.00229013295616705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0170315927937114,0.00560114893737152,0.00605334087646323,0.0280098447109596,0.00236459605128521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB2A2,Mammaglobin-A,40116,-0.00956672107983503,0.00314877649360118,-0.0157383230072933,-0.00339511915237672,0.00238531022277151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0239359893734926,0.00789639661191525,0.00845905201413873,0.0394129267328465,0.00244112194706951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0156232213270411,0.00515546398356889,0.00551851191924605,0.0257279307348361,0.00244688476842634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00901024692389009,0.00297548264703628,0.00317830093569899,0.0148421929120812,0.00246616070820046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3D,Protein FAM3D,40449,-0.0256462140965881,0.00847269292913976,-0.042252692237702,-0.00903973595547418,0.0024761323490783
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR4,Toll-like receptor 4,40199,0.00877724452909028,0.00290163312559049,0.00309004360293292,0.0144644454552476,0.00249262430387423
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YY1,Transcriptional repressor protein YY1,40199,0.00842298508824185,0.00279154469940887,0.00295155747740046,0.0138944126990832,0.00255603086430509
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.00882751288650599,0.00292726538001152,0.00309007274168341,0.0145649530313286,0.00257041649496535
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0139526495048593,0.00463028586984529,0.0048772891999625,0.0230280098097561,0.00258878790869079
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.00902136384374522,0.0029997935706513,0.00314176844526866,0.0149009592422218,0.00264137131886421
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CX3CL1,Fractalkine,42495,-0.0101726888163966,0.00339900757071496,-0.0168347436549979,-0.00351063397779529,0.0027690128523941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,-0.0371506519959436,0.0124135182949554,-0.0614811478540562,-0.0128201561378311,0.00277082700383014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0111069061690474,0.00371961204238926,-0.0183973457721304,-0.00381646656596446,0.0028312686838126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0109820982213489,0.00367862680441636,-0.018192206758005,-0.00377198968469285,0.0028385024768898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST1,Cystatin-SN,39042,0.0325062828065402,0.0109057212551327,0.0111310691464801,0.0538814964666002,0.00288327711439934
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0193596813245805,0.00651146844932245,0.00659720316390852,0.0321221594852525,0.00295368581834962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD83,CD83 antigen,42594,0.0103412147667903,0.0034818870336239,0.00351671618088745,0.0171657133526931,0.00298324661843471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.00947690138523492,0.00319128817099289,0.00322197657008887,0.015731826200381,0.00298700066385217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.0142764922101925,0.00481139195903941,-0.0237068204499098,-0.00484616397047529,0.00301130838735027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00861880494133829,0.00290582249947705,-0.0143142170403133,-0.00292339284236327,0.00302283886407356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MENT,Protein MENT,40283,-0.00677803433244846,0.00228732421884975,-0.011261189801394,-0.00229487886350295,0.00305003509217461
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROCR,Endothelial protein C receptor,40116,-0.0102449383847423,0.00346049370078839,-0.0170275060382875,-0.00346237073119703,0.00307757918430952
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.0228848573158907,0.00774308733670092,0.00770840613595692,0.0380613084958245,0.00312807007287595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,42794,-0.0094429014512571,0.00319699533078923,-0.015709012299604,-0.00317679060291022,0.00314546751893554
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0104962807043237,0.00355656261790137,0.00352541797323699,0.0174671434354104,0.00317170299358698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAX,Apoptosis regulator BAX,42292,0.0257728447312979,0.00875071193907299,0.00862144933071482,0.0429242401318809,0.00323283953312852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0100931623979976,0.00343041758918972,-0.0168167808728095,-0.00336954392318579,0.00326387994981914
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0123804227636337,0.0042146441331604,-0.020641125264628,-0.00411972026263929,0.00331578619773378
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0116877679514181,0.00397952102956764,-0.0194876291693706,-0.00388790673346549,0.00331984618941467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK4,Dickkopf-related protein 4,42477,0.0134244075335896,0.00457521508846834,0.00445698596019163,0.0223918291069875,0.00335025158105536
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPG,Macrophage-capping protein,42461,0.0169067854783651,0.00576633692476035,0.00560476510583484,0.0282088058508954,0.00337383519663333
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0156651561733775,0.00534605552100044,-0.0261434249945384,-0.00518688735221666,0.00339414464017094
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0142278479403425,0.00485566561138681,0.00471074334202438,0.0237449525386607,0.00339504088419518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0177810035531503,0.0060912095970716,-0.0297197743634107,-0.00584223274289,0.00351726550285615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0272466812474007,0.00934413736077322,0.0089321720202852,0.0455611904745162,0.00355364933667256
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0203286212818428,0.00698526517373627,-0.0340197410223659,-0.00663750154131972,0.00361886219121459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMB,Granzyme B,42594,0.0190263562634539,0.00654607242669659,0.00619605430712853,0.0318566582197792,0.00366060507933555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0364202967340356,0.0125607533596816,-0.0610393733190116,-0.0118012201490596,0.00374322763429214
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.0103025691442424,0.00356639931803522,0.00331242648089341,0.0172927118075915,0.00387466161664858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPO,Erythropoietin,42594,-0.0210438735162027,0.00728917844492246,-0.0353306632682507,-0.00675708376415464,0.00389553392995977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0110585345205149,0.00383211990383402,0.00354757950900018,0.0185694895320295,0.00391106449174802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP13,Collagenase 3,42311,-0.00949199475415689,0.00329252159773912,-0.0159453370857256,-0.00303865242258822,0.00394678705047173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRK1,Protein BRICK1,42311,0.0127785561571455,0.0044336165098668,0.00408866779780662,0.0214684445164845,0.00395553826326548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL8,Interleukin-8,42494,0.0197701356815116,0.00686335818180902,0.00631795364516593,0.0332223177178573,0.0039763655675038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.0124715725224265,0.0043367969265083,-0.0209716944983828,-0.00397145054647027,0.00403707082658236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.010544479668286,0.00366740507707028,0.00335636571722824,0.0177325936193437,0.00404559554996628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL19,Interleukin-19,42261,-0.020471607546183,0.00713027195323161,-0.0344469405745169,-0.00649627451784904,0.00409724513682389
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG2,Secretogranin-2,42636,0.00965973927990351,0.00337113568208983,0.00305231334300744,0.0162671652167996,0.00417094671599517
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.0102810510741363,0.00359159688780986,-0.0173205809742436,-0.00324152117402901,0.00420925115045843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL1,Chordin-like protein 1,42654,0.00908449511840981,0.00318245281707936,0.00284688759693427,0.0153221026398854,0.00431626415173133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRN,Progranulin,42552,0.00688611878850696,0.00241869222083394,0.00214548203567242,0.0116267555413415,0.00441947943555244
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00620487529814264,0.00217970779114434,-0.0104771025687855,-0.00193264802749974,0.00442629960183408
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA,Adenosine deaminase,42754,0.00968202933658598,0.00341213914906755,0.00299423660441359,0.0163698220687584,0.004553228323809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZU1,Azurocidin,42216,0.0213229311465989,0.0075261114936714,0.00657175261900295,0.0360741096741948,0.00461562792880036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG3,Secretogranin-3,42638,-0.00950260096517002,0.00336510006208604,-0.0160981970868587,-0.00290700484348137,0.00475175934580213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX3,Syntaxin-3,40483,0.0108132169814383,0.00383413740760737,0.00329830766252785,0.0183281263003487,0.00480702686074014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.00780465701280204,0.00276997210440925,0.00237551168815991,0.0132338023374442,0.00484572911809621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.00969898042328292,0.00344426660257768,0.00294821788223066,0.0164497429643352,0.00487154347517459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0233906701102474,0.00831491180102416,0.00709344298024005,0.0396878972402548,0.00491536341095922
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMBS,Porphobilinogen deaminase,42721,0.0119569682831327,0.00425410349464004,0.0036189254336382,0.0202950111326272,0.00495063653508426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00981284355168139,0.00349491053198051,0.00296281890899959,0.0166628681943632,0.00499763720884676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.00901493971616022,0.00321289871775272,-0.0153122212029556,-0.00271765822936489,0.00502713173192192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.00855223570798968,0.0030588126045525,-0.0145475084129126,-0.00255696300306678,0.00518375471569114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPO,Lactoperoxidase,42134,-0.0168022373062508,0.00601009233572908,-0.0285820182842798,-0.00502245632822185,0.00518685148018609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0121976304042956,0.00436292280189204,0.00364630171258719,0.020748959096004,0.00518702631289715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM2,Paralemmin-2,40483,0.0103718673795096,0.00372265282927038,0.00307546783413968,0.0176682669248796,0.00534272656080982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00798057675872244,0.0028655133561174,-0.0135969829367125,-0.00236417058073234,0.00536113241806114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIF,Leukemia inhibitory factor,42311,0.0141320691951681,0.00507574747543768,0.00418360414331022,0.0240805342470259,0.00537311515478107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB2,Lysosome membrane protein 2,42302,0.00957579471319382,0.00345248616136008,0.00280892183692806,0.0163426675894596,0.00555192122294327
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0148886791787117,0.00537261775298739,0.00435834838285647,0.025419009974567,0.00559389303603892
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WNT9A,Protein Wnt-9a,42370,-0.0081096612952168,0.0029302995089025,-0.0138530483326657,-0.0023662742577679,0.00565634710531948
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0143437722338582,0.00518846643452818,0.00417437802218302,0.0245131664455335,0.00570788666554216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0117422726570596,0.00424910931974617,0.00341401839035713,0.0200705269237621,0.00572702909493023
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX9,Transcription factor SOX-9,40182,0.00756288883779352,0.0027396830426868,0.0021931100741274,0.0129326676014597,0.00578090562290774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0107414999403409,0.00389953969914081,0.00309840213002491,0.0183845977506569,0.00588511862726384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCC1,Regulator of chromosome condensation,40451,0.0142304562129197,0.00518475854391637,0.00406832946684365,0.0243925829589958,0.00606676245912622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.00929807549574662,0.00338976129930526,0.00265414334910831,0.0159420076423849,0.00609791692367471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0116368445075157,0.004244681077362,-0.0199564194191452,-0.00331726959588618,0.00612381164366673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,0.00812214718370364,0.00296706018920988,0.00230670921285226,0.013937585154555,0.00620008094497721
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3,Galectin-3,42669,0.00806046831043214,0.00294556337714347,0.00228716409123094,0.0138337725296333,0.00621821791470075
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0192285584165449,0.00703360421781137,0.0054426941496346,0.0330144226834552,0.00626870789895175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP73,Tumor protein p73,40182,0.00934270708547227,0.00342046920791959,0.00263858743794987,0.0160468267329947,0.00631644394007288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0101092795982097,0.00370768121659561,0.00284222441368236,0.0173763347827371,0.0064077922468586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALY,RNA-binding protein Raly,40451,0.0127371084045674,0.00467706259174134,0.00357006572475437,0.0219041510843804,0.00647302925533018
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP10,Bone morphogenetic protein 10,40283,0.00773465138643701,0.00284191520585392,0.00216449758296332,0.0133048051899107,0.00650615853764586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRUNE2,Protein prune homolog 2,40302,0.00809044329561465,0.00297325319071629,0.00226286704181073,0.0139180195494186,0.0065171454901105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKCQ,Protein kinase C theta type,42370,0.0117654917939011,0.00432455567256501,0.00328936267567369,0.0202416209121285,0.00652442489905678
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0162574241634949,0.00597944941362079,-0.0279771450141916,-0.00453770331279815,0.00655885047288498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFLAM,Pikachurin,40449,0.00832002946357318,0.00306150793185137,0.00231947391714449,0.0143205850100019,0.00658529959127813
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPF,Centromere protein F,40302,0.0146326728913711,0.0053866782806522,0.00407478346129281,0.0251905623214494,0.00660871766493275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0204030522774658,0.00754520090437666,0.00561445850488749,0.035191646050044,0.00685926915695635
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDK,Midkine,42638,0.0135815786760744,0.00502473585904179,0.00373309639235246,0.0234300609597963,0.00688147099757137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMOD4,Tropomodulin-4,40080,-0.011011488543148,0.00408487463845489,-0.0190178428345196,-0.00300513425177643,0.00703544224883726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.00995522897727725,0.00369796774099934,0.00270721220491854,0.017203245749636,0.00710975642916718
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00849962996305779,0.00315812733077788,-0.0146895595313824,-0.00230970039473314,0.00712507859991685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMS1,PMS1 protein homolog 1,40182,0.013808941537006,0.00514182025250823,0.00373097384208983,0.0238869092319221,0.00725055502918685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0132490150946406,0.00493611219941872,-0.0229237950055013,-0.00357423518377988,0.00728345391324848
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0290562398631435,0.0108330301315813,0.00782350080524403,0.0502889789210429,0.00732481658231711
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0395204141840086,0.0147359678117946,0.0106379172728912,0.0684029110951261,0.00732966702632804
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THY1,Thy-1 membrane glycoprotein,42711,-0.00794072095865145,0.00296961582746336,-0.0137611679804796,-0.00212027393682326,0.00750449563978779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIM,Vimentin,42357,0.0305480749648924,0.0114295751142899,0.00814610774088427,0.0529500421889005,0.00753313413089126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0127639368635287,0.00477615236578773,-0.0221251955004726,-0.00340267822658471,0.00753969969750619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITM2A,Integral membrane protein 2A,42594,-0.0162663091050112,0.00608959510724729,-0.0282019155152159,-0.0043307026948065,0.007567996008426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0110175464962343,0.00412658323592617,0.00292944335381904,0.0191056496386496,0.00759874852170821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00934643551386695,0.00350615542110657,0.00247437088849806,0.0162185001392358,0.00769152229044478
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0373346433184935,0.0140391115097123,-0.0648513018775297,-0.0098179847594573,0.00784061086898201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.013889796590144,0.00522472282181176,0.00364933985939299,0.0241302533208951,0.00786057864288799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15,Interleukin-15,42594,-0.00868605550726813,0.00327333774178765,-0.0151017974811719,-0.00227031353336433,0.00797374460550216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGT,Angiotensinogen,40532,0.00625059611692721,0.00235995795814696,0.00162507851895917,0.0108761137148952,0.00809367376327588
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL25,Interleukin-25,40036,0.00916627619872097,0.00346147364733555,0.00238178784994329,0.0159507645474987,0.00810663746046128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.00830172608385118,0.00314056474036585,0.00214621919273411,0.0144572329749682,0.00821944256805806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0143745407386748,0.00545306309026162,0.003686537081762,0.0250625443955876,0.00839919439531619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EP300,Histone acetyltransferase p300,40199,0.00807932868932683,0.00306564584785736,0.0020706628275264,0.0140879945511273,0.00841458504023884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUOX2,Dual oxidase 2,42357,0.018580667416529,0.00705611678629846,0.00475067851538402,0.032410656317674,0.00846656852786744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD1,Polycystin-1,40511,0.00698113471505339,0.00265237326609057,0.00178248311351588,0.0121797863165909,0.00849907333996622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHB,Lutropin subunit beta,42346,0.0218386452289888,0.00830852357219314,0.00555393902749025,0.0381233514304874,0.00858714063892628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.00702847468142309,0.00267955221470145,-0.0122803970222379,-0.00177655234060824,0.00872569421749451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBLN2,Fibulin-2,40527,-0.00842802540381724,0.00322828121863912,-0.0147554565923499,-0.00210059421528457,0.00904800305722493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN15,Lipocalin-15,40482,-0.0161470466603291,0.00618690568872564,-0.0282733818102314,-0.00402071151042686,0.00906950530381583
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB1,Lamin-B1,40434,0.0153905007622923,0.00590221344108268,0.00382216241777023,0.0269588391068143,0.00913049599155417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOC,Brother of CDO,42357,-0.00602618264111536,0.00231120424618633,-0.0105561429636406,-0.00149622231859015,0.00913415697858516
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF4,Neurotrophin-4,42346,0.0100331737514295,0.00384943729433337,0.00248827665453607,0.0175780708483229,0.00916026925269717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0127944857604991,0.00492633830192013,0.00313886268873561,0.0224501088322625,0.00941243396173578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO1,Roundabout homolog 1,42638,0.00625414174296239,0.00241346545900443,0.00152374944331371,0.0109845340426111,0.00957025954491626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.010691789887053,0.00412844163327795,-0.0187835354882778,-0.00260004428582824,0.00961388669191483
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.00916039536736847,0.00354214402430304,0.00221779307973452,0.0161029976550024,0.00971683981239432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0114718336009665,0.00444414940567843,0.00276130076583676,0.0201823664360962,0.00985484679555328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDRG1,Protein NDRG1,42311,0.0165800152538816,0.0064287099455955,0.00397974376051443,0.0291802867472488,0.00991780680421933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBR1,T-box brain protein 1,40182,0.0123758959901378,0.00480064223630666,0.00296663720697679,0.0217851547732989,0.00995125803329856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPS,Calcyphosin,40483,0.0263429054366244,0.010232088796589,0.00628801139530984,0.0463977994779389,0.0100500173874338
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0206152054892964,0.00802079517694423,-0.036335964036107,-0.00489444694248566,0.0101765129740373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.00987678176349673,0.00384929258518106,-0.0174213952304516,-0.00233216829654184,0.0103049775927991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.00778407944017784,0.0030386026204059,0.00182841830418227,0.0137397405761734,0.0104259945896192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.00848597337528591,0.00331887618212161,0.00198097605832756,0.0149909706922443,0.0105725324722249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SBSN,Suprabasin,40511,-0.0088391329353592,0.00345825304765133,-0.0156173089087558,-0.0020609569619626,0.0106026831372759
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.00973008772112796,0.00382400978952728,0.00223502853365449,0.0172251469086014,0.0109574943606542
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH12,Protocadherin-12,40482,0.0064805191164393,0.00254909597343055,0.00148429100851543,0.0114767472243632,0.0110263936860428
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0201597366437847,0.00793886205022859,-0.0357199062622327,-0.00459956702533663,0.0111165326987383
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN7,Septin-7,40302,0.0136678817723483,0.00538288700256786,0.00311742324731534,0.0242183402973813,0.0111261857185081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNG,Interferon gamma,42370,0.0282537438538008,0.011143734318555,0.00641202458943292,0.0500954631181687,0.0112435913483963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00683694105835207,0.00269986973467041,-0.0121286857383061,-0.00154519637839807,0.0113444604014087
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.0132751302178671,0.0052514041352946,0.00298237811268965,0.0235678823230445,0.0114878130116583
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00636016291254016,0.00251765150474988,-0.0112947598618499,-0.00142556596323041,0.0115407335323341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPA33,Cell surface A33 antigen,42587,-0.0345774458150199,0.0136880220913913,-0.0614059691141468,-0.00774892251589301,0.0115447739095126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASN,Vasorin,42449,0.00684282551326553,0.00271541861727794,0.00152060502340077,0.0121650460031303,0.0117474945641914
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.00738749881764734,0.0029358139441226,-0.0131416941481276,-0.00163330348716704,0.0118719486387801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX2,Transcription factor SOX-2,40461,0.00593818153605938,0.0023659157320223,0.00130098670129568,0.0105753763708231,0.0120908800045595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.00675447938803587,0.00269836974037418,-0.0120432840791693,-0.00146567469690248,0.0123231074023211
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.0120646174660595,0.00482055654316271,0.00261632664146054,0.0215129082906584,0.0123354871260562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0135904793141239,0.00543343911091057,0.00294093865673914,0.0242400199715086,0.0123890902429207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0110164342258048,0.00440619934592544,0.00238028350779097,0.0196525849438187,0.01242599931188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN2,Neuroligin-2,40136,-0.0118861241009806,0.00475706161035887,-0.021209964857284,-0.0025622833446772,0.0124820836305524
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL14,C-C motif chemokine 14,42618,0.00991333962188207,0.00397271657865379,0.00212681512772064,0.0176998641160435,0.0125950172680113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.00964502558913172,0.00386553217723729,0.00206858252174663,0.0172214686565168,0.0126028572050257
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.00616502826223521,0.0024723650549384,-0.0110108637699145,-0.00131919275455595,0.0126581664309669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAG,Myelin-associated glycoprotein,40182,0.0120845127505704,0.00485402404068268,0.00257062563083237,0.0215983998703085,0.0128038517848049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST6,Cystatin-M,42332,0.0124422341481368,0.0049987219069654,0.00264473921048464,0.022239729085789,0.0128195828818725
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6,Interleukin-6,42587,-0.0188036498283457,0.00757684398025041,-0.0336542640296365,-0.00395303562705495,0.0130869508965492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0121378731961907,0.00489370034843331,-0.0217295258791199,-0.00254622051326137,0.0131417838956666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNPO1,Transportin-1,40302,0.00867971676404078,0.00350580423553602,0.00180834046239019,0.0155510930656914,0.013308101034918
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0140008968997087,0.00566827606032148,0.00289107582147855,0.0251107179779388,0.0135245174958565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.00754866371269436,0.00306224752632543,0.00154665856109652,0.0135506688642922,0.0137136544777355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0144139286321539,0.00584931718092285,0.00294926695754513,0.0258785903067627,0.0137470137522136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0157704514845637,0.00640390714598808,0.00321879347842701,0.0283221094907003,0.0138074016236649
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLGN,Calmegin,40182,0.0112997073158015,0.00459312800530122,0.00229717642541111,0.0203022382061919,0.0139038200589057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SATB1,DNA-binding protein SATB1,40482,0.00711445218513759,0.00289415027770342,0.00144191764083888,0.0127869867294363,0.0139777522080564
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.029665326578262,0.0121106102952504,0.0059285303995712,0.0534021227569528,0.0143171514397381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.00882430228682394,0.00360507986896266,0.00175834574365714,0.0158902588299907,0.0143910022270989
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTXR,Neuronal pentraxin receptor,42636,0.00818969462767277,0.00335088277406243,0.00162196439051041,0.0147574248648351,0.0145365416473052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.0134488372923077,0.0055070592584187,0.00265500114580708,0.0242426734388084,0.014617345169226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B4,Protein ATP1B4,40080,-0.0102206920278028,0.00418661045281045,-0.0184264485153113,-0.00201493554029432,0.0146510849561019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0163716813028844,0.0067099831019329,0.00322011442309597,0.0295232481826729,0.0147070670977365
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.00638425786587097,0.00261692688428523,0.00125508117267192,0.01151343455907,0.0147162825861656
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00485783361684309,0.00199221264341488,-0.00876257039793627,-0.00095309683574992,0.0147647756126176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL34,Interleukin-34,42292,0.00879608170072366,0.00360924454134668,0.00172196239968417,0.0158702010017631,0.0148188963240528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL20,C-C motif chemokine 20,42754,0.021969916470299,0.00902863240223334,0.00427379696192165,0.0396660359786764,0.0149722351193932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0108822199693088,0.00447319732545887,0.00211475321140945,0.0196496867272082,0.0149974641163224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,42215,-0.0243154834211198,0.0100010634152412,-0.0439175677149925,-0.00471339912724717,0.0150585753878293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00828391676252274,0.00341976951851374,-0.0149866650188097,-0.00158116850623582,0.0154330528767648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00801528126668877,0.00331170961273409,0.00152433042572994,0.0145062321076476,0.0155244547401863
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.00848062391443437,0.00351019968207189,0.00160063253757347,0.0153606152912953,0.0157084634168388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00866530832264739,0.00358943177727057,0.00163002203919706,0.0157005946060977,0.0157896349615996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00706709340088525,0.00292857718279046,-0.0128071046791546,-0.00132708212261594,0.0158315825943267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0116202361448644,0.00483178427792691,-0.0210905333296011,-0.00214993896012766,0.0161880599485168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0112763026643379,0.00468958310263293,-0.0204678855454984,-0.00208471978317735,0.0162064506526578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTO1,Protein LTO1 homolog,42370,0.00999246481663542,0.00415621481118432,0.00184628378671415,0.0181386458465567,0.0162206247888951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.010298478502596,0.00428827323392872,0.00189346296409573,0.0187034940410963,0.0163422948453823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0090115041790548,0.00375488993521318,-0.0163710884520726,-0.00165191990603698,0.0164144420889009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0100699603911618,0.00420404312119422,-0.0183098849087024,-0.00183003587362111,0.0166233906794092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD9,Enhancer of filamentation 1,40199,0.00787639225980368,0.00329638709489681,0.00141547355380594,0.0143373109658014,0.0168925818236682
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.013327272671377,0.00557829391832561,0.0023938165914588,0.0242607287512952,0.0169048816350361
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.007144289791932,0.00299882037037402,0.00126660186599891,0.0130219777178651,0.0172157254374886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA5,Annexin A5,42261,-0.00719962971782515,0.00302867140187631,-0.0131358256655027,-0.00126343377014758,0.0174609343135843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00720063573005244,0.00303026502212776,0.00126131628668203,0.0131399551734228,0.0175043232323005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OCLN,Occludin,40482,0.0105445145757304,0.0044388575178553,0.00184435384073404,0.0192446753107268,0.0175417002547667
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,0.00653745909830203,0.00275758406236742,0.00113259433606189,0.0119423238605422,0.0177704823605488
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGCR6,Protein DGCR6,40136,0.0103906356710395,0.004383724540913,0.00179853557085001,0.018982735771229,0.0177920613915332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00919666157171924,0.00388114030338567,-0.0168036965663552,-0.00158962657708332,0.0178257184064374
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00555270870961966,0.00234617522362228,-0.0101512121479193,-0.000954205271319979,0.0179639277412647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0103722406465904,0.00439733312854118,0.00175346771464973,0.0189910135785312,0.0183536340572143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00617541510316176,0.00262270997598073,0.00103490355023953,0.011315926656084,0.0185606852843493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.00738807033132447,0.00314069022127939,-0.0135438231650321,-0.00123231749761687,0.0186685225568861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB44,Ras-related protein Rab-44,40451,0.00970054434926789,0.00414250637404652,0.00158123185613671,0.0178198568423991,0.019213019301124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB118,Beta-defensin 118,40136,0.0132093496118051,0.00564347276248145,0.00214814299734149,0.0242705562262688,0.0192684790137879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0120920316527591,0.00517808337805977,0.00194298823176193,0.0222410750737562,0.0195489585300561
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5,Interleukin-5,42370,0.0320743651398833,0.013763493659862,0.00509791756655387,0.0590508127132128,0.0198003450775559
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.0151443290236165,0.00651604482561757,0.00237288116540611,0.027915776881827,0.0201320610118374
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.022994944811984,0.00990156907647667,-0.0424020202018783,-0.00358786942208974,0.0202321896710869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31,Interleukin-31,40199,0.0129566529785011,0.00558153558129613,0.00201684323916069,0.0238964627178415,0.0202865637706163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0196603153275445,0.00847307255112583,-0.0362675375277511,-0.00305309312733786,0.0203385154296171
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,0.0137648516749823,0.00593946462097007,0.00212350101788098,0.0254062023320836,0.0204929982273108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLON5,IgLON family member 5,40080,-0.0217337472624324,0.00938450916095859,-0.0401273852179113,-0.00334010930695358,0.0205812689959188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0145144821864182,0.00626880688043311,0.00222762070076932,0.0268013436720671,0.0206115516809804
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK2,Protein AHNAK2,40223,0.00691912932245838,0.00298951332943668,0.00105968319676249,0.0127785754481543,0.0206604070057851
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.011091863177955,0.00481229016269861,-0.0205239518968443,-0.00165977445906572,0.0211872011805692
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G1B,Phospholipase A2,42782,-0.010337695373619,0.00449717441414265,-0.0191521572253386,-0.00152323352189942,0.0215365716302884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.0109862661551442,0.00478343615924586,-0.0203618010272661,-0.00161073128302228,0.0216529520093186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00740850803750169,0.00322680883436359,0.00108396272214906,0.0137330533528543,0.0216990736251789
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC2,Stanniocalcin-2,42591,0.00562466672174009,0.00245264000356007,0.000817492314762362,0.0104318411287178,0.0218455088097111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00984323212911632,0.00429674934740384,-0.0182648608500278,-0.0014216034082048,0.0219904090469598
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA6C,Semaphorin-6C,40199,0.00595435606839238,0.00259933285035568,0.000859663681695247,0.0110490484550895,0.0219981560636941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0102974852857856,0.00449829047542335,-0.0191141346176154,-0.00148083595395586,0.022086425621895
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD55,Complement decay-accelerating factor,42201,0.00614452834399756,0.00268739318454353,0.000877237702292248,0.0114118189857029,0.0222452874113851
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.0105033892216537,0.00460051974139279,-0.0195204079147835,-0.00148637052852379,0.0224409388774744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0121947951486368,0.00534376348450768,0.00172101871900174,0.0226685715782718,0.0225042508650274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL28,C-C motif chemokine 28,42538,0.0132081436316363,0.00579039287909169,0.00185897358861662,0.024557313674656,0.022561502539411
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00927420467101519,0.00406911875849326,0.0012987319043684,0.017249677437662,0.0226761498968179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MELTF,Melanotransferrin,40511,0.00678694299015635,0.00298439615943426,0.000937526517665209,0.0126363594626475,0.0229760410096276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.011806960304922,0.0052008594760125,0.00161327573193752,0.0220006448779065,0.0232148819990642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00652364119936811,0.00288096069664309,0.000876958233947656,0.0121703241647886,0.0235690274145011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH17,Protocadherin-17,42636,-0.00831577524460632,0.0036724950354011,-0.0155138655139925,-0.00111768497522015,0.0235691072624043
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA4,Carboxypeptidase A4,40060,0.00988764283943972,0.00436936149109634,0.0013236943168909,0.0184515913619885,0.023658474303661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA4,Ephrin-A4,42475,0.00758303338109485,0.0033524899354526,0.00101215310760776,0.014153913654582,0.0237190058589228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI3,Elafin,42446,0.0126261292698698,0.0056061880711231,0.00163800065046853,0.0236142578892711,0.0243273716077573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEF,Thyrotroph embryonic factor,40116,0.0096912952335365,0.00430355515899706,0.00125632712190226,0.0181262633451707,0.024346620602819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN10,Ataxin-10,42311,0.0160266466122358,0.00712542957068505,0.00206080465369311,0.0299924885707785,0.0245151291288934
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MBL2,Mannose-binding protein C,40379,0.0241900152440086,0.0107729989816672,0.00307493723994086,0.0453050932480764,0.024759990588107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL3,Follistatin-related protein 3,42574,-0.00746488842795686,0.0033330947707147,-0.0139977541785577,-0.000932022677356043,0.0251315189325169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,-0.013427624916306,0.00599587846464983,-0.0251795467070197,-0.00167570312559238,0.0251411160854997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0164769601638336,0.00736138056205537,-0.0309052660654622,-0.00204865426220511,0.0252216887777346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF9,Fibroblast growth factor 9,40065,0.00913144204328785,0.00408007604890765,0.00113449298742885,0.0171283910991468,0.0252375174544654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL11,Interleukin-11,42370,0.0137842150575707,0.00618716696264301,0.00165736781079037,0.025911062304351,0.0259058785956736
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0127771583766198,0.00574236469406859,-0.0240321931769942,-0.00152212357624536,0.0260931292058979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMH,Granzyme H,42357,0.0170238388317679,0.00765411992537964,0.00202176377802379,0.032025913885512,0.0261558840655934
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0126631499277628,0.00570286145323549,-0.0238407583761044,-0.00148554147942125,0.026402238997513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0113480885112946,0.00511244569940765,-0.0213684820821336,-0.00132769494045564,0.0264559089193403
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0128538560521109,0.00581082325707334,0.00146464246824711,0.0242430696359746,0.0269829228790384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP6,Guanylate-binding protein 6,40116,-0.0100797681019787,0.00457083928774801,-0.0190386131059648,-0.00112092309799256,0.027458469484424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRND,Prion-like protein doppel,40483,-0.0114032215388884,0.00517382053391905,-0.0215439097853698,-0.00126253329240709,0.0275428063501544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00530499106192195,0.0024095066131823,0.000582358100084636,0.0100276240237593,0.0277077581240177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0155791230351602,0.00709284417595638,0.00167714845028567,0.0294810976200347,0.0280802324974656
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0129683897645866,0.00590951174396493,0.00138574674641535,0.0245510327827579,0.0282173028193588
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0114431259450872,0.00522463585200398,0.00120283967515943,0.021683412215015,0.0285254953469008
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBB,Inhibin beta B chain,40283,0.0117764978776453,0.00539212521891168,0.00120793244857838,0.0223450633067122,0.0289818117792599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA1,Annexin A1,40235,0.00896810544726264,0.00410642031956365,0.000919521620917891,0.0170166892736074,0.0289888827300955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.0137805214201706,0.00632116489982566,0.00139103821651229,0.0261700046238289,0.0292741003313892
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.00973712167124302,0.00447417598386098,-0.0185065065996106,-0.000967736742875494,0.0295508303549484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0211487660159139,0.00973423926273647,0.00206965706095044,0.0402278749708774,0.0298300107838418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTN3,Myeloblastin,42276,-0.0104508255337424,0.00481408044784818,-0.0198864232115248,-0.00101522785595998,0.0299576224449567
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC2,Mucin-2,40527,0.0199463648180795,0.00919049634605265,0.00193299197981628,0.0379597376563427,0.0300029249972674
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0153782142840711,0.00709064145865755,0.00148055702510232,0.0292758715430399,0.0301154726286285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSG,Basigin,42746,0.00464038311249277,0.00214174165879615,0.000442569461252313,0.00883819676373322,0.030279685176881
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0087665732753815,0.00405705488314316,0.000814745704420909,0.0167184008463421,0.0307264978397305
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.00969470131031166,0.00448970052892756,0.000894888273613635,0.0184945143470097,0.0308466664736048
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00579360154197133,0.00268638723784738,0.000528282555790472,0.0110589205281522,0.031053863773408
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0252232912734638,0.0117042790763301,-0.0481636782630708,-0.00228290428385692,0.0311757594735528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.00848579831709955,0.00394653056512727,-0.016220998224749,-0.000750598409450106,0.031561918088427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.00855573508805085,0.0039888128656099,0.000737661871455441,0.0163738083046463,0.0319802199805601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTTG1,Securin,40302,0.00868844922835293,0.00405275643161957,0.000745046622378565,0.0166318518343273,0.0320675926113057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00736159182487216,0.00343874559930923,-0.0141015331995182,-0.000621650450226073,0.032309808508079
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.010881227359889,0.00510029969734521,0.000884639953092388,0.0208778147666856,0.0329102355739207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNG,Uracil-DNA glycosylase,40451,0.00717738394910348,0.00337161306942522,0.000569022333030056,0.0137857455651769,0.0332950610102965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,0.00573757982256837,0.0027003523195881,0.000444889276175683,0.0110302703689611,0.0336288571608603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.0112401945484879,0.00530444692941926,0.000843478566826129,0.0216369105301496,0.0341117923974676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0121185129921538,0.00572623543206904,0.000895091545298472,0.0233419344390091,0.0343367987984384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRXN3,Neurexin-3,40182,0.00738689163586772,0.00351748051709547,0.000492629822360599,0.0142811534493748,0.0357470149247956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.00848639577817055,0.0040498735725249,0.000548643576021754,0.0164241479803194,0.0361513560444841
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.00847821278100171,0.00404925629063464,0.000541670451357817,0.0164147551106456,0.0363027178342326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RETN,Resistin,42598,-0.00894955868109971,0.00427561435110165,-0.0173297628092589,-0.000569354552940483,0.0363533357733453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0130006755728943,0.00621444733952151,-0.0251809923583564,-0.000820358787432125,0.0364565194312081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA7A,Semaphorin-7A,42760,0.00584650989932264,0.00280494910311678,0.00034880965721374,0.0113442101414315,0.0371465417460702
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0104273845058888,0.0050151705957504,0.000597650138218013,0.0202571188735596,0.0376212516556896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.00745656722786676,0.00359667789432247,-0.0145060559007388,-0.000407078554994712,0.038174568402988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD9,COMM domain-containing protein 9,40451,0.00813043058147386,0.00392209721908057,0.000443120032075943,0.0158177411308718,0.0381968038725072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK14,Kallikrein-14,42721,0.00962782964781568,0.00464950107660786,0.000514807537664263,0.0187408517579671,0.0384035963159929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.00735779378500511,0.00355661164035909,-0.0143287526001089,-0.00038683496990129,0.0385870765391795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRTN,Neurturin,42370,0.0100012521911364,0.00485763554448277,0.000480286523950166,0.0195222178583226,0.0395260666561757
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0157012888169608,0.00762864460174705,0.000749145397536557,0.030653432236385,0.0395904916693978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE6,Ribonuclease K6,40468,-0.00691024797638292,0.00336159202206748,-0.0134989683396352,-0.000321527613130664,0.0398394917201863
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKIV2L,Helicase SKI2W,40116,-0.00809971782140768,0.00394458053775171,-0.015831095675401,-0.000368339967414326,0.0400596205394811
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0106926438869263,0.00523520124121556,-0.0209536383197088,-0.000431649454143848,0.0411300286967115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00695941927760932,0.00340829644124927,-0.0136396803024579,-0.000279158252760758,0.0411808656988205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00638801039002823,0.00313718523552432,-0.0125368934516559,-0.000239127328400565,0.0417518455649849
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00802367597026497,0.00394639453118733,0.000288742689137794,0.0157586092513921,0.0420590810458806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00592085171306543,0.00291223352444804,-0.0116288294209836,-0.000212874005147265,0.0420661267168444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0124285120631173,0.0061195226578543,0.000434247653722858,0.0244227764725117,0.0422830740670215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH1,Cadherin-1,42188,-0.0079641082159318,0.00392170011788826,-0.0156506404469928,-0.000277575984870802,0.0422976862539437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.011723660207266,0.00577310418944944,-0.0230389444185869,-0.00040837599594506,0.0423048995529655
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR5,Proline-rich protein 5,40199,0.00960191133681967,0.00473398724724135,0.000323296332226617,0.0188805263414127,0.0425544290698817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL1,Interferon lambda-1,42311,-0.00914497308337622,0.0045213059524879,-0.0180067327502525,-0.000283213416499941,0.0431305541982666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0123047390180907,0.00609870700111278,-0.0242582047402717,-0.000351273295909635,0.0436575107756046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00624863285728016,0.00309972057720071,0.000173180525966756,0.0123240851885936,0.0438372460530983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.0073552499554384,0.00365162871912759,0.000198057665948332,0.0145124422449285,0.0440085930019862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0119500910717242,0.00594087517253986,-0.0235942064099023,-0.000305975733546043,0.0442968204243816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP2,Guanylate-binding protein 2,42370,0.0120311114479771,0.00599250519538601,0.000285801265020558,0.0237764216309337,0.0446962904703746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADM,Pro-adrenomedullin,42721,0.0053025313491905,0.00264323227149442,0.000121796097061433,0.0104832666013196,0.0448677487913912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.00957887602946506,0.00478290100129844,0.000204390066920116,0.01895336199201,0.0452304238879424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.00771461119207735,0.00386478141626716,-0.015289582767961,-0.000139639616193714,0.0459444161847459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.00759830533082421,0.00381766937133147,-0.0150809372986339,-0.000115673363014525,0.0465782811223694
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.015343957872001,0.00771313100448728,0.000226221103205972,0.0304616946407961,0.0466897176877813
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.00616967449991338,0.00310450002266955,-0.0122544945443457,-8.48544554810657e-05,0.0469103221188117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.00981474504894845,0.00493889634728768,0.000134508208264607,0.0194949818896323,0.0469206143492707
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300C,CMRF35-like molecule 6,42711,0.00702895844662435,0.00354225533337551,8.61379932083576e-05,0.0139717789000403,0.0472406706031242
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00367551634211371,0.00185277293648108,4.40813866108046e-05,0.00730695129761662,0.0473030822910367
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0163309795760047,0.00824577861381777,0.000169253492921885,0.0324927056590876,0.0476693068736359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0177678126330083,0.00899226655911241,0.000142970177147986,0.0353926550888686,0.0481912719124219
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00666407867387226,0.00338906314374524,-0.0133066424356129,-2.15149121315841e-05,0.0492791808362704
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPE,Carboxypeptidase E,42588,0.0074064570527218,0.00380800069969344,-5.72243186773508e-05,0.0148701384241209,0.051799174730993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00559286006289349,0.00288311376046242,-5.80429076128593e-05,0.0112437630333998,0.0524171443976515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0074270910532887,0.0038360081837193,-9.14849868011297e-05,0.0149456670933785,0.0528705707952882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.00562295102513447,0.00290925169083163,-7.91822888955192e-05,0.0113250843391645,0.0532843890938796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0113414098690848,0.00586979277380065,-0.000163383967564525,0.022846203705734,0.0533605189572201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.00891008506965771,0.00461538140657003,-0.000136062487219535,0.017956232626535,0.0535675536625665
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN3,Perilipin-3,42636,-0.00798674491478825,0.00414538059340935,-0.0161116908778706,0.000138201048294068,0.0540428935540459
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP12,Macrophage metalloelastase,42592,0.0106274444413227,0.00552931883150723,-0.000210020468431472,0.0214649093510769,0.054624809802568
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00989709105339961,0.00515337269569454,-0.0199977015369609,0.00020351943016168,0.0548199535272639
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00553641965510744,0.00288288750451628,-0.0111868791639593,0.000114039853744466,0.0548278839513423
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHPK,Sedoheptulokinase,40302,-0.00778779312939793,0.00406390111574611,-0.0157530393162603,0.000177453057464451,0.0553481911106233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMPD3,AMP deaminase 3,40483,0.0133775799566982,0.00699169576980069,-0.000326143752111126,0.0270813036655076,0.0557281821760223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0103503322256245,0.00542040718314241,-0.000273665853334657,0.0209743303045836,0.0562234665214336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACHE,Acetylcholinesterase,40283,-0.00626967233050198,0.00328797464007691,-0.0127141026250527,0.000174757964048775,0.05656591442182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP350,Centrosome-associated protein 350,40080,0.0071742584678948,0.00376479888840728,-0.000204747353383478,0.0145532642891731,0.0567264483260722
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOC,Myocilin,42611,-0.00839998242025722,0.00440823915572065,-0.0170401311654697,0.000240166324955266,0.0567340239405453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.00777521688847157,0.00408432374707547,-0.0157804914327395,0.00023005765579636,0.0569741966878837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00966905864681678,0.00508458931478333,-0.0196348537037921,0.00029673641015854,0.0572444685455527
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.013439996415235,0.00706881122727089,-0.027294866420686,0.000414873590215912,0.0572828166048573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0121934802813424,0.00644710243980521,-0.000442840500675805,0.0248298010633606,0.0586087405680614
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRNN,Cornulin,42209,0.0128962229128004,0.00682680579542773,-0.000484316446237979,0.0262767622718387,0.0589064487747584
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.00494958546329572,0.00264800060834941,-0.000240495729069123,0.0101396666556606,0.0616238763670913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.00600106277909573,0.00321419017485578,-0.000298749963621592,0.012300875521813,0.0619201157683104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH4,Cadherin-4,40136,0.0091222452473182,0.00492424872599722,-0.000529282255636351,0.0187737727502728,0.0639787982947241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.00791264051561521,0.00427371912508162,-0.00046384896954476,0.0162891300007752,0.0641246311423986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1B,Protein phosphatase 1B,40199,0.0111830923212546,0.00604241692965787,-0.000660044860874783,0.023026229503384,0.0642301817089676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0106089952056959,0.00574480528788153,-0.00065082315855192,0.0218688135699437,0.0648160189120677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00761967745113019,0.00414821506360853,-0.0157501789758029,0.000510824073542532,0.0662573723753358
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN8,Septin-8,40470,-0.00587279020385925,0.0032061321024563,-0.0121568091246736,0.000411228716955096,0.0670170056793115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.0055423563625807,0.00302924497084277,-0.000394963780271126,0.0114796765054325,0.0673299406914836
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM1,Myomesin-1,40136,0.00870770077916448,0.00476438465997199,-0.000630493154380619,0.0180458947127096,0.0676270090660079
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL9,Interleukin-9,40302,0.0101698250750844,0.00556556096514154,-0.000738674416593027,0.0210783245667618,0.0676848523317288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALCAM,CD166 antigen,42794,0.00353573337453318,0.00193768999012254,-0.000262139006106992,0.00733360575517335,0.0680658674871391
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0158695043286798,0.00871730212541674,-0.00121640783713701,0.0329554164944966,0.068716257100779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0166470349420082,0.0091503358669855,-0.0012876233572834,0.0345816932412998,0.0688959821884809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG4,Regenerating islet-derived protein 4,42638,-0.00941781863333563,0.00518334156376615,-0.0195771680983173,0.000741530831646015,0.0692486149143979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00619330270384611,0.00340912590248744,-0.000488584065029275,0.0128751894727215,0.0692875951690024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0133929085643808,0.00738027208460246,-0.0278582418502016,0.00107242472144005,0.0695989282514062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.00896437596553501,0.00494339956624491,-0.000724687184305023,0.018653439115375,0.0697970605413176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC5D,Netrin receptor UNC5D,40199,0.00469345849992006,0.00259137033932988,-0.000385627365166514,0.00977254436500662,0.0701390296079772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00982362786815108,0.00543364626262523,-0.0204735745428965,0.000826318806594378,0.0706455362146724
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0115111304804908,0.00637843451070496,-0.000990601160490873,0.0240128621214726,0.0711497082162923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00640502457301968,0.00356019242593916,-0.000572952581821063,0.0133830017278604,0.0720347887192861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP8,Neutrophil collagenase,42681,-0.0129256361767284,0.0071958553099105,-0.027029512584153,0.00117824023069616,0.0724753458876011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.00375774930480988,0.00209875882340028,-0.000355817989054672,0.00787131659867443,0.0734062474223795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1,Programmed cell death protein 1,42689,0.00794507697331366,0.00444106528319158,-0.00075941098174183,0.0166495649283692,0.0736368302142443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARCL1,SPARC-like protein 1,42644,-0.00486885151327918,0.00272900598985503,-0.010217703253395,0.000480000226836675,0.0744280530108322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB1,Calbindin,42587,0.00801393401992838,0.00449577608328677,-0.000797787103313687,0.0168256551431705,0.0746826522407997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMCH,Pro-MCH,40116,-0.014932851981755,0.008395942448518,-0.0313888991808503,0.00152319521734027,0.0753365196162401
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0152462100826239,0.00857328410189776,-0.00155742675709574,0.0320498469223435,0.0753760098206412
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRP15,RRP15-like protein,40136,-0.016164897198576,0.00909102711012595,-0.0339833103344229,0.00165351593727082,0.0754126322476819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_E,,42594,0.00538903365944123,0.00303910021571989,-0.000567602763369745,0.0113456700822522,0.0762127684362794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0153797984148775,0.00868242459750659,-0.0016377537962354,0.0323973506259904,0.0765269763395774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.00990471954488939,0.0056236375453757,-0.0209270491338258,0.00111761004404699,0.0782162436357125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC4A1,Band 3 anion transport protein,40527,-0.00815719705837019,0.0046366956088655,-0.0172451204517466,0.000930726335006187,0.0785587288324943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPH,Hephaestin,40511,0.00459586535789532,0.00261606759409437,-0.000531627126529648,0.00972335784232028,0.0789816957993176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA6,Carbonic anhydrase 6,42581,-0.0108251297980759,0.006164367169849,-0.02290728945098,0.00125702985482812,0.0790973955495698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.00692636482573522,0.00394486641347583,-0.000805573344677414,0.0146583029961479,0.0791465087987959
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.00775925870432019,0.00441961191448548,-0.000903180648071342,0.0164216980567117,0.0791721648806241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.00657327783118591,0.00374707640953718,-0.000770991931506959,0.0139175475938788,0.0794162871630689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAFB2,Scaffold attachment factor B2,40482,0.00474076035189441,0.00271478140034911,-0.000580211192789846,0.0100617318965787,0.0807900296924873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.00488656338212734,0.00280750764706136,-0.000616151606112919,0.0103892783703676,0.0817924205148559
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.00769158546015414,0.00443007944002221,-0.000991370242289391,0.0163745411625977,0.0825534227752919
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0114679115007946,0.00667821205213191,-0.00162138412138397,0.0245572071229731,0.0859681643798286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNW1,Interferon omega-1,40116,-0.00627050776380288,0.00365230446282871,-0.0134290245109472,0.000888008983341403,0.0860324900950152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO6,Unconventional myosin-VI,40482,0.00615879709527993,0.0035932183766544,-0.000883910922962692,0.0132015051135225,0.0865551159580229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK3,Prostate-specific antigen,40527,0.0166035524986961,0.00970927195834954,-0.00242662053966898,0.0356337255370612,0.0872799622844734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00514275353415938,0.00301894342024949,-0.00077437556952962,0.0110598826378484,0.0884990167221599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRLB,Fc receptor-like B,42346,-0.0109043709296483,0.00640799934959518,-0.0234640496548549,0.00165530779555824,0.0888388135115977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.00544476475102618,0.00322057182770203,-0.000867556031269808,0.0117570855333222,0.0909326318757952
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.00910369050398667,0.00539578995441141,-0.00147205780665969,0.019679438814633,0.091596053114823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.00644949954812087,0.00383564033677037,-0.0139673546081908,0.00106835551194906,0.0926958744348904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD209,CD209 antigen,42668,0.00641562575682365,0.00382724790982513,-0.0010857801464336,0.0139170316600809,0.0937021283846885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO1,Alpha-enolase,42588,0.0129574899680234,0.00775096937473872,-0.00223441000646444,0.0281493899425113,0.0946019033406914
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0168054697354539,0.0100626764995891,-0.00291737620374077,0.0365283156746486,0.0949320741451815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHISA5,Protein shisa-5,40527,-0.00458797711938185,0.00275073997127428,-0.00997942746307945,0.000803473224315741,0.0953619129806379
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLN,Mesothelin,42553,0.00979356472997382,0.00587454001197688,-0.00172053369350087,0.0213076631534485,0.0955139328012655
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0105119951826601,0.00635587655016096,-0.00194552285565539,0.0229695132209756,0.0981760023764316
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0118291943539826,0.00716073780923491,-0.0022058517521178,0.025864240460083,0.0985721726302285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0134736358701137,0.00820175174448557,-0.00260179754907807,0.0295490692893054,0.100452885083578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0096050972583025,0.0058656825636535,-0.00189164056645836,0.0211018350830634,0.101553349604716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.00926934473657978,0.00567059405934079,-0.00184501961972817,0.0203837090928877,0.102149833242916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00553494044142615,0.00338618928061267,-0.0011019905485747,0.012171871431427,0.102168528678491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD160,CD160 antigen,42754,-0.00789497947762946,0.00483595270000188,-0.0173734467696332,0.00158348781437423,0.102584939109355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.00842796768589131,0.00516505625664393,-0.0016955425771308,0.0185514779489134,0.102760010828699
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.00777227912400493,0.00476635036803005,-0.00156976759733397,0.0171143258453438,0.102991649179974
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPO,Myeloperoxidase,42611,0.00747059687286995,0.00458202057505681,-0.00151016345424139,0.0164513571999813,0.103037206276322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.00520643183428832,0.00320386521998947,-0.00107314399689104,0.0114860076654677,0.104176487768304
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.00523201218034024,0.00323211117218396,-0.0115669500778208,0.00110292571714032,0.105522852625061
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.010193972267065,0.00629771468614536,-0.00214954851777993,0.0225374930519099,0.105544575554688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.00497750310593916,0.00307577533438003,-0.00105101654944569,0.011006022761324,0.105628307014553
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COLEC12,Collectin-12,42618,0.00443276396657044,0.00275504731976149,-0.000967128780162084,0.00983265671330296,0.107648362635121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.00908594183279263,0.00565271094970847,-0.00199337162863597,0.0201652552942212,0.108003455839839
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR1B,Cornifin-B,40302,-0.013171503365049,0.00821883175296288,-0.0292804136008562,0.00293740687075823,0.109051330128242
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFC1,Cryptic protein,42346,0.00747456878845513,0.00466934987296369,-0.00167735696255371,0.016626494539464,0.109451243222123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00432933566962604,0.00271442178315355,-0.009649602364607,0.000990931025354921,0.11074923682637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00839391976931038,0.00528887100227513,-0.00197226739514887,0.0187601069337696,0.112520974950223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.011298121124795,0.00712782740554058,-0.00267242059006457,0.0252686628396545,0.112977941224022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0152790292690909,0.00965158235562403,-0.00363807214793217,0.034196130686114,0.113436801069817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22,Interleukin-22,40451,-0.0109513927232597,0.00691833143455778,-0.0245113223349929,0.00260853688847355,0.113460295010861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3C,Protein FAM3C,42613,0.00485258284293743,0.00306658646140912,-0.00115792662142445,0.0108630923072993,0.113580629424467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL21,C-C motif chemokine 21,42676,-0.00657157163965961,0.00415570810469952,-0.0147167595248707,0.00157361624555146,0.113824645776482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0134939895302901,0.00854313403746197,-0.00325055318313538,0.0302385322437156,0.114246957212534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL15,C-C motif chemokine 15,42794,-0.00692018195164599,0.00440760034842672,-0.0155590786345624,0.00171871473127038,0.116425211359057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00425973751742618,0.00271425795132827,-0.00106020806717723,0.00957968310202959,0.116579849088814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.00479211310887845,0.00307180422844703,-0.0108128493966346,0.00122862317887772,0.118775668803169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.00535023452090488,0.00343435017068491,-0.00138109181363754,0.0120815608554473,0.119289987556395
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4,Interleukin-4,42370,0.0143615084755199,0.00924887179023134,-0.0037662802333335,0.0324892971843734,0.120498548451574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00657789135422228,0.00423673408621275,-0.00172610745475471,0.0148818901631993,0.120551023331231
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.00444182103916695,0.00287399665595557,-0.00119121240650598,0.0100748544848399,0.122244506703675
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTR,Methionine synthase,40116,0.0101415548234196,0.00657518078232592,-0.00274579950993917,0.0230289091567785,0.123005540854732
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.00732273397214668,0.00474860120930022,-0.0166299923423751,0.00198452439808175,0.123082561361563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.00728672961277341,0.00473222758564308,-0.00198843645508702,0.0165618956806338,0.123630708267382
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.012902195575607,0.00839129094228013,-0.0293491258224761,0.00354473467126203,0.124182521857688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.00547761232830994,0.00357058764781655,-0.0124759641180304,0.00152073946141051,0.125030866880007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5A,Cytochrome b5,40080,0.0110862845688321,0.00723892377755606,-0.00310200603517783,0.0252745751728419,0.125679263719383
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.00812493448460819,0.00530586637014333,-0.00227456360087274,0.0185244325700891,0.125720511052379
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.00400754341345586,0.00261879278715093,-0.00914037727627169,0.00112529044935997,0.125965651381153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDN1,Endothelin-1,40223,-0.00458829676572668,0.00300990272787247,-0.0104877061123567,0.00131111258090336,0.127437405645674
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00566633377689878,0.00372841047173952,-0.00164135074771068,0.0129740183015082,0.128596177042832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.00582189781488396,0.00383525679287163,-0.00169520549914443,0.0133390011289124,0.129044569474245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00879831256990883,0.00581455005755432,-0.00259820554289763,0.0201948306827153,0.130269449331494
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASET2,Ribonuclease T2,42749,-0.00411215574634632,0.00272570962101894,-0.00945454660354344,0.00123023511085079,0.131410249530475
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH23,Cadherin-23,40483,-0.00387351780366552,0.00258155842657136,-0.00893337231974539,0.00118633671241436,0.133523990607255
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL21R,Interleukin-21 receptor,40199,0.00830803370938409,0.00554286132446516,-0.00255597448656763,0.0191720419053358,0.13393580251455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP1,Caspase-1,42311,0.0102223453231859,0.00682208787345247,-0.00314894690878098,0.0235936375551527,0.134048516256469
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0045511758062066,0.00303768122428177,-0.00140267939338566,0.0105050310057989,0.134094407530496
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.00562024291354219,0.00377196876760159,-0.0130133016980413,0.00177281587095693,0.136247621162983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0129015054333903,0.00866659623082333,-0.029888034045804,0.00408502317902342,0.136603803457644
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO6,Coronin-6,40136,-0.00546208704973431,0.00368353495521783,-0.0126818155619613,0.00175764146249265,0.138146153051991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAVL4,ELAV-like protein 4,40136,0.0124234984118956,0.00840762988292033,-0.00405545615862824,0.0289024529824194,0.139531408445058
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4C,Semaphorin-4C,42587,-0.00404634914904948,0.00274175379147226,-0.00942018658033511,0.00132748828223616,0.140014351262556
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.011835302915611,0.00803095147591414,-0.00390536197718069,0.0275759678084027,0.140587340178061
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD2,Leiomodin-2,40136,0.00909082875788423,0.00617520794328313,-0.00301257881095069,0.0211942363267192,0.1410092947196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0116856680695727,0.00794008000398659,-0.00387688873824101,0.0272482248773864,0.141121916792212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNR,Tenascin-R,42495,0.00616008167999009,0.0041863198015889,-0.00204510513112415,0.0143652684911043,0.141185280043731
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARTN,Artemin,42370,0.00648397960960003,0.00441452308679063,-0.00216848564050962,0.0151364448597097,0.141915336206576
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00572831177037938,0.00391998523722602,-0.0134114828353424,0.00195485929458362,0.143959005379669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00490576485665601,0.0033628777145314,-0.0114970051771376,0.00168547546382554,0.144649013452632
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGA4,Pepsin A-4,40532,0.0116246243336467,0.00797494276682201,-0.0040062634893245,0.0272555121566178,0.144966499787083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.00894315956936899,0.00614035786062449,-0.00309194183745501,0.020978260976193,0.145290522769603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE1,Ribonuclease pancreatic,40532,-0.00379998039773656,0.00261176738373167,-0.00891904446985063,0.00131908367437751,0.145711907270808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0163626419512586,0.0112518582099999,-0.00569100014034134,0.0384162840428584,0.145910010514284
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFRC,Transferrin receptor protein 1,42673,-0.00542171825382734,0.00373112377775794,-0.0127347208582329,0.00189128435057823,0.146217612002351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.00748167957631692,0.00515188408044927,-0.00261601322136365,0.0175793723739975,0.1464677484535
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBQLN3,Ubiquilin-3,40116,-0.00779823807550992,0.00537532905994625,-0.0183338830330046,0.00273740688198472,0.146879270359149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D2,DCN1-like protein 2,40080,0.0114811798472792,0.00793703853459129,-0.00407541568051975,0.0270377753750781,0.148056848116647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH7B,Myosin-7B,40080,-0.0064099285647417,0.00444242423518979,-0.0151170800657137,0.00229722293623029,0.149080292414803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.00712934010568523,0.00494932557657157,-0.0168300182357655,0.00257133802439504,0.149763987562141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00693791048326093,0.00481804385546919,-0.0163812764399805,0.00250545547345869,0.149900327916733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.0119740221628729,0.0083212709039229,-0.00433566880881603,0.0282837131345617,0.150188887265988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,42636,-0.00411073003916997,0.00286626975804586,-0.00972861876493985,0.00150715868659991,0.151545829293039
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00932908838103686,0.00651163422126622,-0.00343371469264494,0.0220918914547187,0.151977437029744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMI,N-myc-interactor,40421,0.0101586002088213,0.00710505404062985,-0.00376730571081321,0.0240845061284558,0.152810581436796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN3,Matrilin-3,42475,0.00461584551930348,0.00323419841496867,-0.00172318337403511,0.0109548744126421,0.15354598340678
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GL3,Endophilin-A3,40250,0.0120396169679746,0.00844389248198217,-0.00451041229671045,0.0285896462326597,0.153943540426593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00628911713646326,0.00442669283907712,-0.0023872008281279,0.0149654351010544,0.155424083467001
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0169168954282752,0.0119484147296871,-0.00650199744191158,0.0403357882984619,0.15685444767749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00443402990040681,0.00314292954779278,-0.0105941718140806,0.00172611201326703,0.158328664078318
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A16,Protein S100-A16,42292,-0.00845325705864404,0.00599631446747806,-0.020206033414901,0.00329951929761296,0.158639586772012
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.007171994560145,0.00509149570472148,-0.0171513261413991,0.00280733702110909,0.158975337383679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0104973328351533,0.00746014616651504,-0.00412455365121622,0.0251192193215227,0.159418865969574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.00890896454517108,0.00633970703697421,-0.00351686124729837,0.0213347903376405,0.159971209414649
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GM2A,Ganglioside GM2 activator,40269,0.00567642830091723,0.00404225839578369,-0.00224639815481879,0.0135992547566533,0.160266056999015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAGE2A,G antigen 2A,40080,0.00921987689589123,0.00660228329147961,-0.00372059835540881,0.0221603521471913,0.162602102226264
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00771025338238218,0.00553694113903199,-0.0185626580148849,0.00314215125012053,0.163795784022547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.00292914018015174,0.00211043198613682,-0.00706558687297991,0.00120730651267644,0.16518065338941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00537655206000375,0.0038806394764123,-0.0129826054337719,0.00222950131376436,0.165933745941932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD177,CD177 antigen,42595,-0.0179626978797605,0.0129996313440322,-0.0434419753140636,0.00751657955454258,0.167060705793931
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0123646671431539,0.00895370862282969,-0.0299139360439001,0.00518460175759234,0.16732026434331
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA3,Carbonic anhydrase 3,42770,-0.008101347475666,0.0058756196451549,-0.0196175619801696,0.0034148670288376,0.167976880792733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00765155579960637,0.00556277269895621,-0.00325147869034779,0.0185545902895605,0.16900676191435
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00907953806166234,0.00660266318033498,-0.00386168177179421,0.0220207578951189,0.169113793278491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.00477658078761642,0.00348087613105678,-0.0115990980044877,0.00204593642925487,0.170013197191422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.00427263897053536,0.00312542993852315,-0.0103984816500407,0.00185320370897001,0.171630225944996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.00774803881299506,0.00567061545312885,-0.0188624451011276,0.00336636747513749,0.171852287769387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSMB,Beta-microseminoprotein,42559,-0.00974796484371632,0.00713833739171531,-0.0237391061314783,0.00424317644404569,0.172094069958872
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.00456984876803329,0.00334760593623195,-0.00199145886698133,0.0111311564030479,0.172245830487842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00588156782240634,0.00431039552995293,-0.0143299430611141,0.00256680741630139,0.172435737496771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTOA,Otoancorin,40136,-0.00735609094252136,0.00540943389908072,-0.0179585813847196,0.00324639949967685,0.173901186724507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00493335554834573,0.00364560106285443,-0.00221202253484895,0.0120787336315404,0.176008053296799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00680470071046024,0.00504131984366448,-0.00307628618312214,0.0166856876040426,0.177112585001298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L,Seizure 6-like protein,42679,0.00373429880875568,0.00276704496401153,-0.00168910932070692,0.00915770693821827,0.177179167136007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00432966858687392,0.00320959639532278,-0.00196114034795873,0.0106204775217066,0.177372581864286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0078867059348826,0.00586195394496661,-0.00360272379725195,0.0193761356670172,0.178522152681827
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TG,Thyroglobulin,40451,-0.0152762742630669,0.0113827873457755,-0.0375865374607868,0.00703398893465311,0.179606722962261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,-0.00367482992507423,0.00274084349614399,-0.00904688317751644,0.00169722332736798,0.180019009731726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.0116756037353934,0.00871025853339042,-0.0287477104608386,0.00539650299005183,0.180129379500435
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18BP,Interleukin-18-binding protein,42689,-0.0042694452106282,0.00318672865158394,-0.0105154333677327,0.00197654294647632,0.180346593306511
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0110264087865828,0.00827512402364689,-0.00519283429976513,0.0272456518729307,0.182730467580757
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00939284146549136,0.00705348071836869,-0.00443198074251127,0.023217663673494,0.182999406862194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA11,Serpin A11,42794,-0.00535360574235482,0.00403087251424514,-0.0132541158702753,0.00254690438556565,0.184150648732344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRC1,Macrophage mannose receptor 1,40532,-0.00383062842903423,0.00288634412845593,-0.00948786292080786,0.0018266060627394,0.184483865379008
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB6,Heat shock protein beta-6,42721,0.00513463821692951,0.00388756056057948,-0.00248498048180627,0.0127542569156653,0.186594844995985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.0052777091397218,0.00400974501677557,-0.00258139109315833,0.0131368093726019,0.188127158420506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLMP,CXADR-like membrane protein,42721,-0.0028498715270694,0.00216565938228031,-0.00709456391633882,0.00139482086220002,0.188217455245094
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.00474566274640636,0.00361079263361162,-0.0118228163082851,0.00233149081547242,0.188772091565554
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.00841388912607025,0.00640826790684333,-0.00414631597134267,0.0209740942234832,0.18921408764643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.00545454455141376,0.00415727233840314,-0.0026937092318564,0.0136027983346839,0.189526519756745
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.0049480200335464,0.00377233524947522,-0.00244575705542503,0.0123417971225178,0.189662096362255
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_A,,40482,-0.00429146952849672,0.00327970141590504,-0.0107196843036706,0.00213674524667716,0.190732459183421
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3A,Uroplakin-3a,40136,0.00662100437736308,0.00506016961135082,-0.00329692806088453,0.0165389368156107,0.190746501084264
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSM,Oncostatin-M,42534,-0.00898642966341041,0.00689887836545387,-0.0225082312597,0.00453537193287917,0.192736284963386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00750855660984658,0.00578863604313522,-0.0188542832543916,0.00383717003469845,0.194617189072369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00838884188873629,0.00648229579537108,-0.00431645787019103,0.0210941416476636,0.195648183042411
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX18,Sorting nexin-18,40449,0.00559311982586852,0.00433119143833658,-0.00289601539327118,0.0140822550450082,0.19660599847225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.00833205617647292,0.00645795089934301,-0.0209896399391852,0.00432552758623938,0.197002892090468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAEP,Glycodelin,42495,-0.0114694506100912,0.00889828310348928,-0.0289100854929302,0.00597118427274776,0.197437549978103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLGAP5,Disks large-associated protein 5,40482,0.00647168558780422,0.00502324752649121,-0.00337387956411855,0.016317250739727,0.197651626077085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00534660539342522,0.0041589645272174,-0.00280496507992089,0.0134981758667713,0.198623173016427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.00688475468733141,0.00537297495924089,-0.00364627623278074,0.0174157856074436,0.200091414431022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK15,Kallikrein-15,40429,0.00675388712074276,0.00527557446496138,-0.00358623883058154,0.0170940130720671,0.200494793072522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00613793342918884,0.00479583906935692,-0.0155377780051284,0.00326191114675072,0.200626634378438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.00890359490321403,0.00696761333421134,-0.0225601170382683,0.00475292723184021,0.201327146718437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0124245253181907,0.0097576640206845,-0.00670049616235095,0.0315495467987323,0.20293535182655
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00631674607416932,0.00497955665891155,-0.00344318497729731,0.016076677125636,0.204633648012253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0120713432460625,0.00955008321569328,-0.00664681985669632,0.0307895063488213,0.206254769146787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.00829742000109762,0.00657882884183566,-0.00459708452890028,0.0211919245310955,0.207248460704915
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNXB,Tenascin-X,42611,0.00320876930936175,0.00254621290179824,-0.0017818079781628,0.0081993465968863,0.207614634514465
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAU,Urokinase-type plasminogen activator,42611,0.00366209354061447,0.00290687184134754,-0.00203537526842671,0.00935956234965566,0.207761397491193
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOD,Apolipoprotein D,40033,-0.00542936321652266,0.00431293721040049,-0.0138827201489076,0.0030239937158623,0.208109767631029
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.00331644437782227,0.00263506675263178,-0.00184828645733602,0.00848117521298056,0.208203914991084
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCL2,Phosducin-like protein 2,40080,0.00660241903805949,0.00525441339083516,-0.00369623120797742,0.0169010692840964,0.208944565081167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH2,Growth hormone variant,42346,0.0206584961710029,0.0164583412949389,-0.0115998527670773,0.0529168451090832,0.20942877199817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00350621058163304,0.00279996923666707,-0.00198172912223442,0.00899415028550049,0.210507190258124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUCL3,Mucin-like protein 3,40080,-0.00527507207439837,0.0042162485581856,-0.0135389192484421,0.00298877509964541,0.210914196904513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.00421477202713694,0.00337447783857729,-0.00239920453647456,0.0108287485907484,0.211681353992036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR3,Small proline-rich protein 3,40483,0.00864280503261691,0.0069231913649914,-0.00492665004276623,0.0222122601080001,0.21191615936208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN7,Tetraspanin-7,40136,-0.0116254399194899,0.00933098402074078,-0.0299141686001419,0.006663288761162,0.212829086862735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0103284486944167,0.00831934663133523,-0.00597747070300035,0.0266343680918337,0.214448493329005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00463908110702477,0.00374585807067951,-0.00270280071150707,0.0119809629255566,0.215573574726976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.00661447725873647,0.00534249159621031,-0.0170857607873087,0.00385680626983573,0.215709869534973
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAPPA,Pappalysin-1,42370,0.00570698432145367,0.00461362230362753,-0.0033357153936563,0.0147496840365636,0.216114477351925
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYT1,Synaptotagmin-1,40483,0.00518057364755381,0.00418845719147646,-0.00302880244774006,0.0133899497428477,0.216161379941024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN1,Cerebellin-1,40136,0.01160895466499,0.00939473575203344,-0.0068047274089955,0.0300226367389756,0.216601387384252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00424386776945192,0.00343972474764811,-0.0109857282748422,0.00249799273593838,0.217310990733605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00318193071983004,0.00257914758957711,-0.00823705999540117,0.0018731985557411,0.217331147273987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR2,Toll-like receptor 2,40302,0.0028433670559738,0.00231723739538314,-0.00169841823897716,0.00738515235092476,0.219829656938727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00412739577005289,0.00336799553968497,-0.0107286670278354,0.00247387548772965,0.220422519896485
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WIF1,Wnt inhibitory factor 1,42721,0.0041594605142219,0.0034000647029426,-0.00250466630354561,0.0108235873319894,0.221219799259473
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.00435265217622451,0.00356840640550613,-0.0026414243785675,0.0113467287310165,0.222571976167229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.00339721887694551,0.00279131277974591,-0.00886819192524749,0.00207375417135647,0.223599455437926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.0088518197265323,0.00729201093237887,-0.00544052170093029,0.0231441611539949,0.224809466993117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHH,Sonic hedgehog protein,40199,-0.00507152109695045,0.00418452128481371,-0.0132731828151853,0.00313014062128441,0.225549259384322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00260873148430954,0.00215739927587527,-0.00161977109640599,0.00683723406502506,0.226606460242748
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.0043999034739975,0.0036479580250527,-0.00275009425510578,0.0115499012031008,0.227794198293916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN4,Alpha-actinin-4,42370,0.00389800371558481,0.00323293250875461,-0.00243854400157423,0.0102345514327438,0.227948037083768
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00343377936442429,0.00284890133090748,-0.00215006724415438,0.00901762597300295,0.228113036384695
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00607896785879347,0.00504374382772755,-0.0159647057611395,0.00380677004355252,0.228133253389871
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSTN,Osteocrin,40182,-0.00498934902386066,0.00414009004649733,-0.0131039255149954,0.0031252274672741,0.228178858483373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.00492120222097789,0.00409137635888144,-0.0129402998843855,0.00309789544242973,0.229065763510233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00672700551710328,0.00559276355533365,-0.00423481105135066,0.0176888220855572,0.229077755501961
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.00508084701191702,0.00423837378066843,-0.00322636559819309,0.0133880596220271,0.230641484672849
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00345100716956604,0.0028920796068579,-0.00221746885987544,0.00911948319900752,0.232789182660413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGN,Mimecan,42611,-0.00521009567072873,0.00437161301428964,-0.0137784571787364,0.00335826583727896,0.233360102685623
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPN1,Epsin-1,40302,0.00521813812327128,0.0044046769813648,-0.00341502876020372,0.0138513050067463,0.236168854659297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13,Interleukin-13,42370,-0.0055483682402709,0.00468870361734135,-0.01473822733026,0.00364149084971816,0.236692590368222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB7,Integrin beta-7,42721,0.00536326137093595,0.00454445030390063,-0.0035438612247093,0.0142703839665812,0.237950083791606
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00537859449962928,0.00456094034083104,-0.0143180375676581,0.00356084856839957,0.238314957866907
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STEAP4,Metalloreductase STEAP4,40136,0.0084434423273372,0.00720936824888795,-0.00568691944048318,0.0225738040951576,0.241553361704391
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP7,Retinoid-binding protein 7,40449,-0.00694001899660281,0.00593067974866322,-0.0185641513039827,0.0046841133107771,0.241949506710852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00781311387533123,0.00667915955445568,-0.0052780388514019,0.0209042666020644,0.242116898991712
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00697238746799578,0.00599457003378588,-0.00477696979822454,0.0187217447342161,0.244807321859793
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXDNL,Peroxidasin-like protein,40451,-0.00640354100137314,0.00550908108657942,-0.0172013399310688,0.00439425792832253,0.2451134997781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0101137717951275,0.00872237676018831,-0.00698208665484161,0.0272096302450966,0.246269650971018
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYMP,Thymidine phosphorylase,42563,-0.00741966954686018,0.00640164910357605,-0.0199669017898692,0.00512756269614888,0.246466811082767
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX1,Neuronal pentraxin-1,42611,0.00458080831995598,0.00395286255444785,-0.0031668022867618,0.0123284189266738,0.246534497414128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.00642160361894414,0.00554987183230023,-0.00445614517236431,0.0172993524102526,0.247267330760503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00820873413909529,0.00710154695976296,-0.00571029790204011,0.0221277661802307,0.247744120633904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00556896641612069,0.00481910192227464,-0.015014406183779,0.00387647335153761,0.247869047990447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00343298931991211,0.00297611915782275,-0.00926618286924471,0.00240020422942049,0.24872089041585
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN8,Tetraspanin-8,40449,-0.0116766977400526,0.0101234123461788,-0.0315185859385631,0.00816519045845786,0.248756391675818
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NINJ1,Ninjurin-1,42346,0.00613801705494254,0.00532419757686072,-0.00429741019570447,0.0165734443055896,0.248991685658638
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAX,Integrin alpha-X,40302,0.0062077306874584,0.0053859655843381,-0.00434876185784427,0.0167642232327611,0.249109565199285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.00670227658483897,0.00583229414653728,-0.00472901994237411,0.018133573112052,0.250507886216681
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBN,Ameloblastin,42370,-0.00324578889712254,0.00282895533179873,-0.00879054134744805,0.00229896355320297,0.251259728467946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCP11,T-complex protein 11 homolog,40302,0.00663632034682701,0.00585810144175189,-0.0048455584790067,0.0181181991726607,0.257303843130878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.00471666570315723,0.0041643470914486,-0.0128787860023965,0.00344545459608202,0.257393593448727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.00551154652047797,0.00488644694606313,-0.00406588949380576,0.0150889825347617,0.259375494503788
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B2M,Beta-2-microglobulin,40539,-0.00349922999571394,0.00310433951630853,-0.00958373544767866,0.00258527545625077,0.259679252180937
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,-0.00691105117298779,0.00613698481164522,-0.0189395414038124,0.00511743905783683,0.260134656489768
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00356032482015917,0.00317913052446865,-0.00979142064811773,0.0026707710077994,0.262778600573276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00449870448814529,0.00402201378029807,-0.00338444252123893,0.0123818514975295,0.263369350995386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH15,Cadherin-15,42692,0.00685618613060345,0.0061493175026294,-0.00519647617455016,0.0189088484357571,0.264891379817097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAN,Versican core protein,42711,-0.00335761108273506,0.00301398059337284,-0.00926501304574583,0.0025497908802757,0.265293770737828
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00698383547021967,0.00627162950953457,-0.0192762293089074,0.00530855836846809,0.265492109527516
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEBP1,Heme-binding protein 1,42357,0.00578669025323822,0.0052051855128556,-0.00441547335195876,0.0159888538584352,0.26628039790842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.00702157512690741,0.00633643629577041,-0.0194409902666174,0.00539784001280259,0.267830649353754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.00634323629223985,0.00575016720330788,-0.0049270914262436,0.0176135640107233,0.269990996274946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.00672917368648443,0.00610010551392187,-0.0186853804937713,0.00522703312080244,0.269993214021479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1,DNA topoisomerase 1,40449,0.0122268927606974,0.0110931391560549,-0.00951565998517016,0.033969445506565,0.270396937477992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX2,Peroxiredoxin-2,40333,0.0068047517283668,0.00617772976174127,-0.0053035986046461,0.0189131020613797,0.270704144348366
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.00398922286837683,0.00363526160938328,-0.00313588988601439,0.011114335622768,0.27250437524605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR1,Folate receptor alpha,42600,-0.00323961050248047,0.00299439830000841,-0.00910863117049696,0.00262941016553602,0.279320731542709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEB,Nebulin,40116,-0.00411534641098774,0.00380498596073912,-0.0115731188940364,0.00334242607206093,0.279468951939413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,42438,0.0040632425359441,0.00376260292905772,-0.00331145920500903,0.0114379442768972,0.280205475028626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00798576754841714,0.00741890662836236,-0.0225268245400074,0.00655528944317309,0.281768732675574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD59,CD59 glycoprotein,42130,0.00265117611641759,0.00246552262402185,-0.00218124822666524,0.00748360045950042,0.282260556811135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.00788480004591365,0.00733772274016754,-0.00649713652481473,0.022266736616642,0.282596885502654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOP56,Nucleolar protein 56,40116,0.0118880579107076,0.0110880587693617,-0.00984453727724135,0.0336206530986566,0.283676527309872
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL9,C-X-C motif chemokine 9,42676,-0.00714903436428765,0.00667114804723867,-0.0202244845368754,0.00592641580830014,0.283903281521939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.0052060326609548,0.00486649158831406,-0.00433229085214076,0.0147443561740504,0.284741982893052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00298909336188044,0.00279660754543571,-0.00847044415093443,0.00249225742717355,0.285169886551038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00556236440842785,0.00520806285555744,-0.00464543878846474,0.0157701676053204,0.285530138858868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.00304302036374942,0.00285308201711455,-0.00254902038979509,0.00863506111729393,0.286183778419572
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00892250662707235,0.00837694476997943,-0.025341318376232,0.00749630512208734,0.286842271031655
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.00387492215488646,0.00364981474026019,-0.0032787147360235,0.0110285590457964,0.288406171449332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP2,Dipeptidase 2,42587,0.00308185219007431,0.00290930604038661,-0.00262038764908344,0.00878409202923205,0.28947847588555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00666836747228451,0.00629805105416275,-0.00567581259387448,0.0190125475384435,0.289714546629101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00383961029354398,0.00364060188657585,-0.0109751899912326,0.00329596940414468,0.291602611333846
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,42346,-0.00326065803298115,0.00311068784392461,-0.00935760620707339,0.00283629014111109,0.294560544469415
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB5,Serpin B5,42357,0.00503355940316294,0.004804086701862,-0.00438245053248658,0.0144495693388125,0.294765602174342
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.007482115555404,0.00719936410184898,-0.00662863808422,0.021592869195028,0.298695782078612
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00591919018913516,0.00569680017113375,-0.0170849185245573,0.00524653814628699,0.298810158730959
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00283752882815301,0.00273566251514436,-0.00252436970152994,0.00819942735783595,0.299644736117448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0108968979213312,0.0105908076635164,-0.00986108509916095,0.0316548809418233,0.303544671557836
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC8,Histone deacetylase 8,40199,0.00601756936681699,0.0058550261797308,-0.00545828194545538,0.0174934206790894,0.304084709171452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.00442954755480278,0.00432050058448381,-0.0128977287003911,0.00403863359078549,0.305269672128756
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2,Interleukin-2,42370,-0.00324191611711243,0.00316814827098984,-0.00945148672825251,0.00296765449402765,0.306192271396677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCN,Decorin,42357,-0.00242415555118974,0.00237229744110392,-0.00707385853575343,0.00222554743337395,0.30686600850687
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00495086409396434,0.00485074888654821,-0.00455660372367015,0.0144583319115988,0.307447881951724
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00488426900712291,0.00479192169931111,-0.00450789752352687,0.0142764355377727,0.308092844328157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00705542759890357,0.00697711470701663,-0.00661971722684903,0.0207305724246562,0.311931137046597
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.00273325990546851,0.00270338538294788,-0.00803189525604637,0.00256537544510934,0.312010112367288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM2,Isthmin-2,40527,0.00431424065385864,0.00428538770763765,-0.00408511925311115,0.0127136005608284,0.31408465695501
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSG1,Tryptase gamma,40199,0.00265087073552251,0.00263382011890498,-0.00251141669753125,0.00781315816857628,0.314209875351302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX101,Testis-expressed protein 101,40182,0.00526987416721508,0.00523675130320134,-0.00499415838705955,0.0155339067214897,0.314281380186503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAST,Gastrin,40483,-0.0144098410647113,0.0143668499292693,-0.0425688669260792,0.0137491847966566,0.315886033553359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00359015634085496,0.0035827762077515,-0.00343208502633799,0.0106123977080479,0.316336733493819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00311575713285971,0.00312416369808135,-0.00923911798109915,0.00300760371537973,0.318636626957167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UMOD,Uromodulin,42764,-0.00542383983677216,0.00544012337749799,-0.0160864816566682,0.00523880198312389,0.318779001381514
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0063227579131741,0.00637109969519463,-0.00616459748940738,0.0188101133157556,0.321018370146502
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,-0.00444439597258245,0.00448674787261266,-0.0132384218029033,0.00434962985773837,0.32191804636873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00399974825599528,0.00405637107768374,-0.0119502355682554,0.00395073905626485,0.324134697749773
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00627304459981875,0.00636727607066749,-0.00620681649868953,0.018752905698327,0.324543605947949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.00778946854356937,0.00790678360317266,-0.00770782731864904,0.0232867644057878,0.324565600356544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBX2,Chromobox protein homolog 2,40116,0.00391556821535414,0.0039773705270169,-0.00388007801759899,0.0117112144483073,0.324910451954915
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00530317944210323,0.0053916821546826,-0.0158708764652811,0.00526451758107468,0.325340906834158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.00313758344486398,0.00320521562536569,-0.00314463918085277,0.00941980607058072,0.327651192039501
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3B,Protein FAM3B,42587,0.00339226619058673,0.00347482065590123,-0.00341838229497968,0.0102029146761531,0.328962140766445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00265555535667815,0.0027309427952196,-0.00800820323530856,0.00269709252195227,0.330871463746032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFA,Protransforming growth factor alpha,42594,0.00454106595524809,0.0046748365426169,-0.00462161366828104,0.0137037455787772,0.331374143520555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.00676619789260148,0.00699620710581405,-0.00694636803479406,0.020478763819997,0.333503241010733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.00537767822913441,0.00556913692316946,-0.00553783014027773,0.0162931865985466,0.334254842321907
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTKN2,Rhotekin-2,40116,-0.00493084978565259,0.00511338373549622,-0.0149530819072252,0.00509138233592001,0.334915533040133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00662631179287136,0.00689224082517426,-0.0201351038102129,0.00688248022447018,0.336364239464113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0120092674845049,0.0125170924382167,-0.0125242336943999,0.0365427686634097,0.33736006696475
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.0040451938888115,0.0042354095207738,-0.0123465965495281,0.00425620877190514,0.339553523258522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.0025800757263029,0.00270851883776245,-0.00788877264831732,0.00272862119571151,0.340821059890066
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.00393518328498757,0.00413271127200403,-0.00416493080814034,0.0120352973781155,0.341014031939337
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KEL,Kell blood group glycoprotein,42311,0.00340482073772994,0.00357974505472226,-0.00361147956952569,0.0104211210449856,0.341553384897059
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A14,Protein S100-A14,40482,0.00514766399500548,0.00541840766328338,-0.00547241502502994,0.0157677430150409,0.342116020802947
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.00320954602133148,0.00337987241379941,-0.00341500390971537,0.00983409595237833,0.342333193635209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.00474089717759874,0.00499808354914502,-0.014537140933923,0.0050553465787255,0.342870519969698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESPL1,Separin,40080,0.00539273880923774,0.0056971917858231,-0.00577375709097554,0.016559234709451,0.343883601496513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.00588331668544655,0.00621923668198952,-0.018073020582146,0.00630638721125291,0.344176187674653
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLINT1,Clathrin interactor 1,40080,0.00430733600792982,0.00457514013827427,-0.00465993866308775,0.0132746106789474,0.346487318222608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00566812136984365,0.00603906111685861,-0.00616843841919922,0.0175046811588865,0.347968895313137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00440210125151417,0.00469567988596712,-0.0136056338280097,0.00480143132498139,0.348528974173389
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53BP1,TP53-binding protein 1,40199,-0.00802861889350876,0.00859927979714777,-0.0248832072959184,0.00882596950890088,0.350510870163882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00565114550531742,0.00605737753110559,-0.0175236054662844,0.00622131445564953,0.350870190519694
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTNNA1,Catenin alpha-1,40136,-0.00324396161407189,0.00348203586794542,-0.0100687519152449,0.00358082868710114,0.351549436019134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00390648533878492,0.00423892458579355,-0.00440180684937045,0.0122147775269403,0.356770732321191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.00297241937087343,0.003227506402224,-0.00335349317748561,0.00929833191923246,0.35708901628814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCLN,Nicalin,42370,-0.00470772874810066,0.00511966457473424,-0.0147422713145798,0.00532681381837844,0.357830804636862
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.00502909370359476,0.00547184879714741,-0.00569572993881417,0.0157539173460037,0.3580679985089
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.00474500988213749,0.00518916560310142,-0.0149157744642163,0.00542575469994129,0.360519403549369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00645090544572718,0.0070576661795091,-0.020283931157565,0.00738212026611066,0.36072211865673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0056436224205852,0.0061843870399099,-0.0064777761776382,0.0177650210188086,0.361493697049711
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.00334412122702441,0.00367824945020455,-0.0105534901494253,0.00386524769537651,0.363284832599547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00431750360132234,0.00475911385772758,-0.00501035955982371,0.0136453667624684,0.364317113528643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNN,Tenascin-N,40527,-0.00394597185203398,0.00435715008264106,-0.0124859860140105,0.00459404230994251,0.365150245263228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00662990180059825,0.00732833775922677,-0.0209934438086827,0.00773364020748621,0.365647242573933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0100088076352247,0.0110888216035767,-0.0117252827077855,0.0317428979782349,0.366756311309367
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS2,Podocin,40199,-0.00936952573904095,0.0104056551357389,-0.0297646098050892,0.0110255583270073,0.36791312357565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00593439951943081,0.00661462145643538,-0.0188990575740441,0.00703025853518253,0.369647936134806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN2,Contactin-2,42721,0.00394507917679484,0.00439781453086948,-0.00467463730370933,0.012564795657299,0.369705817491387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00305365503600953,0.00340601189907268,-0.00362212828617291,0.00972943835819198,0.369979632504751
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,40483,-0.00241619725844788,0.00269827630917675,-0.00770481882443431,0.00287242430753855,0.370560578198291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.00605816661456736,0.00676764428549924,-0.00720641618501116,0.0193227494141459,0.370717812653341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL2,Interferon lambda-2,40136,0.00546355427202557,0.00612899295167897,-0.00654927191326521,0.0174763804573163,0.372719348153916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00630055164149888,0.00709665240147439,-0.00760888706539093,0.0202099903483887,0.374656886498508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A3,Protein S100-A3,40451,0.00381527525210213,0.00430143341269418,-0.00461553423677846,0.0122460847409827,0.375109888467819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.00246401075816924,0.00278957099796871,-0.00793156991418792,0.00300354839784944,0.377093458824388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00397032795616994,0.00450366777336298,-0.00485686087962151,0.0127975167919614,0.378021987411449
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00962479136657824,0.0109230332695316,-0.0117843538417037,0.0310339365748602,0.378257979125328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.00703211430416376,0.00799563804393007,-0.0227035648702667,0.00863933626193918,0.379153018844176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK11,Kallikrein-11,42543,0.00282798494808056,0.0032262794374466,-0.00349552274931478,0.0091514926454759,0.380748613995189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00693874517592237,0.00797367472209107,-0.0225671476312209,0.00868965727937613,0.384206258779141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.00669315696237571,0.00769713091543904,-0.00839321963188481,0.0217795335566362,0.384557250371718
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALB,Ras-related protein Ral-B,40199,0.00256750996871831,0.00296919465820601,-0.00325211156136546,0.00838713149880209,0.387213562727513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.00235349082508036,0.00272274569047087,-0.00298309072824255,0.00769007237840326,0.387393766778904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESR1,Estrogen receptor,40199,-0.00473351346167272,0.005479041600956,-0.0154724349995465,0.00600540807620104,0.387644667844178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA3,GDNF family receptor alpha-3,42474,0.00245408952546095,0.00284290758886069,-0.00311800934870601,0.00802618839962791,0.388025372764282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,0.004774085819408,0.00555349937262581,-0.00611077295093859,0.0156589445897546,0.389995720702311
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00284973871809876,0.00333497567217861,-0.00938629103556883,0.00368681359937132,0.392846418232341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.00240275928760399,0.00282055120820056,-0.00312552108046911,0.00793103965567708,0.394298053173597
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GKN1,Gastrokine-1,42017,0.00236361248818701,0.00277605515890865,-0.00307745562327394,0.00780468059964797,0.394547263601639
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI2B,Protein EVI2B,40080,-0.0034482633573164,0.00405521206675762,-0.0113964790081613,0.00449995229352854,0.395161045266451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSP90B1,Endoplasmin,42247,-0.00559376333982083,0.0065869290472922,-0.0185041442725135,0.00731661759287188,0.395773493234864
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.00290859109810268,0.00344167119110761,-0.00965426663267359,0.00383708443646823,0.398064409211367
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36G,Interleukin-36 gamma,40154,0.00572924965185338,0.00682100618979257,-0.00763992248014005,0.0190984217838468,0.400959223026449
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00411812034641476,0.00495299790108373,-0.0138259962325389,0.00558975553970934,0.405740910765447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.00194358162017421,0.0023404112289721,-0.00653078762895954,0.00264362438861111,0.406302320570139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ULBP2,UL16-binding protein 2,42495,-0.00327169578739232,0.00394739740524786,-0.0110085947016781,0.00446520312689348,0.407219153230845
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,42311,0.00403455954605927,0.00487109178984504,-0.005512780362037,0.0135818994541556,0.407534962467543
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00170123046144379,0.0020587018155576,-0.00573628601993668,0.00233382509704911,0.408617509345663
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.00539621897621482,0.00653321637370317,-0.018201323068673,0.0074088851162434,0.408840503284135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR1,TGF-beta receptor type-1,40199,-0.00176157173158093,0.00214090844132549,-0.00595775227657889,0.00243460881341702,0.410630993066263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF3,Fibroblast growth factor 3,40199,0.00236238286388344,0.00288235833625825,-0.00328703947518274,0.00801180520294961,0.412461533113803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,42600,0.00142830131574802,0.00174754406299091,-0.00199688504771417,0.00485348767921021,0.413760561901013
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00266783294116905,0.00328252652072326,-0.00376591903944854,0.00910158492178664,0.416383180041158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM132A,Transmembrane protein 132A,40223,0.00503771263410125,0.00620173576125826,-0.00711768945796493,0.0171931147261674,0.416633095402222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMP,Olfactory marker protein,40136,-0.0040355222507246,0.0049821491693185,-0.0138005346225889,0.00572949012113967,0.417959933357899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLLT1,Protein ENL,40080,0.00532405234181029,0.00657518195375833,-0.00756330428755605,0.0182114089711766,0.418119167782281
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.0027037185501915,0.00337192925591244,-0.00390526279139687,0.00931269989177988,0.422667339753341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.00293060000350347,0.00365535506680574,-0.00423389592743578,0.0100950959344427,0.422727204553843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,42689,0.00237403980937274,0.0029810669026002,-0.00346885131972365,0.00821693093846912,0.425829545363602
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG3,Proteoglycan 3,40527,0.00391431151856756,0.00492562770014952,-0.00573991877372551,0.0135685418108606,0.426814692165093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.00609136852290974,0.00767332334858884,-0.00894834524032438,0.0211310822861439,0.427304599087192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00246486242582299,0.00312230558554773,-0.00365485652185057,0.00858458137349654,0.429871068332246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXOSC10,Exosome component 10,40116,0.00471822459375548,0.00598486206413087,-0.00701210505194102,0.016448554239452,0.430503394604493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00587672425270975,0.00748577926394726,-0.00879540310462688,0.0205488516100464,0.432440213336008
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHIT1,Chitotriosidase-1,42699,-0.0119299534953762,0.0152142292679588,-0.0417498428605755,0.0178899358698231,0.432976819157122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRING1,SREBP regulating gene protein,40080,0.004594292084459,0.00586023835252403,-0.0068917750864881,0.0160803592554061,0.433070663472085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA11,Integrin alpha-11,42594,-0.00262153693686384,0.00334765743060173,-0.00918294550084323,0.00393987162711557,0.433584615588954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00607866141077933,0.00777632875338053,-0.0091629429458465,0.0213202657674052,0.434414908533981
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.00160134431803516,0.0020509259881085,-0.00241847061865751,0.00562115925472782,0.434942290067026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00229932469299948,0.00297184359589876,-0.0035254887549621,0.00812413814096105,0.439122506751326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00207534704539928,0.00269221824553795,-0.00735209480665366,0.00320140071585509,0.440800765890779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.0056133950049372,0.00729490971747722,-0.00868462804131816,0.0199114180511926,0.441613456855234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGM2,Phosphoglucomutase-2,40182,0.00452444342018551,0.00591737619941663,-0.00707361393067108,0.0161225007710421,0.444524419446154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00220341858623377,0.00290353016396701,-0.00348750053514157,0.0078943377076091,0.447943148415003
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSD1,Tryptase delta,40482,-0.00287161774281082,0.00379680872634723,-0.0103133628464514,0.00457012736082975,0.449470717428081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,0.00365253493129668,0.00484141553685835,-0.00583663952094568,0.013141709383539,0.450601123078253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.0020064823735001,0.00266408878800244,-0.00321513165098469,0.00722809639798488,0.451370677776047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL6,Fc receptor-like protein 6,42594,0.00520752668497015,0.00691435849994757,-0.00834461597492709,0.0187596693448674,0.45137496102823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00293535263169545,0.00390631189411716,-0.00472101868077418,0.0105917239441651,0.452405070531875
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.00355163249538805,0.00473269575701855,-0.00572445118836831,0.0128277161791444,0.452999325017802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSF,Cathepsin F,42679,0.00292096402033939,0.00390068814957848,-0.00472438475283442,0.0105663127935132,0.453970926282014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00373856946826398,0.00500422243474039,-0.00606970650382718,0.0135468454403551,0.455029451771976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00233355696090769,0.00313360683666029,-0.00380831243894647,0.00847542636076185,0.456476820591965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.00464914114840915,0.00625347966999463,-0.00760767900478032,0.0169059613015986,0.45722613132839
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00350336250541651,0.00471487990986074,-0.00573780211791054,0.0127445271287436,0.457471116202354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00359479957090417,0.00484958561655564,-0.00591038823754488,0.0130999873793532,0.458552159592715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST2,Bone marrow stromal antigen 2,42711,-0.00373483859445114,0.00504042977967904,-0.0136140809626221,0.00614440377371978,0.458720732030204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00244810124779161,0.00331087911670864,-0.00404122182095732,0.00893742431654054,0.45967320735427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.00209769043862542,0.00284174830939069,-0.00347213624778034,0.00766751712503117,0.46042711744693
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00513524966530323,0.00704913557127344,-0.0189515553849992,0.00868105605439271,0.466327117187136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA1,Apolipoprotein A-I,40539,-0.00198623704072991,0.00272898051223735,-0.00733503884471513,0.0033625647632553,0.466731970491292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00321067410331729,0.00441558148298141,-0.0118652138099609,0.00544386560332627,0.46716571572749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK12,Kallikrein-12,42346,0.0100092068481192,0.0137743485532088,-0.0169885163161702,0.0370069300124085,0.467449920941917
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00286669835687801,0.00395200787884801,-0.00487923708566409,0.0106126337994201,0.468235802063024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC1,Syndecan-1,42636,-0.00290595932586668,0.00401003223720487,-0.0107656225107882,0.00495370385905485,0.468665699428767
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.00177079376733532,0.00244757322871722,-0.00656803729562108,0.00302644976095043,0.469391586606325
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR2,TGF-beta receptor type-2,42679,-0.00255579379605583,0.00353531490272164,-0.00948501100539025,0.0043734234132786,0.469733935803291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00284460419919329,0.00395750472158847,-0.00491210505512011,0.0106013134535067,0.472287201336138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MN1,Transcriptional activator MN1,40182,-0.00420782111826268,0.00586799708239013,-0.0157090953997473,0.00729345316322197,0.473340212213488
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00620724684467778,0.00868113255457302,-0.0232222666516409,0.0108077729622853,0.474607337055944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00391830205334518,0.00549974371144215,-0.0146977997277718,0.00686119562108142,0.476200346554133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00198066578251253,0.002784832665345,-0.00743893780658873,0.00347760624156368,0.476954824893237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF12,Fibroblast growth factor 12,40199,0.00328891872760081,0.00463859668198161,-0.00580273076908314,0.0123805682242848,0.478318937229371
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCLRE1C,Protein artemis,40080,0.00218937259680813,0.00309520816241203,-0.00387723540151944,0.0082559805951357,0.47936873841503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0105143583118606,0.0148850997471212,-0.0396891538162181,0.0186604371924968,0.479971589603519
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MET,Hepatocyte growth factor receptor,42654,0.00137678599607174,0.00195732939511529,-0.00245957961835424,0.00521315161049771,0.481818514096531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR1,Cadherin-related family member 1,42311,0.00296976999249161,0.00422603110500046,-0.00531325097330929,0.0112527909582925,0.48223485380693
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00308775186381501,0.00440101820877224,-0.00553824382537858,0.0117137475530086,0.482943511673216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00197281063528046,0.00281680092896981,-0.00354811918550037,0.00749374045606129,0.483709350429501
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.0037967164468543,0.00543066606113035,-0.0144408219266698,0.0068473890329612,0.48448845687358
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.00312304294941319,0.00448072253068723,-0.00565917321073379,0.0119052591095602,0.4858200320473
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.00190558770104349,0.00277620558607709,-0.00353577524766761,0.00734695064975459,0.492472663868667
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.00203317133747703,0.00296222925985259,-0.00377279801183405,0.00783914068678812,0.492494587679295
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPTC,Opticin,42587,-0.00313344846531236,0.00456708971529547,-0.0120849443072915,0.00581804737666676,0.492666316436853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00294255370348944,0.00429147574121648,-0.0113538461562738,0.00546873874929486,0.492933205167847
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSND,Barttin,40080,0.00231217931634941,0.0033814487287339,-0.00431546019196904,0.00893981882466786,0.494126353731521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJP3,Tight junction protein ZO-3,40136,-0.00284537241743298,0.00416550863345415,-0.0110097693390031,0.00531902450413715,0.494571243241253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.00290813450029599,0.00426339355918588,-0.00544811687570833,0.0112643858763003,0.495176489723528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.00777230380775273,0.0113948447584424,-0.0145615919187943,0.0301061995342998,0.495196363512287
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.00392277630366461,0.00576787970611823,-0.0152278205276563,0.00738226792032712,0.496448248351336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.00185327107341199,0.00276076990731265,-0.0035578379449208,0.00726438009174478,0.502048725381569
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.00257918229283941,0.00384485429580779,-0.00495673212694386,0.0101150967126227,0.50235266438368
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.00179076366231826,0.00269169018801354,-0.00348494910618828,0.00706647643082481,0.505874240664973
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH22,Cadherin-22,40302,-0.00184864739041489,0.00278120972233,-0.00729981844618168,0.00360252366535191,0.506261416438119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.00144817063564996,0.00217945852224571,-0.00571990933925156,0.00282356806795164,0.506407519667272
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.00938302276295034,0.0141934754515778,-0.0372022346480428,0.0184361891221421,0.508575000304222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.00412493951831122,0.00627499674791308,-0.00817405410759842,0.0164239331442209,0.510962449798188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10,Interleukin-10,42370,-0.00550857710083238,0.00838730244675963,-0.0219476898964812,0.0109305356948165,0.511336570850738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG2,"Arginase-2, mitochondrial",40451,-0.00277336340986132,0.00422309255724916,-0.0110506248220697,0.00550389800234703,0.51137834603121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.00356261338000562,0.00542755938605967,-0.0142006297766826,0.00707540301667133,0.51158260760444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00246770321836017,0.00376378072673429,-0.00490930700603904,0.00984471344275938,0.512066433862965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLHL41,Kelch-like protein 41,40482,-0.00310275826466557,0.00473759747026164,-0.0123884493063784,0.00618293277704724,0.512531122177933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.0033302707932813,0.0050856976296745,-0.00663769656088073,0.0132982381474433,0.512590921451778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL24,Interleukin-24,42370,0.00326330683297683,0.00499100069851834,-0.00651905453611911,0.0130456682020728,0.513227473645869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD2,Bromodomain-containing protein 2,40136,0.00230136791738023,0.00354036873916879,-0.00463775481139059,0.00924049064615106,0.515682471532685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH4,Myosin-4,40116,-0.00291236988139583,0.0044934632913832,-0.0117195579325069,0.00589481816971524,0.516911399663802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOS,Proto-oncogene c-Fos,40065,-0.00227245739915463,0.00353890571923226,-0.00920871260884986,0.0046637978105406,0.520798673768126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSHB,Follitropin subunit beta,40223,0.00339196027856145,0.00535790484497737,-0.00710953321759419,0.0138934537747171,0.526697224136208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,40302,-0.0054191612220121,0.0085918593525949,-0.0222592055530981,0.0114208831090739,0.528228703411314
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00223513122024508,0.00354587621580124,-0.00471478616272534,0.00918504860321551,0.52847855189144
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00202422659856866,0.00321171590345175,-0.00427073657219677,0.00831918976933409,0.528535101803252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.00497400905877612,0.00790168359774704,-0.0105132907928081,0.0204613089103603,0.529040779120392
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00214496549755798,0.00343152121363816,-0.00458081608117281,0.00887074707628877,0.531931177618295
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.00372472200935272,0.00596872595604685,-0.00797398086449911,0.0154234248832045,0.532612136675632
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0105832778340679,0.0170191379568527,-0.0227742325613633,0.0439407882294992,0.53405404453009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00210323829818347,0.00338430148761999,-0.00452999261755171,0.00873646921391864,0.534304130168036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00467852716975542,0.00761559529647084,-0.0196050939508383,0.0102480396113274,0.539006779786433
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD70,CD70 antigen,42594,0.00262238771629621,0.00427228078939194,-0.00575128263091199,0.0109960580635044,0.539348361936445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00252616982561211,0.00413047416898844,-0.0106218991968295,0.00556955954560523,0.540819585984653
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00243998234408658,0.00399046102331516,-0.00538132126161113,0.0102612859497843,0.54090982677605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00285374911539799,0.00467512116271844,-0.00630948836353016,0.0120169865943261,0.541601659618151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRAS,GTPase Hras,40286,0.00601754610433851,0.0098626180639066,-0.0133131853009184,0.0253482775095954,0.54178369862016
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00310725729371522,0.00510703036157703,-0.0131170368024062,0.00690252221497577,0.542916661115554
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD48,CD48 antigen,42654,-0.00184134107435879,0.0030550434736019,-0.00782922628261851,0.00414654413390093,0.546703980299831
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00154373407825521,0.00256306758052219,-0.00347987837956828,0.00656734653607869,0.546987360440413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.00177720701028873,0.00295380625606545,-0.00401225325159956,0.00756666727217702,0.547406357744773
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCG22,Protein PBMUCL2,40116,-0.00339485944490433,0.00564848656316753,-0.0144658931087127,0.00767617421890403,0.547838424380931
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABO,Histo-blood group ABO system transferase,40532,0.00861896405120618,0.0143608524653437,-0.0195283067808675,0.0367662348832799,0.548404418906893
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB2,Lamin-B2,40483,-0.00168355856683184,0.00283217929705385,-0.00723462998905738,0.0038675128553937,0.552230268658921
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN1,Transcobalamin-1,40337,0.00199420896400831,0.00337504195737902,-0.00462087327245457,0.00860929120047119,0.554619924773472
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00229934001381169,0.00390397009370394,-0.00995112139747141,0.00535244136984803,0.555889932559696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3G,Semaphorin-3G,40283,0.00259342920936354,0.00442597553052146,-0.00608148283045852,0.0112683412491856,0.557916661059318
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00330161498739171,0.00563885225113009,-0.0143537653996067,0.00775053542482327,0.558215655334323
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00214863473022841,0.0036696917501245,-0.00934123056047244,0.00504396110001561,0.558217737581662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00172040985216245,0.00293839227175824,-0.0040388390004837,0.00747965870480859,0.558225900011956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN6,Prefoldin subunit 6,40182,0.00371895870448216,0.00641157161137537,-0.00884772165381357,0.0162856390627779,0.56190051447631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,0.00263966007103212,0.00460458249295369,-0.0063853216151571,0.0116646417572213,0.566474661578404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP1,Dipeptidase 1,42476,-0.00282521709442248,0.00493609763220314,-0.0124999684535406,0.00684953426469569,0.567088859330811
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK1,Kallikrein-1,42505,-0.00728416367743974,0.0127881370558744,-0.0323489123069536,0.0177805849520742,0.568956475600295
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.00290552447428929,0.00513778662543615,-0.0129755862601441,0.00716453731156556,0.571729216144783
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00369175969643746,0.00663367267838484,-0.0166937581460717,0.00931023875319682,0.577867854880045
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.00342303115342396,0.00615259243377034,-0.0154821123236138,0.00863605001676591,0.577978886148244
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.00207346011536173,0.00375569204279067,-0.00943461651923145,0.00528769628850799,0.580901252829355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,-0.00172290485693365,0.00312319317331678,-0.00784436347663454,0.00439855376276725,0.581198364672272
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17F,Interleukin-17F,42370,0.00410972563473335,0.00746335547333234,-0.010518451092998,0.0187379023624647,0.581880302960032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.00241608428228151,0.0044232539489596,-0.0062534934576793,0.0110856620222423,0.584921547501038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0145112091513186,0.026815406724715,-0.0380469880291229,0.06706940633176,0.588413795803082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANPEP,Aminopeptidase N,42666,0.00147755055097508,0.00273583842584356,-0.0038846927636783,0.00683979386562846,0.589156099877883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLVRB,Flavin reductase,42611,0.00347168444253354,0.00648033882241025,-0.00922977964939055,0.0161731485344576,0.592156977529448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00357434353027559,0.00669794995394471,-0.0167023254400072,0.00955363837945604,0.593596372027188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCNA,Proliferating cell nuclear antigen,40080,-0.00330263939347611,0.00619485456875322,-0.0154445543482324,0.0088392755612802,0.593957093795803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.00258093403106981,0.00485120752808937,-0.012089300786125,0.00692743272398535,0.594721695743578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNLZ,DNL-type zinc finger protein,40136,0.00479463716037875,0.00901290632186152,-0.0128706592304698,0.0224599335512273,0.594754393858714
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HK2,Hexokinase-2,42357,0.00144487614808461,0.00272378564570472,-0.00389374371749663,0.00678349601366585,0.595797704954709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN15,Tetraspanin-15,40116,0.00273889420057532,0.00516402466698366,-0.00738259414671264,0.0128603825478633,0.595859433914653
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00215643825415593,0.0040770791474567,-0.00583463687485921,0.0101475133831711,0.596871418317978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK3,NT-3 growth factor receptor,42711,0.00113103607705968,0.00214586049876335,-0.0030748505005165,0.00533692265463585,0.598148003247072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.00264254178591935,0.00504667679662712,-0.0072489447354698,0.0125340283073085,0.600553056016194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,-0.00247747229955262,0.00476519552504575,-0.0118172555286423,0.00686231092953704,0.603135129517387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.00245430107283114,0.00472683062487758,-0.0117188890975912,0.00681028695192891,0.603612532905276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF3,Neurotrophin-3,42594,0.00183287753336163,0.00354048570418438,-0.00510647444683975,0.00877222951356301,0.60468243478212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00358078839771233,0.00692741171840843,-0.0171585153657929,0.0099969385703682,0.605235498888278
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX33,Testis-expressed protein 33,40302,0.00193204712190921,0.00377566262681658,-0.00546825162665129,0.00933234587046972,0.608863639542215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00272550648697365,0.00534896835871881,-0.00775847149611521,0.0132094844700625,0.610384787904735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",40511,-0.00263618985549035,0.00518646443391489,-0.0128016601459635,0.00752928043498283,0.611265047137436
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00350714712948148,0.0069122204234506,-0.0100408049004817,0.0170550991594447,0.611895779069113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00225159011436692,0.00443975962493971,-0.00645033875051491,0.0109535189792488,0.612063431633469
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00242992910422871,0.00483108523962537,-0.0118988561738944,0.00703899796543702,0.614988384546843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.00193290037716779,0.00386858101528944,-0.00951531916713508,0.00564951841279951,0.617338186317136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1A,Interleukin-1 alpha,42370,0.00287321481934407,0.00575701083827005,-0.00841052642366522,0.0141569560623534,0.617730643043187
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLNL,Mesothelin-like protein,40182,-0.00193300761459757,0.00389566861578487,-0.00956851810153592,0.00570250287234077,0.619767428781739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN4,Prefoldin subunit 4,40080,0.00257693764522652,0.00520110865559169,-0.00761723531973318,0.0127711106101862,0.62028594687661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF830,Zinc finger protein 830,40451,-0.00379019844730186,0.00766451486398178,-0.0188126475807061,0.0112322506861024,0.620953927111052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD1,Glutamate decarboxylase 1,40080,0.00127751906967744,0.00259227677069098,-0.00380334340087688,0.00635838154023177,0.622151562643848
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPGN,Epigen,40451,0.00221031002917364,0.00449810791616469,-0.00660598148650916,0.0110266015448564,0.623162608546189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI16,Peptidase inhibitor 16,40532,-0.00121908418007368,0.00248176656412173,-0.00608334664575227,0.00364517828560491,0.623282982062445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLNS1A,Methylosome subunit pICln,40182,0.00161424387426774,0.00330058708496201,-0.00485490681225781,0.00808339456079329,0.624796378737235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,0.00716912605560282,0.0146927545465178,-0.0216286728555721,0.0359669249667777,0.625604574088539
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKLR,Pyruvate kinase PKLR,42636,-0.00312754191105897,0.00642227663271191,-0.0157152041111743,0.00946012028905638,0.626278057351594
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00337017732944487,0.00694692808289579,-0.0102458017130309,0.0169861563719206,0.627592404464289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFASC,Neurofascin,42754,-0.00138037991050026,0.00285844400779788,-0.00698293016578411,0.00422217034478359,0.62916527240864
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00234679091486567,0.00487574007240589,-0.00720965962704987,0.0119032414567812,0.630298712637741
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD248,Endosialin,40527,-0.00192988231757494,0.00402933280934166,-0.00982737462388459,0.00596760998873471,0.631977548553939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.00418208959251972,0.00877918176088148,-0.013025106658808,0.0213892858438474,0.633824254498235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM25,RNA-binding protein 25,40080,-0.00223544108590525,0.00470164267854803,-0.0114506607358594,0.00697977856404888,0.634468971553275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSB,Lupus La protein,42311,-0.00273029527833981,0.00575225344379163,-0.0140047120281714,0.00854412147149179,0.63504582826421
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD10,Frizzled-10,40182,0.00284936450996569,0.00600536823533222,-0.00892115723128547,0.0146198862512168,0.635174518503149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.00330271914603317,0.00698687157797662,-0.0169969874388673,0.010391549146801,0.63643381687708
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS8,Prostasin,42568,-0.00193907392098795,0.00412625566615759,-0.0100265350266568,0.00614838718468092,0.638408779649698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBN2,Fibrillin-2,40182,0.00282305112946571,0.00602635357466605,-0.00898860187687976,0.0146347041358112,0.639471423736641
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD82,CD82 antigen,40302,-0.00189445404858365,0.0040538356737143,-0.00983997196906368,0.00605106387189639,0.640277370242827
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00248228963930821,0.00531483985478254,-0.00793479647606556,0.012899375754682,0.640474202202714
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.0013594375439946,0.00292569034108778,-0.00709379061252665,0.00437491552453746,0.642187257768869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00362103095458217,0.00780066878158296,-0.0116682798573204,0.0189103417664848,0.642517284488666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100G,Protein S100-G,40482,0.00221212149505371,0.00476914448069396,-0.00713540168710645,0.0115596446772139,0.642771098600503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300E,CMRF35-like molecule 2,42677,-0.00197636316761081,0.0042622431096627,-0.0103303596625497,0.00637763332732808,0.642876732716069
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00129879594175159,0.00280755722694049,-0.00680160810655495,0.00420401622305177,0.64365345619388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00103540029536317,0.00224389515279593,-0.00336263420411686,0.00543343479484319,0.644497590155998
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NENF,Neudesin,40451,-0.00501459226817398,0.0108784991161884,-0.0263364505359033,0.0163072659995553,0.644833615837943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.0027518989945738,0.0059796243090033,-0.0144719626402203,0.00896816465107268,0.645372707288781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,0.00229685167432362,0.00504921479191645,-0.00759960931783263,0.0121933126664799,0.649195105440177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI2,Protein-arginine deiminase type-2,42370,-0.0024825226004548,0.00549976656735146,-0.0132620650724637,0.00829701987155406,0.651718149776271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00258216306717198,0.00574278447343223,-0.00867369450075518,0.0138380206350991,0.652980301622289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBS,Cystathionine beta-synthase,40223,0.00228134269289079,0.00507590867767778,-0.00766743831535765,0.0122301237011392,0.653119377060492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0038438990009976,0.00856148775946213,-0.0206244150095434,0.0129366170075482,0.653456527629613
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171A2,Protein FAM171A2,40482,0.00704707283721316,0.0158119245586586,-0.0239442992977576,0.0380384449721839,0.65583630757549
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00190156048794307,0.00428107925633498,-0.0102924758303596,0.00648935485447348,0.656922804673786
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00250177290455911,0.00567859769896136,-0.00862827858540516,0.0136318243945234,0.659539022649497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPN3,Calpain-3,40451,-0.00165120335131,0.00377904094146199,-0.0090581235965755,0.00575571689395549,0.662165315173794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00217136545823168,0.00500718321396712,-0.00764271364114387,0.0119854445576072,0.664551146966649
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.00166771256119879,0.00386125424428583,-0.00923577087999902,0.00590034575760144,0.665815711789408
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.00205318278054924,0.00478271002464133,-0.0114272944288462,0.00732092886774776,0.667718547242891
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00202422006033523,0.00472149088010749,-0.0112783421853459,0.00722990206467545,0.668132020181492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO3,R-spondin-3,42721,0.0012528843402669,0.00293180508159878,-0.0044934536196667,0.00699922230020051,0.669136825979364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00123127631713496,0.00288314064820478,-0.0044196793533464,0.00688223198761632,0.669343343900763
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGN,Cingulin,40182,-0.00174083783901841,0.00407862966187378,-0.00973495197629102,0.00625327629825419,0.669519313443148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.0024421536189908,0.00573546972186362,-0.0087993670358619,0.0136836742738435,0.670263197698856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.00239944382184499,0.0056388041735535,-0.00865261235831987,0.0134515000020098,0.6704633976802
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00359910940222817,0.00847454179748801,-0.0130109925208483,0.0202092113253047,0.671066186026701
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELB,Transcription factor RelB,40199,-0.00208427922786951,0.00492218515724167,-0.0117317621360632,0.00756320368032416,0.671978221820047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00157142098313648,0.00375477317287603,-0.0089307764019735,0.00578793443570054,0.675580390879784
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0016959278349306,0.004057539596267,-0.00625684977375273,0.00964870544361393,0.675977329014972
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00150986864085091,0.00361647857395631,-0.00557842936410345,0.00859816664580526,0.67632178435618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.002209805807312,0.00533142444590031,-0.0126593977212766,0.0082397861066526,0.678525654487252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.00160218004977321,0.0038818757762382,-0.00921065657120007,0.00600629647165366,0.679809962612596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASQ2,Calsequestrin-2,40116,0.00199786063674566,0.00486617089306455,-0.00753983431366085,0.0115355555871522,0.681402421856618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTH3,Cytohesin-3,40080,-0.00302324740606452,0.00739818321965842,-0.017523686516595,0.011477191704466,0.682806570807962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00164701588499852,0.00403752554207494,-0.00956056594746541,0.00626653417746836,0.683334969381349
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHDC3L,KH domain-containing protein 3,40080,0.00277747428979479,0.00683643829769266,-0.0106219447736828,0.0161768933532724,0.684548503907896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.00134287499104975,0.00331463953888759,-0.00515381850516992,0.00783956848726942,0.685386487834005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.00148060744581449,0.00365993905924767,-0.00569287311031095,0.00865408800193993,0.685820361252193
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERVV_1,,40116,0.00172200683932312,0.00432458948445609,-0.00675418855021082,0.0101982022288571,0.690498166415543
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00202861264914644,0.00512681677506996,-0.0120771735282836,0.00801994822999069,0.692343931276762
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA2,Carboxypeptidase A2,42670,0.00257154201938056,0.00650662209626701,-0.0101814372893028,0.0153245213280639,0.692687375203374
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGR,Progesterone receptor,40199,0.0038063199228343,0.00968962757099831,-0.0151853501163224,0.022797989961991,0.694456959044573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,0.0011797621032437,0.00303342406514637,-0.00476574906444319,0.00712527327093059,0.697342246759529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00192858229490043,0.00496603283732249,-0.0116620066560525,0.00780484206625166,0.697761000149964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP4,Caspase-4,40302,0.00661584003047925,0.0170942868926527,-0.02688896227912,0.0401206423400785,0.698748421001832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3,Interleukin-3,40080,0.00236507298054683,0.00612052327609472,-0.00963115264059883,0.0143612986016925,0.699195566837658
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDAN1,Codanin-1,40483,0.000850025481222344,0.00223626665115383,-0.00353305715503915,0.00523310811748384,0.703871523207043
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00285898214193423,0.00757405369762284,-0.0119861631054065,0.017704127389275,0.705831069494514
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAG,S-arrestin,40136,-0.00195634494076335,0.00518767792306981,-0.0121241936699802,0.00821150378845348,0.706096348618811
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.00183369455023893,0.00494587519638008,-0.0115276099351439,0.00786022083466601,0.710829017935772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB2,Plexin-B2,42743,-0.000881212259456156,0.00237811910342289,-0.00554232570216502,0.00377990118325271,0.710978450916933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GJA8,Gap junction alpha-8 protein,40080,-0.00238129814808379,0.00646344789078629,-0.0150496560140249,0.0102870597178573,0.712563251081217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDSN,Corneodesmosin,42710,0.00160710011631344,0.00439202061437903,-0.00700126028786946,0.0102154605204963,0.714435267318925
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00191342235349909,0.00525758429392093,-0.0122182875695841,0.00839144286258594,0.715911928913801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00152477656864564,0.00420613418493876,-0.00671924643383432,0.0097687995711256,0.716975983411885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC1A4,Neutral amino acid transporter A,40182,-0.00185348171305082,0.00515746954539597,-0.0119621220220269,0.00825515859592528,0.719319145906188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00076436081951334,0.00212763628696358,-0.00340580630293529,0.00493452794196197,0.719412183587462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR3,Folate receptor gamma,42629,-0.00647745517176181,0.0182831578337942,-0.0423124445259984,0.0293575341824748,0.72313059767212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RYR1,Ryanodine receptor 1,40116,-0.00120571073722669,0.00341786359946672,-0.00790472339218146,0.00549330191772807,0.724269658796024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKZF2,Zinc finger protein Helios,42346,0.00304830127602629,0.00867917442573942,-0.013962880598423,0.0200594831504756,0.72542879155756
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.00130874671924215,0.00374215163557312,-0.00602587048648116,0.00864336392496545,0.72654594450761
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00124691383726397,0.0036072747280282,-0.00831717230419925,0.0058233446296713,0.729600020631192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00164904670019528,0.00477840637560396,-0.011014723196379,0.00771662979598848,0.730022903294128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000965701986190313,0.00281797321554947,-0.00648892948866727,0.00455752551628665,0.731835170525216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPE,Coatomer subunit epsilon,42311,0.0016017126135554,0.00468540159470482,-0.00758167451206605,0.0107850997391768,0.732467958171784
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPEP,Aspartyl aminopeptidase,40483,-0.00192872301749922,0.00564244663536475,-0.0129879184228141,0.00913047238781569,0.732489797859629
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX1B,Syntaxin-1B,40182,0.00136340155133828,0.00401524146734092,-0.00650647172464991,0.00923327482732647,0.734196991456774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.000585299228554121,0.00172574566573014,-0.0039677607333852,0.00279716227627696,0.734496537817986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.00166417546964978,0.00492264709422454,-0.00798421283503032,0.0113125637743299,0.735320617608757
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.00111394771776809,0.00330577813831004,-0.00759327286885578,0.00536537743331959,0.736144965625111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCIN,Adseverin,40136,-0.00242836710006542,0.00721943588373347,-0.016578461432183,0.0117217272320522,0.736601927735939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.000966013534670054,0.00287318427492321,-0.00466542764417944,0.00659745471351955,0.736713645257531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00152462689933748,0.0045680341105126,-0.0104779737559422,0.00742871995726721,0.73856705604651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,42721,0.00198319548767654,0.00594300061818489,-0.00966508572396585,0.0136314766993189,0.738609067356953
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,40511,-0.0011466424999636,0.00344627119997008,-0.00790133405190496,0.00560804905197776,0.739352000932293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFD,Complement factor D,40539,0.000690025129643197,0.00207410902098068,-0.00337522855147893,0.00475527881076532,0.739378158520886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00122277133115074,0.00373047330533124,-0.00608895634729848,0.00853449900959996,0.743084848809366
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JUN,Transcription factor AP-1,42370,0.00152915470509525,0.00472836627554567,-0.00773844319497427,0.0107967526051648,0.746397293543983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBZ,Hemoglobin subunit zeta,40511,0.00338012348172684,0.0105192548045948,-0.0172376159352789,0.0239978628987326,0.747968322945386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.0010921061705352,0.00340268311972474,-0.00776136508519569,0.0055771527441253,0.748251065813174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00166527894901401,0.005216921996582,-0.0118904460623147,0.0085598881642867,0.74957553893297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.000659299939628006,0.00207808200726205,-0.00473234067386163,0.00341374079460562,0.751049541505486
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALLD,Palladin,40199,0.00122384075024815,0.00386096147132196,-0.0063436437335429,0.0087913252340392,0.751266130537069
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.00129985326228653,0.00413905827538291,-0.00681270095746397,0.00941240748203703,0.753492382470298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST7,Cystatin-F,42642,-0.00289130264388399,0.00922845214560609,-0.0209790688492719,0.0151964635615039,0.754055255771988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OBP2B,Odorant-binding protein 2b,42462,0.00187336465159143,0.00606584490364367,-0.0100156913595502,0.013762420662733,0.757449454489834
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB2,Integrin beta-2,42569,0.000871215282373673,0.00282235668313333,-0.00466060381656766,0.00640303438131501,0.757567011512475
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0018934351247624,0.00613733635079901,-0.0139226143723285,0.0101357441228037,0.75769840776365
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00126679396193469,0.00410860333497252,-0.00931965649848083,0.00678606857461145,0.75783924373181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF8,SLAM family member 8,42346,-0.00167661585923613,0.00545732663646106,-0.0123729760666998,0.00901974434822754,0.758678560332318
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM3,Paralemmin-3,40116,0.00216251625175788,0.0070896821713294,-0.0117332608040477,0.0160582933075635,0.760354433595128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2BP,LRP2-binding protein,40182,-0.00257372022957614,0.00854064906256135,-0.0193133923921964,0.0141659519330441,0.763153709440772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.00269438833153116,0.00897238194151966,-0.0148914802738474,0.0202802569369097,0.763955532628145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00110669630170185,0.00371928189362676,-0.0083964888132103,0.00618309620980659,0.766046505074843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00207793913872063,0.0070336661949271,-0.0117080466033365,0.0158639248807778,0.767672823691715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF20,Fibroblast growth factor 20,40199,0.00131156662226736,0.00447072339128019,-0.00745105122464181,0.0100741844691765,0.769246509322202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTN,Neuroplastin,42346,0.00222699277146901,0.00775974617238927,-0.012982109726414,0.017436095269352,0.774122207271109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB116,Beta-defensin 116,40136,0.00218008817097099,0.00762358175745231,-0.0127621320736355,0.0171223084155775,0.774909275682775
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHC1,SHC-transforming protein 1,40080,0.00330621215347466,0.0117012508773032,-0.0196282395660395,0.0262406638729889,0.777525631063002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00124468517000128,0.00443781364288513,-0.00994279991005614,0.00745342957005359,0.779120091471776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00176713786461853,0.00631478801327806,-0.0106098466414065,0.0141441223706435,0.779604629505134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0017767161978466,0.00636129150243319,-0.0106914151469225,0.0142448475426156,0.780018960513046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00159224469799273,0.00571214422284532,-0.00960355797878409,0.0127880473747696,0.780444066058601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,-0.00282755431512859,0.0101821283520526,-0.0227845258851517,0.0171294172548945,0.781249598752762
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00180579439133622,0.00653676380722641,-0.0146178514535,0.0110062626708276,0.782359727355941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00123431443410093,0.00447934724253146,-0.0100138350294626,0.00754520616126074,0.782893751247885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.00203495887431562,0.00741875485606157,-0.0125058006435651,0.0165757183921963,0.783858877820524
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00165331926054643,0.00607348343040981,-0.0135573467841497,0.0102507082630568,0.785458567135999
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.000763559623289304,0.00281453770317197,-0.00628005352150637,0.00475293427492776,0.786172077205262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA1,Ephrin-A1,42590,-0.000804328878881017,0.00298858586143119,-0.00666195716728614,0.00505329940952411,0.787831017985669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00153027407345696,0.0056860913880779,-0.0126750131940897,0.00961446504717573,0.787837953145708
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.000870018478236374,0.00329321139316929,-0.00558467585237544,0.00732471280884818,0.79164201057909
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RA,Interleukin-17 receptor A,42611,0.00114055670079718,0.00433933288150976,-0.00736453574696194,0.0096456491485563,0.792676794320696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00105183274749493,0.0040411058481781,-0.00686873471493415,0.00897240020992402,0.794649266098547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00126751553428561,0.00490956697551127,-0.0108902668062877,0.00835523573771648,0.796278589225019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.0013138756384953,0.00515018411911592,-0.00878048523497191,0.0114082365119625,0.798641119501093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN3,CCN family member 3,42779,-0.000887614565933063,0.00349932943198706,-0.00774630025262771,0.00597107112076158,0.799767671765787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN1,Prorelaxin H1,40482,0.00121288308742418,0.00478717631142186,-0.00816998248296267,0.010595748657811,0.799993987500548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSCA,Prostate stem cell antigen,40449,0.0062278344404297,0.026316841187936,-0.0453531742879248,0.0578088431687842,0.81293399089909
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF174,Zinc finger protein 174,40199,0.00087407769643598,0.00370872841166823,-0.00639502999043376,0.00814318538330572,0.813684416768801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMD,Osteomodulin,42676,0.000971849794753327,0.00415977645664478,-0.00718131206027045,0.00912501164977711,0.815275554774269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.000904037894420255,0.00390008655557591,-0.00674013175450853,0.00854820754334904,0.816698010657016
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNB2,Ephrin-B2,40182,-0.00124773952939386,0.00539996777877585,-0.0118316763757945,0.0093361973170068,0.817269186592472
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB2,Beta-crystallin B2,40483,-0.00185939147926312,0.00807284377085984,-0.0176821652701484,0.0139633823116222,0.817842086773595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00135009448525097,0.00593596791430309,-0.012984591597285,0.0102844026267831,0.8200835265734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00104694431732623,0.00468533249544306,-0.0102301960083946,0.00813630737374217,0.823188277884083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.000662019039961645,0.00298797019110651,-0.00519440253460712,0.00651844061453041,0.824659421266547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00131212147490883,0.00602430188647169,-0.0104955102225757,0.0131197531723934,0.827584631372738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.000708415181526267,0.00326187322998536,-0.00710168671229756,0.00568485634924503,0.828070995423344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",42357,-0.00176270200189945,0.00832377531533772,-0.0180773016199614,0.0145518976161625,0.832291992705462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.000875588311432831,0.00415743263407913,-0.00902415627422793,0.00727297965136227,0.833197123422387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.000860396051296891,0.00415023609509422,-0.00727406669508778,0.00899485879768157,0.835769627041262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.000971310210378587,0.00484923177808802,-0.0104758044954311,0.00853318407467393,0.841248239018987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN1,Neuroligin-1,40182,0.00138484292433909,0.00691591264685201,-0.0121703458634908,0.014940031712169,0.841296525741415
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,40286,-0.00202803228933322,0.0101284716949382,-0.0218798368114122,0.0178237722327457,0.841303727700632
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00121447367419061,0.0062724543450528,-0.0110795368421129,0.0135084841904941,0.846476916415296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPB41L5,Band 4.1-like protein 5,40182,-0.00117016947677276,0.00606480228684551,-0.01305718195899,0.0107168430054444,0.847006098966944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL33,Interleukin-33,42370,-0.000730966673111294,0.00382714646263102,-0.0082321737398681,0.00677024039364551,0.84853228239801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM2,Junctional adhesion molecule B,42711,-0.000535341937668598,0.00280335961655808,-0.00602992678612244,0.00495924291078524,0.848556338445678
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.000635053726069367,0.00336570344960002,-0.00596172503514667,0.0072318324872854,0.850343495053564
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,0.000745081713260888,0.00395191416176887,-0.00700067004380611,0.00849083347032788,0.850459222796151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00325884205981049,0.0173192588159341,-0.0306869052194203,0.0372045893390413,0.850752342417482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEFL,Neurofilament light polypeptide,42262,-0.000856811425003828,0.00456696011549451,-0.00980805325137307,0.00809443040136541,0.851184606223015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRX,Cone-rod homeobox protein,42357,0.00186140146539862,0.0104913465697238,-0.01870163781126,0.0224244407420572,0.859179225599955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP1,Retinol-binding protein 1,40182,-0.00118774457454864,0.00676345437403907,-0.0144441151476652,0.0120686259985679,0.860601914371335
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL25,C-C motif chemokine 25,42754,0.000812097208102394,0.00472178001613258,-0.00844259162351747,0.0100667860397223,0.863448246467593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN1,Calsyntenin-1,42311,0.000891190701704143,0.00524849023348483,-0.00939585015592612,0.0111782315593344,0.865170486018996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPE4,NXPE family member 4,40116,0.000562539639537698,0.00334053542576972,-0.00598490979497095,0.00710998907404634,0.866273263072535
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD5,Sushi domain-containing protein 5,40235,0.000572925750302502,0.00343993533754966,-0.00616934751129484,0.00731519901189984,0.867726154166332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPLX2,Complexin-2,40080,0.000523205712570021,0.00314517888188558,-0.00564134489592571,0.00668775632106575,0.867883306846939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0047035049406276,0.0292119146417153,-0.0525518477571343,0.0619588576383895,0.872085397848993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVPL,Envoplakin,40302,0.000554629298226245,0.00348327827684746,-0.00627259612439478,0.00738185472084727,0.873493526933138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.000577834265874841,0.00367246512565194,-0.00777586591215264,0.00662019738040296,0.874977942274347
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENG,Endoglin,42794,-0.000269230353152977,0.00171490041390729,-0.00363043516441126,0.00309197445810531,0.875251320117359
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.00103388277291763,0.00666505658619364,-0.0140973936818572,0.0120296281360219,0.876729659706559
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRN1,Neuritin,40482,0.000553100840261105,0.00359674780593898,-0.00649652485937929,0.0076027265399015,0.877787495663486
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAP1,Antigen peptide transporter 1,40302,-0.00093556432998193,0.00609733856705592,-0.0128863479214115,0.0110152192614477,0.878055551454865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.000553966905883623,0.00361892112729092,-0.00653911850360659,0.00764705231537383,0.878341753471799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.000740173125907559,0.00498549207420459,-0.0105117375913486,0.00903139133953344,0.881977764223317
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000505379959459512,0.0034260708595853,-0.0072204788442467,0.00620971892532768,0.882732162141764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB5,Integrin beta-5,42679,0.000539947169959004,0.00366608022844508,-0.00664557007779334,0.00772546441771135,0.882911739942218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.000431209532636051,0.00300614999509209,-0.00546084445774444,0.00632326352301654,0.885942901150051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.000631473578842774,0.00441346557380497,-0.00928186610350051,0.00801891894581496,0.886230503516689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRAXIN,Draxin,42495,-0.000618632863924467,0.00433115010280522,-0.00910768706542269,0.00787042133757376,0.886423927344989
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAND5,DAN domain family member 5,40199,-0.000777451185261858,0.00549108820458917,-0.0115399840662566,0.00998508169573292,0.887411060265765
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA8,Carbonic anhydrase-related protein,40199,-0.000400191196234786,0.00283710960121593,-0.005960926014618,0.00516054362214843,0.88782832245461
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.000544796917591634,0.00387679516241978,-0.00814331543593441,0.00705372160075114,0.888245255032566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.000372859043276477,0.0026840028549287,-0.00488778655238377,0.00563350463893673,0.889516610127259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC9,Histone deacetylase 9,40136,0.000898922101389095,0.0064971980765298,-0.0118355861286093,0.0136334303313875,0.889962130590249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36A,Interleukin-36 alpha,40199,0.000773197742953374,0.00570309998393162,-0.0104048782255526,0.0119512737114593,0.892159754844147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL6B,Myosin light chain 6B,40182,-0.00118951352797465,0.00900221005268918,-0.0188338452312454,0.0164548181752961,0.894879360653626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY6D,Lymphocyte antigen 6D,42548,-0.000528743730969838,0.0040219445797502,-0.00841175510728022,0.00735426764534055,0.895409691239824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.000434403038279803,0.00331704553431992,-0.00693581228554684,0.00606700620898724,0.895808681724659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BEX3,Protein BEX3,40080,-0.000600313901874099,0.00473531678935924,-0.00988153480901822,0.00868090700527002,0.89912180805643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.00036277721501265,0.00288858481549859,-0.00529884902336459,0.00602440345338989,0.900058401470134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.000527259310650622,0.00422421201640591,-0.00880671486280621,0.00775219624150496,0.900669638890229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.000494336160449815,0.00397518703791178,-0.0082857027547569,0.00729703043385727,0.901036118915458
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.000894307457292074,0.00736645861363707,-0.0153325663400207,0.0135439514254366,0.903374288400971
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDNRB,Endothelin receptor type B,40199,0.000521638143390274,0.00441683260624627,-0.00813535376485242,0.00917863005163297,0.905988746819328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.000331985114069201,0.00285536451015765,-0.00526452932583979,0.00592849955397819,0.907442530571089
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.000524052483513698,0.00456111286102697,-0.00841572872409917,0.00946383369112656,0.908529507656117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.00086786508906258,0.00776704098367308,-0.0143555352389367,0.0160912654170618,0.911034069320155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSPN,Claspin,42292,0.000378228401069484,0.00346455768083634,-0.00641230465336975,0.00716876145550871,0.913068722811782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.000676577586378857,0.00619775731936464,-0.0128241819323335,0.0114710267595758,0.913073697786772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA4,Apolipoprotein A-IV,40539,0.000389545441440361,0.0035687795755768,-0.00660526252669016,0.00738435340957088,0.913082525273983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,40116,-0.000516783934300707,0.00481941555206146,-0.00996283841634117,0.00892927054773976,0.91460881402296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,40080,0.00044358872889366,0.00417414593175294,-0.00773773729734211,0.00862491475512943,0.915369665551621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20,Interleukin-20,42370,0.000515641741250231,0.0048557365211664,-0.00900160184023592,0.0100328853227364,0.915431411127356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00100399147265602,0.00947837492793099,-0.0195816063314008,0.0175736233860887,0.915644255104203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.000747787436633284,0.00726148863115651,-0.0134847302804335,0.0149803051537,0.917980803822694
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLFM4,Olfactomedin-4,39870,-0.00124104829087274,0.0122128457419815,-0.0251782259451565,0.022696129363411,0.919061583243053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD8,Frizzled-8,40136,0.00045883264798495,0.00453000948247119,-0.00841998593765858,0.00933765123362847,0.919324215015427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.000277705517696599,0.00278887956411314,-0.00574390946335836,0.00518849842796516,0.920682415344784
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.000724267992089541,0.00736042314272505,-0.0137021613676516,0.0151506973518306,0.921615889816859
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.000729116939185591,0.00762557575359262,-0.0156752454162271,0.014217011537856,0.92382835409533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.000757299299465267,0.00802846505566694,-0.0164930908085725,0.0149784922096419,0.924851274524019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.000322412651613265,0.00347426560268259,-0.00648714792964461,0.00713197323287114,0.926063655272025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REST,RE1-silencing transcription factor,40080,0.000314822638914949,0.00339774647022343,-0.00634476044272298,0.00697440572055287,0.926178314873125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,0.000504665900159889,0.00550286536769524,-0.0102809502205228,0.0112902820208426,0.926930411321979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.000218304150598372,0.00249962986346611,-0.00468097038179521,0.00511757868299195,0.930407102765964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANK2,Ankyrin-2,40116,0.000630329152674208,0.00729608620770874,-0.0136699998144349,0.0149306581197833,0.931155771801198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN1,Contactin-1,42794,-0.000233114062930027,0.00274481555715675,-0.00561295255495725,0.0051467244290972,0.932319195860958
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.000188747925555845,0.00229681342706737,-0.0043130063914962,0.00469050224260789,0.934506248861931
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON1,Spondin-1,42638,0.000272194114501665,0.00333909205865019,-0.0062724263204527,0.00681681454945603,0.935031698462572
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN2,Nectin-2,42613,0.000252736174576735,0.00310884044642493,-0.00584059110041612,0.00634606344956959,0.935207797688987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.00025837051629307,0.00319900421816891,-0.006011677751318,0.00652841878390414,0.935629344197907
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.000344058580976329,0.0043432858364875,-0.00816878165853918,0.00885689882049184,0.936862071045351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.000484815144150179,0.00622781155169322,-0.0126913257854689,0.0117216954971685,0.937951327660999
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF75D,Zinc finger protein 75D,40302,-0.000467605657906599,0.00607161922776366,-0.0123679793443234,0.0114327680285102,0.938613011892498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.000295018527886554,0.00395845922661183,-0.00805359861204575,0.00746356155627264,0.940591115757022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000266914197555788,0.00373927931511043,-0.00759590165517224,0.00706207326006066,0.943095688632831
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.000445261985404266,0.00645421682871995,-0.0130955269696954,0.0122050029988868,0.945000406322297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.000321008950267726,0.00474315924394003,-0.00897558316785473,0.00961760106839018,0.946042733749019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RUVBL1,RuvB-like 1,42346,-0.000698243602721018,0.0104271863049618,-0.0211355287604461,0.019739041555004,0.94661157150197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXK,Tyrosine-protein kinase TXK,40302,-0.000483119822434562,0.0074254257605172,-0.0150369543130483,0.0140707146681792,0.948125080629273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.000219575993766346,0.00359268572260708,-0.00726124001007622,0.00682208802254352,0.95126674514354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR1,Toll-like receptor 1,40199,-0.00014892214493344,0.00265200165075909,-0.00534684538042125,0.00504900109055437,0.955219651497954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.000216356533428904,0.00401638818444701,-0.00808847737494505,0.00765576430808724,0.957040936898096
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00022491659263076,0.0043436752229824,-0.00873852002967626,0.00828868684441473,0.958704723055088
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.000283022374949031,0.00597759482443208,-0.0114330634809378,0.0119991082308359,0.962237376113843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2,T-cell surface antigen CD2,40116,-0.000176554696036303,0.00381733519250157,-0.00765853167333937,0.00730542228126677,0.963111221872025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.000144600747351409,0.00339860377608032,-0.00680586414846884,0.00651666265376602,0.966063195504113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAGLN3,Transgelin-3,40080,0.00019598694629025,0.00607142655219291,-0.0117040090960079,0.0120959829885883,0.974249179989897
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,-8.16446943660417e-05,0.00285284255944534,-0.0056732161108789,0.00550992672214681,0.977169106482089
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF7,Fibroblast growth factor 7,40080,-0.000123878254011454,0.00785315133187323,-0.015516054864483,0.0152682983564601,0.987414711236649
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-2.44717540601123e-05,0.00249763397495485,-0.00491983434497161,0.00487089083685139,0.992182652021276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,9.21794044883024e-05,0.00953601074683192,-0.0185984016593023,0.0187827604682789,0.992287583234491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,2.28569150061614e-05,0.00472428334980811,-0.00923673845061773,0.00928245228063006,0.996139797664578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,1.12560516904179e-05,0.00278338097914137,-0.00544417066742667,0.00546668277080751,0.996773406547628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD7,T-cell antigen CD7,40166,1.0870964376347e-05,0.00442592869785946,-0.00866394928342819,0.00868569121218089,0.99804028287055
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,9.00842219756823e-06,0.00529502449034878,-0.010369239578886,0.0103872564232812,0.998642590699007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP15,Matrix metalloproteinase-15,40511,-7.83115135209466e-06,0.00483132090688356,-0.00947722012884388,0.00946155782613969,0.99870672759841
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,-3.45143888677159e-06,0.00232989698026537,-0.00457004952020689,0.00456314664243335,0.998818060602395
